<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Redox Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Redox Biol</journal-id>
<journal-title-group>
<journal-title>Redox Biology</journal-title>
</journal-title-group>
<issn pub-type="epub">2213-2317</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32336668</article-id>
<article-id pub-id-type="pmc">7327986</article-id>
<article-id pub-id-type="publisher-id">S2213-2317(19)31511-3</article-id>
<article-id pub-id-type="doi">10.1016/j.redox.2020.101475</article-id>
<article-id pub-id-type="publisher-id">101475</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles from the Special Issue on Impact of environmental pollution and stress on redox signaling and oxidative stress pathways; Edited by Thomas Münzel and Andreas Daiber</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Redox toxicology of environmental chemicals causing oxidative stress</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="au1">
<name>
<surname>Zheng</surname>
<given-names>Fuli</given-names>
</name>
<email>f.zheng@fjmu.edu.cn</email>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
<contrib contrib-type="author" id="au2">
<name>
<surname>Gonçalves</surname>
<given-names>Filipe Marques</given-names>
</name>
<xref ref-type="aff" rid="aff2">b</xref>
</contrib>
<contrib contrib-type="author" id="au3">
<name>
<surname>Abiko</surname>
<given-names>Yumi</given-names>
</name>
<xref ref-type="aff" rid="aff3">c</xref>
</contrib>
<contrib contrib-type="author" id="au4">
<name>
<surname>Li</surname>
<given-names>Huangyuan</given-names>
</name>
<email>lhy@fjmu.edu.cn</email>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="corresp" rid="cor2">∗∗</xref>
</contrib>
<contrib contrib-type="author" id="au5">
<name>
<surname>Kumagai</surname>
<given-names>Yoshito</given-names>
</name>
<email>yk-em-tu@md.tsukuba.ac.jp</email>
<xref ref-type="aff" rid="aff3">c</xref>
<xref ref-type="corresp" rid="cor3">∗∗∗</xref>
</contrib>
<contrib contrib-type="author" id="au6">
<name>
<surname>Aschner</surname>
<given-names>Michael</given-names>
</name>
<email>michael.aschner@einsteinmed.org</email>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="corresp" rid="cor4">∗∗∗∗</xref>
</contrib>
<aff id="aff1"><label>a</label>Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou, Fujian, 350122, China</aff>
<aff id="aff2"><label>b</label>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer 209, 1300 Morris Park Avenue, Bronx, NY, 10461, United States</aff>
<aff id="aff3"><label>c</label>Environmental Biology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, 305-8575, Japan</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author. Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou, Fujian, 350122, China. <email>f.zheng@fjmu.edu.cn</email></corresp>
<corresp id="cor2"><label>∗∗</label>Corresponding author. <email>lhy@fjmu.edu.cn</email></corresp>
<corresp id="cor3"><label>∗∗∗</label>Corresponding author. <email>yk-em-tu@md.tsukuba.ac.jp</email></corresp>
<corresp id="cor4"><label>∗∗∗∗</label>Corresponding author. <email>michael.aschner@einsteinmed.org</email></corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>4</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>4</month>
<year>2020</year>
</pub-date>
<volume>34</volume>
<elocation-id>101475</elocation-id>
<history>
<date date-type="received">
<day>4</day>
<month>12</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>18</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 The Authors</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0010">
<p>Living organisms are surrounded with heavy metals such as methylmercury, manganese, cobalt, cadmium, arsenic, as well as pesticides such as deltamethrin and paraquat, or atmospheric pollutants such as quinone. Extensive studies have demonstrated a strong link between environmental pollutants and human health. Redox toxicity is proposed as one of the main mechanisms of chemical-induced pathology in humans. Acting as both a sensor of oxidative stress and a positive regulator of antioxidants, the nuclear factor erythroid 2-related factor 2 (NRF2) has attracted recent attention. However, the role NRF2 plays in environmental pollutant-induced toxicity has not been systematically addressed. Here, we characterize NRF2 function in response to various pollutants, such as metals, pesticides and atmospheric quinones. NRF2 related signaling pathways and epigenetic regulations are also reviewed.</p>
</abstract>
<abstract abstract-type="graphical" id="abs0015">
<title>Graphical abstract</title>
<p>
<fig id="undfig1" position="anchor">
<alt-text id="alttext0010">Image 1</alt-text>
<graphic xlink:href="fx1"></graphic>
</fig>
</p>
</abstract>
<abstract abstract-type="author-highlights" id="abs0020">
<title>Highlights</title>
<p>
<list id="ulist0010" list-type="simple">
<list-item id="u0010">
<label>•</label>
<p id="p0010">Environmental chemicals cause redox toxicity via oxidative stress.</p>
</list-item>
<list-item id="u0015">
<label>•</label>
<p id="p0015">NRF2 acts as a sensor of oxidative stress and a positive regulator of antioxidants.</p>
</list-item>
<list-item id="u0020">
<label>•</label>
<p id="p0020">NRF2 responds to metals, pesticides and atmospheric pollutants.</p>
</list-item>
<list-item id="u0025">
<label>•</label>
<p id="p0025">NRF2 and related pathways can be epigenetically regulated.</p>
</list-item>
</list>
</p>
</abstract>
<kwd-group id="kwrds0010">
<title>Keywords</title>
<kwd>NRF2</kwd>
<kwd>Heavy metals</kwd>
<kwd>Pesticides</kwd>
<kwd>Air pollutants</kwd>
<kwd>Epigenetic modifications</kwd>
<kwd>Redox signaling pathways</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="nomen0010">
<title>Abbreviations</title>
<def-list>
<def-item>
<term id="d0010">9,10-PQ</term>
<def>
<p id="p0030">9,10- phenanthraquinone</p>
</def>
</def-item>
<def-item>
<term id="d0015">ARE</term>
<def>
<p id="p0035">antioxidant response elements</p>
</def>
</def-item>
<def-item>
<term id="d0020">As</term>
<def>
<p id="p0040">Arsenic</p>
</def>
</def-item>
<def-item>
<term id="d0025">Cd</term>
<def>
<p id="p0045">Cadmium</p>
</def>
</def-item>
<def-item>
<term id="d0030">Co</term>
<def>
<p id="p0050">cobalt</p>
</def>
</def-item>
<def-item>
<term id="d0035">CoNPs</term>
<def>
<p id="p0055">cobalt nanoparticles</p>
</def>
</def-item>
<def-item>
<term id="d0040">DEP</term>
<def>
<p id="p0060">diesel exhaust particles</p>
</def>
</def-item>
<def-item>
<term id="d0045">GSH</term>
<def>
<p id="p0065">glutathione</p>
</def>
</def-item>
<def-item>
<term id="d0050">GSK-3</term>
<def>
<p id="p0070">glycogen synthase kinase-3</p>
</def>
</def-item>
<def-item>
<term id="d0055">HO-1</term>
<def>
<p id="p0075">heme oxygenase 1</p>
</def>
</def-item>
<def-item>
<term id="d0060">HSPs</term>
<def>
<p id="p0080">heat shock proteins</p>
</def>
</def-item>
<def-item>
<term id="d0065">KEAP1</term>
<def>
<p id="p0085">kelch-like ECH-associated protein 1</p>
</def>
</def-item>
<def-item>
<term id="d0070">LncRNA</term>
<def>
<p id="p0090">long noncoding RNA</p>
</def>
</def-item>
<def-item>
<term id="d0075">MeHg</term>
<def>
<p id="p0095">methylmercury</p>
</def>
</def-item>
<def-item>
<term id="d0080">miRNA</term>
<def>
<p id="p0100">microRNAs</p>
</def>
</def-item>
<def-item>
<term id="d0085">Mn</term>
<def>
<p id="p0105">manganese</p>
</def>
</def-item>
<def-item>
<term id="d0090">NOS</term>
<def>
<p id="p0110">nitric oxide synthase</p>
</def>
</def-item>
<def-item>
<term id="d0095">NQO-1</term>
<def>
<p id="p0115">NAD(P)H dehydrogenase (quinone 1)</p>
</def>
</def-item>
<def-item>
<term id="d0100">NRF2</term>
<def>
<p id="p0120">nuclear factor erythroid 2-related factor 2</p>
</def>
</def-item>
<def-item>
<term id="d0105">PD</term>
<def>
<p id="p0125">Parkinson's disease</p>
</def>
</def-item>
<def-item>
<term id="d0110">PI3K</term>
<def>
<p id="p0130">phosphatidyl inositol 3′ kinase</p>
</def>
</def-item>
<def-item>
<term id="d0115">PTPs</term>
<def>
<p id="p0135">protein tyrosine phosphatases</p>
</def>
</def-item>
<def-item>
<term id="d0120">ROS</term>
<def>
<p id="p0140">reactive oxygen species</p>
</def>
</def-item>
</def-list>
</sec>
<sec id="sec1">
<label>1</label>
<title>Introduction</title>
<p id="p0145">We are exposed on a daily basis to a variety of environmental chemicals, such as pesticides, heavy metals and air pollutants in our living environment. Evidence from epidemiological findings, cultured cells and animal studies has indicated strong association among many of these toxicants and the onset of a plethora of pathological diseases, such as neurodegenerative/psychiatric disorders and cardiovascular diseases [<xref ref-type="bibr" rid="bib1">[1]</xref>, <xref ref-type="bibr" rid="bib2">[2]</xref>, <xref ref-type="bibr" rid="bib3">[3]</xref>, <xref ref-type="bibr" rid="bib4">[4]</xref>, <xref ref-type="bibr" rid="bib5">[5]</xref>]. Informative reviews on health impact of environmental chemicals are available, including metals [<xref ref-type="bibr" rid="bib6">[6]</xref>, <xref ref-type="bibr" rid="bib7">[7]</xref>, <xref ref-type="bibr" rid="bib8">[8]</xref>], pesticides [<xref ref-type="bibr" rid="bib9">9</xref>], endocrine-disrupting chemicals [<xref ref-type="bibr" rid="bib10">10</xref>,<xref ref-type="bibr" rid="bib11">11</xref>] and air pollutants [<xref ref-type="bibr" rid="bib12">12</xref>]. However, intracellular mechanisms associated with the toxic effects of these compounds have yet to be fully understood. Yet, generation of reactive oxygen/nitrogen species (ROS/RNS) and imbalance in the antioxidant defense system represent a common toxic mechanism for many compounds [<xref ref-type="bibr" rid="bib13">[13]</xref>, <xref ref-type="bibr" rid="bib14">[14]</xref>, <xref ref-type="bibr" rid="bib15">[15]</xref>, <xref ref-type="bibr" rid="bib16">[16]</xref>, <xref ref-type="bibr" rid="bib17">[17]</xref>]. Under homeostatic conditions, free radicals are produced in a controlled manner to fine-tune signaling pathways associated with cell division, inflammation, autophagy and stress response [<xref ref-type="bibr" rid="bib18">18</xref>,<xref ref-type="bibr" rid="bib19">19</xref>]. However, exacerbated production of oxidants and induction of oxidative stress impaire a wide range of biochemical pathways, leading to pathological consequences [<xref ref-type="bibr" rid="bib20">20</xref>,<xref ref-type="bibr" rid="bib21">21</xref>]. Environmental toxicants such as heavy metals, pesticides and air pollutants have been demonstrated to generate ROS/RNS, in turn, disrupting circadian rhythms with ensuing pathogenesis [<xref ref-type="bibr" rid="bib22">[22]</xref>, <xref ref-type="bibr" rid="bib23">[23]</xref>, <xref ref-type="bibr" rid="bib24">[24]</xref>, <xref ref-type="bibr" rid="bib25">[25]</xref>].</p>
<p id="p0150">The concept of exposome has been recently introduced, referring to lifelong total exposures one receives, both externally (such as environmental toxicants from air or water, life-style related factors) and internally, first proposed by Wild in 2005 [<xref ref-type="bibr" rid="bib26">26</xref>]. Oxidative stress along with other endogenous processes, such as inflammation, gut flora and epigenetic modifications, are considered to be the internal expoures [<xref ref-type="bibr" rid="bib27">27</xref>]. Using population-based cohort studies, starting with blood samples and in combination with biomarker technologies, the exposome framework has been advanced, aiming to provide an integrated approach to epidemiological data [<xref ref-type="bibr" rid="bib28">28</xref>]. In practice, by undertaking exposome-wide association studies (EWAS), the relationship between external exposures and biological samples (molecular features) can be linked to decipher disease risks [<xref ref-type="bibr" rid="bib29">29</xref>]. Here, we discuss the link between external environmental toxicants and internal biological responses, focusing on the oxidative stress aspect.</p>
<p id="p0155">The nuclear transcription factor erythroid 2-related factor 2 (NRF2 or NFE2L2) has emerged as an important regulator of oxidative stress and as a target for various intracellular signaling pathways involved in cellular response to a wide range of toxicants [<xref ref-type="bibr" rid="bib21">21</xref>,<xref ref-type="bibr" rid="bib30">30</xref>]. Accordingly, the present review provides state-of-the-art synopsis on the mechanisms associated to NRF2 activation in response to environmental toxicants. Considerable attention is directed to the effects of heavy metals, pesticides and air pollutant exposures on NRF2 activation, as well as its epigenetic modifications.</p>
</sec>
<sec id="sec2">
<label>2</label>
<title>Activation of redox signaling pathways by environmental pollutants</title>
<p id="p0160">In cells, a variety of redox signaling pathways consist of effector molecules (e.g., kinases and transcription factors) that are negatively regulated by sensor proteins with thiolate ions under normal conditions [<xref ref-type="bibr" rid="bib31">[31]</xref>, <xref ref-type="bibr" rid="bib32">[32]</xref>, <xref ref-type="bibr" rid="bib33">[33]</xref>, <xref ref-type="bibr" rid="bib34">[34]</xref>]. The current consensus is that such cellular signaling can be activated through modification of the thiol groups of sensor proteins under oxidative stress [<xref ref-type="bibr" rid="bib31">[31]</xref>, <xref ref-type="bibr" rid="bib32">[32]</xref>, <xref ref-type="bibr" rid="bib33">[33]</xref>, <xref ref-type="bibr" rid="bib34">[34]</xref>] (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). It should be noted that not only oxidant stress but also electrophilic stress is categorized as “oxidative stress” because of the modification of protein thiols in either case. First, we would like to provide well-known examples of the signaling activated by ROS and electrophiles besides NRF2.<fig id="fig1"><label>Fig. 1</label><caption><p><bold>Scheme illustration of the activation of redox signaling pathways.</bold> Redox signaling pathways are composed of sensor proteins with deprotonated thiol groups (S) and their targeted effector molecules. Under basal condition, the effector molecules are suppressed by the sensor proteins. When electrophiles (E) or reactive oxygen species (ROS) are present, the sensor proteins are inhibited by <italic>S</italic>-modification, resulting in activation of the effector molecules. This activation of effector molecules such as transcription factors or kinases leads to the activation of redox signaling pathways.</p></caption><alt-text id="alttext0015">Fig. 1</alt-text><graphic xlink:href="gr1"></graphic></fig></p>
<sec id="sec2.1">
<label>2.1</label>
<title>PTP1B/EGFR signaling</title>
<p id="p0165">The protein tyrosine phosphatase 1B (PTP1B) is a member of the family of Cys-based protein tyrosine phosphatases (PTPs), which have HCX5R(S/T) motifs in their active sites [<xref ref-type="bibr" rid="bib35">35</xref>]. Because PTPs have a reactive thiol with low p<italic>K</italic>a at their active site [<xref ref-type="bibr" rid="bib35">35</xref>], the thiol in PTPs is readily oxidized by endogenous H<sub>2</sub>O<sub>2</sub> generated by epidermal growth factor (EGF)-mediated activation of NADPH oxidases (<xref ref-type="fig" rid="fig1">Fig. 1</xref>) [<xref ref-type="bibr" rid="bib36">36</xref>]. Once the PTP activity is inhibited by <italic>S</italic>-modification at the active site, the EGF receptor (EGFR) will escape dephosphorylation by PTPs such as PTP1B and phosphorylate, leading to activation of EGFR downstream cascades [<xref ref-type="bibr" rid="bib37">37</xref>,<xref ref-type="bibr" rid="bib38">38</xref>]. These findings suggest that ROS derived from environmental pollutants are able to oxidize PTP1B and thereby activate EGFR, which is involved in cell survival and proliferation. A recent study shows that 9,10-PQ-derived H<sub>2</sub>O<sub>2</sub> activates PTP1B/EGFR/ERK signaling through S-oxidation at Cys121, which is the same modification as that performed by endogenous H<sub>2</sub>O<sub>2</sub>, in A431 cells (Luong et al., unpublished). 1,2-Naphthoquinone (1,2-NQ, <xref ref-type="fig" rid="fig2">Fig. 2</xref>), also an environmental pollutant especially common in the vapor phase of ambient air samples [<xref ref-type="bibr" rid="bib39">39</xref>], covalently modifies Cys121 and Cys215 on the 37-kDa recombinant human PTP1B [<xref ref-type="bibr" rid="bib40">40</xref>]. <italic>In vitro</italic> experiments with its C121S mutant indicate that 1,2-NQ is covalently bound to Cys121, leading to inhibition of its enzymatic activity. Cys121 is not in the active site of PTP1B, but is located only about 8 Å from Cys215, which is in the active site, and allosterically inhibits the enzyme activity [<xref ref-type="bibr" rid="bib41">41</xref>,<xref ref-type="bibr" rid="bib42">42</xref>]. This finding is consistent with the hypothesis that other environmental electrophiles may also modify, not only Cys215, but also Cys121, resulting in diminished PTP activity, thereby activating substantial EGFR signaling. Yoshida et al. reports that an environmental electrophile, methylmercury, causes inhibition of PTP1B activity and induction of COX-2 through activation of EGFR/p38 MAPK signaling in human brain microvascular endothelial cells [<xref ref-type="bibr" rid="bib43">43</xref>], suggesting that covalent modification of PTP1B Cys215 and/or Cys121 may participate in the EGFR activation mediated by MeHg exposure because of its high association constant for thiols (1015–1016) [<xref ref-type="bibr" rid="bib44">44</xref>].<fig id="fig2"><label>Fig. 2</label><caption><p><bold>Structures of a variety of chemicals that serve as ROS generators and modifying agents in the environment.</bold> The ROS generators in pink circle are redox active and thus cause redox cycle reaction associated with ROS production. The modifying agents cause covalent binding to nucleophiles such as protein cysteine residues. 1,2-Naphthoquinone and 1,4-naphthoquinone, however, can generate ROS by both redox cycling and direct protein modification.</p></caption><alt-text id="alttext0020">Fig. 2</alt-text><graphic xlink:href="gr2"></graphic></fig></p>
</sec>
<sec id="sec2.2">
<label>2.2</label>
<title>PTEN/Akt signaling</title>
<p id="p0170">The phosphatase and tensin homolog deletion from chromosome 10 (PTEN) is associated with PTEN hamartoma tumor syndrome, many types of tumor and Cowden's disease [<xref ref-type="bibr" rid="bib45">45</xref>]. PTEN dephosphorylates phosphatidylinositol 3,4,5-triphosphate, which is formed from phosphatidylinositol 4,5-diphosphate by the kinase activity of PI3K (phosphatidyl inositol 3′ kinase), back to phosphatidylinositol 4,5-diphosphate [<xref ref-type="bibr" rid="bib46">46</xref>]. Akt binds to phosphatidylinositol 3,4,5-triphosphate on the cellular membrane through the N-terminal pleckstrin homology (PH) domain and is then activated by phosphorylation of Ser473 or Thy308 by mTORC2 or PDK1, respectively, leading to activation of the downstream cascade [<xref ref-type="bibr" rid="bib47">[47]</xref>, <xref ref-type="bibr" rid="bib48">[48]</xref>, <xref ref-type="bibr" rid="bib49">[49]</xref>, <xref ref-type="bibr" rid="bib50">[50]</xref>]. In basal conditions, PTEN negatively regulates PI3K/Akt signaling through dephosphorylation of phosphatidylinositol 3,4,5-triphosphate, resulting in reduced cell survival [<xref ref-type="bibr" rid="bib51">51</xref>]. PTEN has 10 Cys residues in both mice and humans, including reactive Cys124 in its phosphatase domain, like PTPs [<xref ref-type="bibr" rid="bib46">46</xref>], and Cys71 and Cys83 located near basic amino acids [<xref ref-type="bibr" rid="bib52">52</xref>] (suggesting that the thiols of these cysteine residues potentially undergo deprotonation by the basic amino acid effect, leading to formation of thiolate ions). Through these cysteines, the phosphatase may be a target for chemical modification. Supporting this concept, a recent <italic>in vitro</italic> experiment has demonstrated that H<sub>2</sub>O<sub>2</sub> reversibly inactivates PTEN by oxidation to form a disulfide bond between Cys71 and Cys124 [<xref ref-type="bibr" rid="bib53">53</xref>]. This result suggests that H<sub>2</sub>O<sub>2</sub>-derived from redox cycling of environmental chemicals such as 9,10-PQ or paraquat (<xref ref-type="fig" rid="fig2">Fig. 2</xref>), inhibits PTEN, leading to activation of its downstream cascade (see <xref ref-type="fig" rid="fig1">Fig. 1</xref>). Mild oxidants such as NO are reported to activate Akt signaling by <italic>S</italic>-nitrosylation at PTEN Cys83, while the alcohol-induced 4-hydroxy-2-nonenal (HNE) phosphorylates Akt, presumably through covalent modification of PTEN Cys71 <italic>in vivo</italic> [<xref ref-type="bibr" rid="bib54">54</xref>,<xref ref-type="bibr" rid="bib55">55</xref>]. Kumagai and his colleague have reported that 1,4-NQ, a structural isomer of 1,2-NQ (<xref ref-type="fig" rid="fig2">Fig. 2</xref>), covalently modifies Cys71 and Cys81 of recombinant human PTEN and activates PTEN/Akt/cAMP response element-binding protein (CREB) signaling in mouse primary hepatocytes, while an excess concentration of 1,4-NQ disrupts the signal cascade via non-specific protein modification [<xref ref-type="bibr" rid="bib56">56</xref>]. Interestingly, the 1,4-NQ-mediated activation of Akt/CREB signaling at lower concentration, and disruption of the signaling at higher concentration, are markedly suppressed by simultaneous exposure to a model of a highly nucleophilic polysulfide, Na<sub>2</sub>S<sub>4</sub>, through formation of 1,4-NQ–sulfur adducts without electrophilicity [<xref ref-type="bibr" rid="bib56">56</xref>]. 2-NQ, is also classified as a class III inducer, modified KEAP1 through not only Cys151, Cys273, and Cys288, but also Cys257 and Cys489 [<xref ref-type="bibr" rid="bib57">57</xref>,<xref ref-type="bibr" rid="bib58">58</xref>]. It is also found that MeHg (up to 2 μM) activates Akt/CREB signaling and upregulates BCL-2, at least in part through <italic>S</italic>-mercuration of PTEN in human neuroblastoma SH-SY5Y cells; however, exposure to over 5 μM of MeHg modifies not only PTEN, but also CREB, resulting in disruption of the signaling [<xref ref-type="bibr" rid="bib59">59</xref>].</p>
</sec>
<sec id="sec2.3">
<label>2.3</label>
<title>HSP90/HSF1 signaling</title>
<p id="p0175">Heat shock proteins (HSPs), also known as chaperons, are upregulated in response to various stresses such as heat, oxidants, or electrophiles [<xref ref-type="bibr" rid="bib60">60</xref>]. In basal conditions, HSP90 and HSP70 interact with a transcriptional factor, heat shock factor 1 (HSF1), to negatively regulate the transactivation capacity [<xref ref-type="bibr" rid="bib61">61</xref>]. An endogenous electrophile, HNE, modifies Cys572 of HSP90α [<xref ref-type="bibr" rid="bib62">62</xref>] and Cys267 of HSP72, which is a cytosolic variant of HSP70 [<xref ref-type="bibr" rid="bib63">63</xref>]. HSP90α and HSP90β show high homology (although at least 99 of the 732 amino acids in hHSP90α are different from hHSP90β) [<xref ref-type="bibr" rid="bib64">64</xref>]. Using recombinant hHSP90β, Cd or 1,4-NQ binds to both Cys412 and Cys564 (which correspond respectively to Cys420 and Cys572 of hHSP90α), rather than to the other four Cys residues of hHSP90β (Cys366, Cys512, Cys589, and Cys590) [<xref ref-type="bibr" rid="bib56">56</xref>,<xref ref-type="bibr" rid="bib65">65</xref>,<xref ref-type="bibr" rid="bib66">66</xref>]. Exposure of bovine aortic endothelial cells (BAECs) or A431 cells to Cd or 1,4-NQ, respectively, also modifies cellular HSP90 and disrupted the interaction of HSP90 with HSF1, leading to nuclear translocation of HSF1 to upregulate HSPs such as HSP90 and HSP70 [<xref ref-type="bibr" rid="bib56">56</xref>,<xref ref-type="bibr" rid="bib65">65</xref>]. Sulfoxythiocarbamate inhibits the chaperon activity of HSP90 through binding at Cys412, Cys564, and Cys589 or Cys590, resulting in destabilization of client oncoproteins, such as CDK1, CHK1, HER2, mutant p53, and RAF1 and inhibition of cell proliferation [<xref ref-type="bibr" rid="bib67">67</xref>]. Because Cys412 and Cys564 are next to Lys411 and Lys565, the p<italic>K</italic>a of these Cys residues is lowered by the proximal basic amino acids, and these Cys can be preferable targets for electrophiles. 6-Methylsulfinylhexyl isothiocyanate (6-HITC), contained in edible plants such as wasabi, appears to modify Cys521, but not Cys412 and Cys564, suggesting that the hydrophobic pocket near Cys521 provides a suitable environment for 6-HITC binding [<xref ref-type="bibr" rid="bib68">68</xref>]. Taken together, it is suggested that electrophilic modification of HSPs such as HSP90 leads to activation of HSF1 (see <xref ref-type="fig" rid="fig1">Fig. 1</xref>).</p>
</sec>
</sec>
<sec id="sec3">
<label>3</label>
<title>NRF2 signaling pathway</title>
<p id="p0180">NRF2 is a transcription factor encoded by the <italic>nfe2l2</italic> gene in humans, that belongs to the cap n collar family due the basic leucine zipper in its structure [<xref ref-type="bibr" rid="bib13">13</xref>,<xref ref-type="bibr" rid="bib30">30</xref>,<xref ref-type="bibr" rid="bib69">69</xref>]. NRF2 is first described as a homolog of the nuclear factor-erythroid 2 p45 (NF-E2), which is associated to the expression of the β-globin gene [<xref ref-type="bibr" rid="bib70">70</xref>,<xref ref-type="bibr" rid="bib71">71</xref>]. However, no alterations related to hematopoiesis nor an anemic phenotype are noted in NRF2 knockout mice [<xref ref-type="bibr" rid="bib72">72</xref>,<xref ref-type="bibr" rid="bib73">73</xref>]. These results have raised the hypothesis that this transcription factor regulates a different set of genes. Later, it is discovered that NRF2 binds to the antioxidant responsive element (ARE) in the DNA inducing the expression of phase-II detoxing enzymes and antioxidants proteins/enzymes such as glutamate cysteine ligase, heme oxygenase-1 (HO-1) and NAD(P)H dehydrogenase (quinone 1) (NQO-1) [<xref ref-type="bibr" rid="bib74">[74]</xref>, <xref ref-type="bibr" rid="bib75">[75]</xref>, <xref ref-type="bibr" rid="bib76">[76]</xref>, <xref ref-type="bibr" rid="bib77">[77]</xref>]. Knockout of NRF2 in mice markedly increases susceptibility to a wide-range of toxicants and worsens pathological conditions associated with oxidative stress [<xref ref-type="bibr" rid="bib21">21</xref>,<xref ref-type="bibr" rid="bib78">[78]</xref>, <xref ref-type="bibr" rid="bib79">[79]</xref>, <xref ref-type="bibr" rid="bib80">[80]</xref>, <xref ref-type="bibr" rid="bib81">[81]</xref>]. In contrast, pharmacological or genetic increment of NRF2 activity is able to induce protection against oxidative damage in diverse <italic>in vitro</italic> and <italic>in vivo</italic> models [<xref ref-type="bibr" rid="bib79">79</xref>,<xref ref-type="bibr" rid="bib82">[82]</xref>, <xref ref-type="bibr" rid="bib83">[83]</xref>, <xref ref-type="bibr" rid="bib84">[84]</xref>]. In addition to NRF2's well-known role as a master regulator of antioxidant responses, it plays an important role in the regulation of inflammatory response, autophagy, and cell proliferation [<xref ref-type="bibr" rid="bib85">[85]</xref>, <xref ref-type="bibr" rid="bib86">[86]</xref>, <xref ref-type="bibr" rid="bib87">[87]</xref>, <xref ref-type="bibr" rid="bib88">[88]</xref>].</p>
<p id="p0185">NRF2 exhibits a dual role in the context of tumor biology and cancer. NRF2-deficient rodents are more prone to develop cancer in response to diverse carcinogenic agents such as benzopyrene, ultraviolet and ionizing radiation, highlighting the role of this transcription factor in cancer prevention [<xref ref-type="bibr" rid="bib89">[89]</xref>, <xref ref-type="bibr" rid="bib90">[90]</xref>, <xref ref-type="bibr" rid="bib91">[91]</xref>]. In contrast, NRF2 can cause cancer progression. NRF2 activation is associated with increased cancer cell survival, senescence, and also increases resistance to several chemotherapeutic agents such as cisplatin [<xref ref-type="bibr" rid="bib88">88</xref>,<xref ref-type="bibr" rid="bib92">92</xref>,<xref ref-type="bibr" rid="bib93">93</xref>]. Collectively, those findings suggest NRF2 acts as a “double-sword” in cellular processes and pathogenesis.</p>
<p id="p0190">The cellular and biochemical events that lead to NRF2-related gene expression are not yet fully understood. Under basal conditions NRF2 is associated with the Kelch-like ECH-associated protein 1 (KEAP1), promoting NRF2 ubiquitination by E3 ubiquitin ligase, and consequent degradation through 26S proteasome. Two KEAP1 molecules are associated with one molecule of NRF2. Each of the Kelch domains in the KEAP1 structure binds to one of two motifs in the NRF2 protein allowing the attachment of ubiquitin-ligase enzymes, leading to NRF2 polyubiquitination and subsequent degradation by the proteasome [<xref ref-type="bibr" rid="bib94">[94]</xref>, <xref ref-type="bibr" rid="bib95">[95]</xref>, <xref ref-type="bibr" rid="bib96">[96]</xref>]. Upon cellular stress, the KEAP1/NRF2 association is disrupted and NRF2 is degraded, causing <italic>de novo</italic> NRF2 to build up within the cell. Those events lead to increased NRF2 translocation into the nucleus where it heterodimerizes with other nuclear factors (Jun and small MAF protein) and binds to the antioxidant responsive elements (ARE) located in the regulatory regions of many response genes, including the ones related to the antioxidant response [<xref ref-type="bibr" rid="bib30">30</xref>,<xref ref-type="bibr" rid="bib97">97</xref>]. After its nuclear import, NRF2 also recruits a complex transcriptional machinery in order to transactivate the ARE-driven genes. This machinery involves others co-activators such as the receptor associated co-activator (RAC3) which starts the transactivation domain of NRF2, while other co-regulators such as CREB binding protein, the coactivator-associated arginine methyltransferase and protein arginine methyl-transferase, further enhance the ability of RAC3 to initiate the transactivation domain [<xref ref-type="bibr" rid="bib98">98</xref>,<xref ref-type="bibr" rid="bib99">99</xref>].</p>
</sec>
<sec id="sec4">
<label>4</label>
<title>Regulation of NRF2 activity</title>
<p id="p0195">In addition to the regulatory role of KEAP1 on NRF2 activity, several intracellular signaling pathways may induce post-translational modifications in the structure of this transcription factor, in turn, regulating its function. The following sections will describe some of the main mechanisms associated with NRF2 activation.</p>
<sec id="sec4.1">
<label>4.1</label>
<title>KEAP1-dependent mechanism</title>
<p id="p0200">As mentioned above, the negative regulation of KEAP1 on NRF2 activation has been extensively described. KEAP1 acts as an intracellular sensor for oxidative and/or electrophilic stress. The KEAP1 structure consists of an N-terminal region (residues 1–49), a BTB domain (residues 50–179), and a C-terminal Kelch domain (residues 327–611) as well as an intervening region (IVR, residues 180–314) [<xref ref-type="bibr" rid="bib94">94</xref>]. The BTB/POZ domain is essential for the ubiquitin-protein ligase complex interaction, sustaining the basal NRF2 levels, while the IVR domain can act as a functional regulatory region of the protein, controlling the interaction between KEAP1 and NRF2, and consequently NRF2 ubiquitination [<xref ref-type="bibr" rid="bib30">30</xref>,<xref ref-type="bibr" rid="bib100">100</xref>].</p>
<p id="p0205">NRF2 activation is induced by various activators via divergent mechanisms, for example, the negative regulation of NRF2 by KEAP1 which interacts with Cul-3 through the BTB and IVR domain [<xref ref-type="bibr" rid="bib101">101</xref>]. Human and mouse KEAP1 have 27 and 25 Cys residues among their 624 amino acids, respectively (PRO_0000119,093 and PRO_0000119,094). Using some of its reactive Cys residues, KEAP1 can sense ROS and electrophiles to change its conformation, resulting in escape of NRF2 from KEAP1-dependent degradation by the Ub-proteasome pathway. Especially, Cys151, Cys273, Cys288, Cys297, Cys434, and Cys613 are known to be highly reactive Cys residues, involved in sensing electrophiles. Suzuki et al. classified NRF2 inducers into five classes: class I, Cys151-preferring inducers (e.g., sulforaphane, diethyl maleate, nitric oxide, and ebselen); class II, Cys288-preferring inducers (e.g., 15-deoxy-Δ12,14-prostaglandin J2); class III, Cys151/273/288-selective inducers (e.g., HNE, sodium meta-arsenite); class IV, Cys226/613/622/624-preferring inducers (e.g., H<sub>2</sub>O<sub>2</sub>); and class V, non-electrophilic inducers [<xref ref-type="bibr" rid="bib102">102</xref>,<xref ref-type="bibr" rid="bib103">103</xref>]. Various inducers can modify specific combinations of cysteines in order to tightly control the KEAP1/NRF2 association and stress-sensing response [<xref ref-type="bibr" rid="bib94">94</xref>].</p>
<p id="p0210">The stability of the complex KEAP1/NRF2 can be controlled by other intracellular processes as well. p21 is a cyclin dependent kinase inhibitor that regulates some cellular process like differentiation, senescence and also is able to inhibit gene transcription and apoptosis [<xref ref-type="bibr" rid="bib104">104</xref>]. p21 competes with KEAP1 for NRF2 binding, lessening KEAP1-dependent NRF2 ubiquitination, leading to increased NRF2 transcriptional activity [<xref ref-type="bibr" rid="bib105">[105]</xref>, <xref ref-type="bibr" rid="bib106">[106]</xref>, <xref ref-type="bibr" rid="bib107">[107]</xref>]. The role of p62 on the cellular metabolism extends beyond regulation of autophagy [<xref ref-type="bibr" rid="bib108">108</xref>]. p62 processes a KEAP1‐interacting region that binds to the KEAP1 domain associated to NRF2 interaction. Under basal conditions, the interaction between p62 and KEAP1 is too weak to affect KEAP1/NRF2 interactions. However, under cellular stress, mTORC1 and TGF‐β‐activated kinase can phosphorylate p62 at S349, resulting in the phosphorylated form of p62, which exhibits high affinity for KEAP1, disrupting the KEAP1/NRF2 complex and also decreasing KEAP1 levels through autophagy [<xref ref-type="bibr" rid="bib86">86</xref>,<xref ref-type="bibr" rid="bib108">108</xref>]. In addition, oxidative stress increases the expression of a splicing variation of the p62 pre-mRNA, which lacks the domain responsible for its interactions with KEAP1. This variant is associated with proteasomal NRF2 degradation, allowing for the fine tunning of NRF2 activation, counteracting the positive-feedback loop executed by full-length p62 [<xref ref-type="bibr" rid="bib109">109</xref>]. Moreover, NRF2 phosphorylation at Ser40 by Protein Kinase C induces the dissociation of NRF2 from the complex with KEAP1, increasing the transcription of ARE-driven genes [<xref ref-type="bibr" rid="bib110">110</xref>,<xref ref-type="bibr" rid="bib111">111</xref>]. Several phosphorylation sites on NRF2 are proposed to be targets for mitogen-activated protein kinases (MAPKs) mediate phosphorylation, but the role of MAPK in NRF2 activation has yet to be fully investigated [<xref ref-type="bibr" rid="bib112">112</xref>,<xref ref-type="bibr" rid="bib113">113</xref>].</p>
<p id="p0215">In addition to these mechanisms, some toxicants, such as S-(1,1,2,2-tetrafluoroethyl)-<sc>l</sc>-cysteine, a metabolite of industrial gas, can induce NRF2 activation in the absence of oxidative-stress [<xref ref-type="bibr" rid="bib114">114</xref>]. The complicated mechanisms of the ROS-independent NRF2 activation are not yet fully understood. It appears that the endoplasmic reticular stress response is able to induce NRF2 phosphorylation through ER-mediated protein kinases such as PKR-like endoplasmic reticular kinase (PERK). The PERK mediated phosphorylation appears to destabilize the KEAP1/NRF2 complex inducing NRF2 activation [<xref ref-type="bibr" rid="bib115">115</xref>].</p>
</sec>
<sec id="sec4.2">
<label>4.2</label>
<title>KEAP1-independent mechanism</title>
<p id="p0220">In addition to the KEAP1 negative regulation on NRF2 activation, NRF2 stability and nuclear localization can be regulated by signaling pathways involving the activation of glycogen synthase kinase3 (GSK3). This enzyme is constitutively active but can be inactivated by phosphorylation at S9 or S21 (in GSK3β and GSK3α, respectively) by protein kinase B (PKB)/Akt. Thus, GSK3 plays a crucial role in cellular process such as cell growth differentiation and survival [<xref ref-type="bibr" rid="bib116">116</xref>,<xref ref-type="bibr" rid="bib117">117</xref>]. In addition, a positive correlation between Akt and NRF2 activation has been described [<xref ref-type="bibr" rid="bib118">[118]</xref>, <xref ref-type="bibr" rid="bib119">[119]</xref>, <xref ref-type="bibr" rid="bib120">[120]</xref>].</p>
<p id="p0225">McMahon et al. have demonstrated that the Neh6 domain of NRF2 contains a KEAP1-independent degradation region with a putative sequence for GSK3 phosphorylation. This is in line with other reports associating the inhibition of this enzyme and increased NRF2 activity. Within this context, it has been already demonstrated that this kinase phosphorylates specific serine residues in the Neh6 domain of NRF2 creating a degradation domain that is recognized by the ubiquitin ligase adapter β-TrCP and labeled for proteasome degradation by a Cullin1/Rbx1 complex [<xref ref-type="bibr" rid="bib121">121</xref>,<xref ref-type="bibr" rid="bib122">122</xref>].</p>
<p id="p0230">The nuclear localization of NRF2 can also be modulated by GSK3. To date, no phosphorylation site on the NRF2 structure that can be targeted by GSK3 has been described. However, this kinase is able to phosphorylate and activate another kinase, named Fyn. Once activated, Fyn is translocated to the nucleus and phosphorylates NRF2 at Y568, inducing its nuclear export [<xref ref-type="bibr" rid="bib122">122</xref>,<xref ref-type="bibr" rid="bib123">123</xref>]. Taken together, these findings allow us to speculate that the modulation of GSK-3 and/or Fyn might connect the activation of NRF2 after the upregulation of the Akt pathway, but additional evidence is still necessary to confirm this hypothesis.</p>
</sec>
</sec>
<sec id="sec5">
<label>5</label>
<title>Heavy metals activate the redox sensor NRF2 and its signaling pathways</title>
<p id="p0235">As stated above, NRF2 is a master regulator of cellular responses against environmental stresses. In this section, we discuss the NRF2 pathway as it relates to the effects of heavy metals.</p>
<sec id="sec5.1">
<label>5.1</label>
<title>Methylmercury (MeHg)</title>
<p id="p0240">Mercury (Hg) is a heavy metal ubiquitously present in the environment. Hg is released to the atmosphere by natural sources such as forest fire and volcanic activity or by anthropogenic sources (mining, coal combustion and other industrial activities). Once in the environment, Hg deposits into aquatic systems and is biomethylated by aquatic sulfate-reducing bacteria forming methylmercury [<xref ref-type="bibr" rid="bib124">124</xref>] where it undergoes biomagnification, accumulating across the food chain and reaching the highest concentrations in large predatory fish [<xref ref-type="bibr" rid="bib125">125</xref>]. Thus, the consumption of fish contaminated with MeHg is the most relevant exposure source in human populations [<xref ref-type="bibr" rid="bib8">8</xref>].</p>
<p id="p0245">MeHg, as an organometallic cation with the chemical formula [CH<sub>3</sub>Hg]<sup>+</sup>, is a potent electrophilic substance, possessing high affinity for thiol and selenol groups. MeHg is readily absorbed by the gastrointestinal tract, and accumulates preferably in the central nervous system (CNS). Rodents exposed to MeHg in drinking water exhibit similar deficits as the humans exposed to this toxicant, such as impairment in motor coordination, disturbances in learning and memory processing and depressive like behavior [<xref ref-type="bibr" rid="bib8">8</xref>,<xref ref-type="bibr" rid="bib126">[126]</xref>, <xref ref-type="bibr" rid="bib127">[127]</xref>, <xref ref-type="bibr" rid="bib128">[128]</xref>, <xref ref-type="bibr" rid="bib129">[129]</xref>]. The intracellular mechanisms associated to MeHg exposure are not yet fully understood, but depletion of reduced glutathione levels, induction of oxidative stress and mitochondrial dysfunction play important roles in its cellular toxicity [<xref ref-type="bibr" rid="bib8">8</xref>,<xref ref-type="bibr" rid="bib13">13</xref>]. NRF2 nuclear translocation has been increased after exposure to MeHg <italic>in vivo</italic> [<xref ref-type="bibr" rid="bib130">130</xref>] and also <italic>in vitro</italic> [<xref ref-type="bibr" rid="bib79">79</xref>,<xref ref-type="bibr" rid="bib118">118</xref>,<xref ref-type="bibr" rid="bib131">131</xref>,<xref ref-type="bibr" rid="bib132">132</xref>]. NRF2-related gene expression (such as: <italic>ho-1, nqo-1, cglc and nfe2l2)</italic> is also increased upon metal exposure [<xref ref-type="bibr" rid="bib79">79</xref>,<xref ref-type="bibr" rid="bib118">118</xref>,<xref ref-type="bibr" rid="bib131">131</xref>,<xref ref-type="bibr" rid="bib132">132</xref>]. Thus, this data provides strong evidence of MeHg-induced increase in NRF2 activation.</p>
<p id="p0250">The role of NRF2 in MeHg-induced cellular toxicity has been demonstrated by Kumagai and his colleague [<xref ref-type="bibr" rid="bib84">84</xref>]. NRF2-deficient (NRF2<sup>−/−</sup>) mice exposed to MeHg show increased sensitivity to this toxicant and higher mercury accumulation in the brain and liver when compared to wild type animals. In addition, isolated hepatocytes obtained from NRF2<sup>−/−</sup> mice exhibit increased sensibility to MeHg. Furthermore, pretreatment with the NRF2 activators isothiocyanate and sulforaphane suppresses cellular accumulation of mercury and cytotoxicity in wild-type, but not in NRF2<sup>−/−</sup> primary mouse hepatocytes. Taken together, this data supports the hypothesis that the upregulation of NRF2 is associated with cell defense mechanisms, and the upregulation of NRF2 decreases MeHg accumulation, ameliorating its toxic consequences.</p>
<p id="p0255">MeHg can increase NRF2 activation in KEAP1-dependent and -independent ways. Due its electrophilic properties, the cysteine residues on KEAP1 are an important target for MeHg. MeHg can directly bind to the Cys151, Cys319, Cys368 and Cys489 on KEAP1 [<xref ref-type="bibr" rid="bib79">79</xref>,<xref ref-type="bibr" rid="bib133">[133]</xref>, <xref ref-type="bibr" rid="bib134">[134]</xref>, <xref ref-type="bibr" rid="bib135">[135]</xref>]. As mentioned previously, the Cys151 residue is essential to NRF2 upregulation after electrophile stress and may play an important role on the NRF2 upregulation upon MeHg exposure. The Cys319 residue seems also important for the ubiquitin E3 ligase activity and consequent NRF2 degradation, and can be also associated to these effects [<xref ref-type="bibr" rid="bib79">79</xref>,<xref ref-type="bibr" rid="bib101">101</xref>,<xref ref-type="bibr" rid="bib136">136</xref>,<xref ref-type="bibr" rid="bib137">137</xref>].</p>
<p id="p0260">Aschner et al. have shown inhibition of GSK3β by phosphorylation after <italic>in vitro</italic> MeHg exposure in primary cortical astrocytes. MeHg also decreases Fyn nuclear localization and mRNA expression, concomitant with increased NRF2 activity [<xref ref-type="bibr" rid="bib118">118</xref>]. These results corroborate previous reports, demonstrating that MeHg-induced NRF2 activation is linked to PI3K/Akt activation [<xref ref-type="bibr" rid="bib132">132</xref>]. Taken together, it appears that MeHg promotes Akt activation leading to consequent inhibitory phosphorylation of GSK3β, decreasing of Fyn phosphorylation and Fyn-mediated NRF2 nuclear export. Further experiments are necessary to confirm this hypothesis, addressing KEAP1-independent mechanisms associated with MeHg-induced increase in NRF2 activation.</p>
</sec>
<sec id="sec5.2">
<label>5.2</label>
<title>Manganese (Mn)</title>
<p id="p0265">Mn is an essential trace element for human normal developments and functions [<xref ref-type="bibr" rid="bib138">138</xref>]. As an enzyme co-factor or activator for metabolic reactions such as Mn-superoxide dismutase (Mn-SOD), Mn is also required [<xref ref-type="bibr" rid="bib139">139</xref>]. However, excessive Mn causes primarily neurotoxicity, characterized by Parkinsonism-like symptoms with degeneration of dopaminergic neurons in the basal ganglia. The similarities and differences between PD and manganism have been extensively reviewed elsewhere [<xref ref-type="bibr" rid="bib140">140</xref>,<xref ref-type="bibr" rid="bib141">141</xref>]. Li et al. have demonstrated that MnCl<sub>2</sub> upregulates NRF2 protein level and increases the binding activity of NRF2 with ARE. This upregulation is accompanied with promotion of HO-1 expression and reduction in levels of reduced GSH [<xref ref-type="bibr" rid="bib142">142</xref>]. In aquatic organisms, analogous upregulation of NRF2 is found. In the gill of grass carp, excessive Mn leads to upregulation of NRF2 [<xref ref-type="bibr" rid="bib143">143</xref>]. In contrast, Mn deficiency causes depression of intestinal immunity, induction of inflammation and dysfunction of the intestinal physical barrier secondary to NRF2 activation in grass carp [<xref ref-type="bibr" rid="bib144">144</xref>]. Reproductive toxicology studies have shown that Mn exposure inhibits NRF2 expression, unexpectedly, disrupting gonadotropin-releasing hormone (GnRH) synthesis both <italic>in vitro</italic> and <italic>in vivo</italic> [<xref ref-type="bibr" rid="bib145">145</xref>,<xref ref-type="bibr" rid="bib146">146</xref>].</p>
<p id="p0270">Mn-induced injury can be antagonized by various chemicals. For example, <italic>tert</italic>-butylhydroquinone (<italic>t</italic>BHQ) pretreatment activates NRF2/ARE pathway and attenuates both the cytotoxicity and apoptosis in PC12 cells by MnCl<sub>2</sub> [<xref ref-type="bibr" rid="bib147">147</xref>]. Similarly, melatonin, quercetin and 15 d-PGJ<sub>2</sub> exert protective effects in astrocytes against Mn-induced toxicity (inflammation and oxidative stress) by modulating the activation of the NRF2/ARE signaling pathways in various organisms [<xref ref-type="bibr" rid="bib146">[146]</xref>, <xref ref-type="bibr" rid="bib147">[147]</xref>, <xref ref-type="bibr" rid="bib148">[148]</xref>, <xref ref-type="bibr" rid="bib149">[149]</xref>].</p>
</sec>
<sec id="sec5.3">
<label>5.3</label>
<title>Cadmium (Cd) and Arsenic (As)</title>
<p id="p0275">Cadmium and Arsenic are widespread pollutants of concern [<xref ref-type="bibr" rid="bib150">[150]</xref>, <xref ref-type="bibr" rid="bib151">[151]</xref>, <xref ref-type="bibr" rid="bib152">[152]</xref>]. Exposure to Cd and As from cigarette smoke, rice, water or other environmental and occupational conditions may lead to deleterious consequences, including defects on the liver, bones, kidneys, lungs testes, brain, immunological and cardiovascular systems [<xref ref-type="bibr" rid="bib153">[153]</xref>, <xref ref-type="bibr" rid="bib154">[154]</xref>, <xref ref-type="bibr" rid="bib155">[155]</xref>, <xref ref-type="bibr" rid="bib156">[156]</xref>, <xref ref-type="bibr" rid="bib157">[157]</xref>, <xref ref-type="bibr" rid="bib158">[158]</xref>, <xref ref-type="bibr" rid="bib159">[159]</xref>]. NRF2, as an ROS sensor, can be activated by Cd and As [<xref ref-type="bibr" rid="bib160">[160]</xref>, <xref ref-type="bibr" rid="bib161">[161]</xref>, <xref ref-type="bibr" rid="bib162">[162]</xref>]. It is also subsequently found that covalent modification of KEAP1 through Cys249, Cys368 and/or Cys613 are involved in Cd-mediated activation of NRF2 [<xref ref-type="bibr" rid="bib163">163</xref>]. NRF2 has also been implicated in responses to lung injuries caused by Cd originating from cigarettes [<xref ref-type="bibr" rid="bib164">164</xref>]. For example, NRF2 knockdown enhances Cd cytotoxicity, whereas KEAP1 knockdown diminishes such a heavy-metal toxicity in the vascular endothelial cells [<xref ref-type="bibr" rid="bib163">163</xref>]. Pretreatment with sulforaphane, an NRF2 activator, represses As cytotoxicity through reduced intracellular As levels due to increase in NRF2-related protein expressions such as GCSh, GCSl, GSTs MRP1 in primary mouse hepatocytes [<xref ref-type="bibr" rid="bib165">165</xref>]. Human keratinocytes overexpressing NRF2 are hyper-resistant to arsenic toxicity, an effect that is abolished by NRF2 stable knockdown [<xref ref-type="bibr" rid="bib166">166</xref>].</p>
<p id="p0280">Curcumin and lycopene attenuate Cd-induced lipid peroxidation, GSH depletion and alternations in antioxidant enzymes via induction of the NRF2/KEAP1/ARE pathway [<xref ref-type="bibr" rid="bib167">[167]</xref>, <xref ref-type="bibr" rid="bib168">[168]</xref>, <xref ref-type="bibr" rid="bib169">[169]</xref>]. Attenuation of As<sub>2</sub>O<sub>3</sub> -induced toxicity in cardiomyocytes is noted in response to <sc>l</sc>-ascorbic acid and α-tocopherol treatment, secondary to the activation of NRF2 and BCL-2 [<xref ref-type="bibr" rid="bib170">170</xref>]. In male mice, lutein activates the NRF2 signaling pathway, alleviating As induced reproductive defects [<xref ref-type="bibr" rid="bib171">171</xref>].</p>
</sec>
<sec id="sec5.4">
<label>5.4</label>
<title>Cobalt (Co) and cobalt nanoparticles (CoNPs)</title>
<p id="p0285">As a component of vitamin B12, cobalt (Co) is an essential metal. However, high levels of cobalt lead to metallosis, characterized by sensorineural hearing loss, visual and cognitive impairment and peripheral neuropathy [<xref ref-type="bibr" rid="bib172">172</xref>,<xref ref-type="bibr" rid="bib173">173</xref>]. Excessive serum cobalt may arise from a variety of sources, including diet, exposure from industrial fabrication, or from alloys used in tooth and hip joint replacements (see reviews [<xref ref-type="bibr" rid="bib174">[174]</xref>, <xref ref-type="bibr" rid="bib175">[175]</xref>, <xref ref-type="bibr" rid="bib176">[176]</xref>] for details).</p>
<p id="p0290">As a well-known hypoxia inducer, cobalt is directly linked with oxidative stress and cytotoxicity in varying cell types. Previously, Zheng et al. have shown that cobalt and its nanoparticles overdose result in defects in rat neural cells, including lethality, hypoxia and the loss of learning, memory and spatial-exploration abilities [<xref ref-type="bibr" rid="bib177">177</xref>,<xref ref-type="bibr" rid="bib178">178</xref>]. Tungsten carbide-cobalt particles activate NRF2 and its downstream targets such as GST and NQO-1 initiated by ROS and contribute to adverse effects in lymphoma cells JB6 [<xref ref-type="bibr" rid="bib179">179</xref>]. Compared with CoO NPs and Co<sub>3</sub>O<sub>4</sub> NPs, CoNPs are highly cytotoxic and induce NRF2 signaling related to oxidative stress and DNA strand breaks [<xref ref-type="bibr" rid="bib180">180</xref>,<xref ref-type="bibr" rid="bib181">181</xref>]. Microarray and mass spectrometry analysis study have shown that exposure to cobalt causes transcriptomic and proteomic changes in rat liver cells, including HIF-1α signaling, NRF2-mediated response, protein degradation and GSH production [<xref ref-type="bibr" rid="bib182">182</xref>]. In human keratinocytes, NRF2 has been shown to be involved in the antioxidant response triggered by cobalt chloride [<xref ref-type="bibr" rid="bib183">183</xref>]. Yuan et al. have demonstrated that overexpression of NRF2 in mesenchymal stem cells prevents apoptosis caused by cobalt, maintaining the stemness [<xref ref-type="bibr" rid="bib184">184</xref>]. Thymoquinone and mfat-1 transgene expression (which overproduces omega-3 polyunsaturated fatty acid) both exhibit neuroprotective effects against cobalt chloride by upregulating NRF2 [<xref ref-type="bibr" rid="bib185">185</xref>,<xref ref-type="bibr" rid="bib186">186</xref>]. Andrographolide, the main bioactive component generated from plant <italic>Andrographis paniculate</italic>, suppresses cobalt induced inflammation by activating NRF2/HO-1 and inhibiting p38 MAPK signaling [<xref ref-type="bibr" rid="bib187">187</xref>].</p>
<p id="p0295">In summary, heavy metals induce oxidative stress and upregulate the ROS sensor NRF2. By further induction of NRF2 and its downstream antioxidant compounds or scavenging excess ROS, the metal induced-defects are likely to be rescued.</p>
</sec>
</sec>
<sec id="sec6">
<label>6</label>
<title>Pesticide exposures stimulate NRF2-induced cellular defense mechanisms</title>
<p id="p0300">Pesticides are heavily used in agriculture for crop protection, but excessive use of them contaminates soil, water and atmosphere, harming the non-targeted organisms.</p>
<sec id="sec6.1">
<label>6.1</label>
<title>Deltamethrin (DM)</title>
<p id="p0305">Deltamethrin ((<italic>S</italic>)a-cyano-3-phenoxybenzyl-(1R)-cis-3- (2.2-dibromovinyl)-2,2-dimethylcyclopropane carboxy-late, DM) is one of the most potent pyrethroid insecticides [<xref ref-type="bibr" rid="bib188">188</xref>,<xref ref-type="bibr" rid="bib189">189</xref>]. Pyrethroid pesticides are highly selective as nerve poisons for mammals in agriculture and urban settings. DM produces specific damages to dopaminergic nerve terminals of the striatum in mice [<xref ref-type="bibr" rid="bib190">190</xref>]. DM inhibits dopamine biosynthesis and causes increased apoptosis in brain [<xref ref-type="bibr" rid="bib191">[191]</xref>, <xref ref-type="bibr" rid="bib192">[192]</xref>, <xref ref-type="bibr" rid="bib193">[193]</xref>, <xref ref-type="bibr" rid="bib194">[194]</xref>, <xref ref-type="bibr" rid="bib195">[195]</xref>]. Li et al. have further demonstrated that DM activates NRF2 at multiple levels including enhancing cellular expression, increasing nuclear accumulation as well as activating HO-1 and gamma-glutamylcysteine synthetase catalytic heavy subunit (GCSh). When pretreated with ROS scavenger NAC, the DM-induced NRF2 signaling pathway is suppressed, suggesting that ROS is one of the mediators of this process [<xref ref-type="bibr" rid="bib196">196</xref>]. Moreover, <italic>tert</italic>-butyl- hydroquinone (<italic>t</italic>BHQ), a cytoprotective compound that functions via a mechanism involving NRF2 activation and ARE-dependent genes expression, protects cells from DM-induced oxidative stress and regulates DM-mediated adaptive responses in PC12 cells and rat brain via the translocation of NRF2 [<xref ref-type="bibr" rid="bib196">[196]</xref>, <xref ref-type="bibr" rid="bib197">[197]</xref>, <xref ref-type="bibr" rid="bib198">[198]</xref>, <xref ref-type="bibr" rid="bib199">[199]</xref>]. The <italic>Artemisia campestris</italic> essential oil can also protect DM-induced oxidative stress in kidney and brain of rats [<xref ref-type="bibr" rid="bib200">200</xref>]. It has been also shown that sitagliptin and curcumin limit the poisonous impact of DM by ROS scavenging and activating NRF2 pathway [<xref ref-type="bibr" rid="bib201">201</xref>]. Similar results were found in zebrafish cell lines of DM induced NRF2 activity, upon treatment with pesticides such as diazinon, diuron and metazachlor [<xref ref-type="bibr" rid="bib202">202</xref>]. A bioinformatic analysis study has shown the importance of KEAP1-NRF2-ARE pathway in DM stress in <italic>Drosophila melanogaster</italic> upon RNASeq analysis [<xref ref-type="bibr" rid="bib203">203</xref>]. Collectively, DM induced-toxicity is accompanied with NRF2 activation involved cellular defense system, which can be ameliorated with ROS scavengers.</p>
</sec>
<sec id="sec6.2">
<label>6.2</label>
<title>Paraquat (PQ)</title>
<p id="p0310">Paraquat (1,10-dimethyl-4,40-bipyridilium dichloride, PQ), a widely used nonselective herbicide, has been strongly linked to Parkinson's diseases (PD) [<xref ref-type="bibr" rid="bib198">198</xref>,<xref ref-type="bibr" rid="bib204">[204]</xref>, <xref ref-type="bibr" rid="bib205">[205]</xref>, <xref ref-type="bibr" rid="bib206">[206]</xref>, <xref ref-type="bibr" rid="bib207">[207]</xref>]. Studies have demonstrated that PQ treatment results in several of the hallmarks of dopaminergic pathogenesis associated with PD, including decreased dopamine levels, reduction of dopaminergic neurons in the substantia nigra and increased α-synuclein expression [<xref ref-type="bibr" rid="bib208">[208]</xref>, <xref ref-type="bibr" rid="bib209">[209]</xref>, <xref ref-type="bibr" rid="bib210">[210]</xref>]. The NRF2-ARE pathway has been shown to play a role in neuroprotection against PQ-associated neurodegeneration in the CNS, <italic>in vitro</italic> and in nigrostriatal dopaminergic neurons [<xref ref-type="bibr" rid="bib4">4</xref>,<xref ref-type="bibr" rid="bib120">120</xref>,<xref ref-type="bibr" rid="bib198">198</xref>,<xref ref-type="bibr" rid="bib204">204</xref>,<xref ref-type="bibr" rid="bib211">[211]</xref>, <xref ref-type="bibr" rid="bib212">[212]</xref>, <xref ref-type="bibr" rid="bib213">[213]</xref>, <xref ref-type="bibr" rid="bib214">[214]</xref>, <xref ref-type="bibr" rid="bib215">[215]</xref>, <xref ref-type="bibr" rid="bib216">[216]</xref>]. Moreover, the NRF2-ARE pathway has been shown to be activated by inhibition of 26S proteasome in PC12 cells [<xref ref-type="bibr" rid="bib217">217</xref>]. As stated above, PQ exerts its toxic effects through the production of superoxide anions in organisms and contribution to mitochondrial dysfunction leading to cell death. Though no treatment for PQ poisoning is currently available, an antioxidant therapy might be a viable alternative. In fact, antioxidants such as naringin, sylimarin, edaravone, Bathysa cuspidata extracts, alpha-lipoic acid, pirfenidone, lysine acetylsalicylate, selenium, quercetin, C-phycocyanin, bacosides, and vitamin C may be useful in the treatment against PQ toxicity ([<xref ref-type="bibr" rid="bib218">218</xref>] and references herein). Li et al. have shown that PQ neurotoxicity can be ameliorated by <italic>t</italic>BHQ. <italic>t</italic>BHQ pretreatment restored motor performance, protected against the reduction in nigral tyrosine hydroxylase -positive neurons, increased TUNEL-positive cells, and led to upregulation of NRF2 and HO-1, which were impaired by PQ exposure [<xref ref-type="bibr" rid="bib198">198</xref>]. Moreover, the JAW gene, also known as ARL6IP5, exerts a protective effect on PQ-induced PD through the regulation of the MEK/PI3K-NRR2 axis [<xref ref-type="bibr" rid="bib219">219</xref>].</p>
<p id="p0315">In addition to PQ, Betarbet et al. first proposed that the insecticide rotenone is able to reproduce the pathological hallmarks of PD [<xref ref-type="bibr" rid="bib220">220</xref>]. The rotenone model of PD has been recently reviewed [<xref ref-type="bibr" rid="bib221">221</xref>]. Rotenone causes mitochondrial dysfunction by specifically inhibiting complex I of the mitochondrial electron transport chain (NADH:ubiquinone oxidoreductase activity) [<xref ref-type="bibr" rid="bib222">222</xref>]. In addition to this inhibition, rotenone also induces mitochondrial membrane depolarization, which in turn, leads to oxidative stress by generating ROS and RNS [<xref ref-type="bibr" rid="bib223">223</xref>,<xref ref-type="bibr" rid="bib224">224</xref>]. In response to ROS, signaling pathways such as c-Jun N-terminal kinase 3 and p38 mitogen-activated kinases/p53 signaling pathway as well as NRF2 were activated [<xref ref-type="bibr" rid="bib225">[225]</xref>, <xref ref-type="bibr" rid="bib226">[226]</xref>, <xref ref-type="bibr" rid="bib227">[227]</xref>]. Rapamycin is a natural anti-fungal product originally isolated from a soil sample from Easter Island [<xref ref-type="bibr" rid="bib228">228</xref>]. Later, rapamycin demonstrates immunosuppressive, antitumor, neuroprotective, and neuro-regenerative properties (see reviews for details [<xref ref-type="bibr" rid="bib229">229</xref>,<xref ref-type="bibr" rid="bib230">230</xref>]). Concurrently, the target of rapamycin (TOR) was identified in several animal models [<xref ref-type="bibr" rid="bib231">231</xref>,<xref ref-type="bibr" rid="bib232">232</xref>]. The mammalian target of rapamycin (mTOR) is composed of two functionally distinct complexes, mTORC1 and mTORC2; the first one exhibiting greater sensitivity to rapamycin [<xref ref-type="bibr" rid="bib230">230</xref>]. Dysregulated mTOR and its signaling pathway have been observed in malignant and neurodegenerative diseases. Therefore, rapamycin, a drug that selectively targets mTORC1, might be potentially efficacious as a potential anti-cancer treatment. However, recent clinal trails have shown that rapalogs show only modest therapeutic efficacy in solid tumors. This is likely due to mTORC1-regulated negative feedback loops. Thus, alternatives such as the inhibition of rictor/mTORC2 have been proposed in cancer treatment [<xref ref-type="bibr" rid="bib233">233</xref>].</p>
<p id="p0320">Links between NRF2 and other pesticides have been proposed. Mancozeb, a broad-spectrum fungicide, induces oxidative damage and modulated NRF2 levels in <italic>Drosophila melanogaster</italic> [<xref ref-type="bibr" rid="bib234">234</xref>]. Another fungicide prochloraz, used as a post-harvest anti-mold treatment, induces NRF2 activity in cultured human cells and DNA damages in non-toxic concentrations [<xref ref-type="bibr" rid="bib235">235</xref>]. An oxidizing organophosphate pesticide methyl parathion can generate ROS and modulates NRF2 methylation level in germ cells rather than its expression level [<xref ref-type="bibr" rid="bib236">236</xref>]. Atrazine has been shown to associated with environmental nephrosis [<xref ref-type="bibr" rid="bib237">237</xref>], which can be alleviated by lycopene via the activation of autophagy and NRF2 signaling pathway [<xref ref-type="bibr" rid="bib238">238</xref>].</p>
</sec>
</sec>
<sec id="sec7">
<label>7</label>
<title>Redox cycling (in the content of NRF2) of atmospheric quinones and its related diseases</title>
<p id="p0325">Air pollution from industrial activities (e.g., power plants, combustion of fossil fuels, or traffic emissions) is a health risk causing adverse medical effects (<xref ref-type="table" rid="tbl1">Table 1</xref>). Air pollutants contain various compounds such as aldehydes, nitrogen oxides, aromatic hydrocarbons, trace metals and particulate matter (PM) [<xref ref-type="bibr" rid="bib252">252</xref>]. An average increase of 10 μg/m<sup>3</sup> of PM, less than 2.5 μm in diameter (PM<sub>2.5</sub>), is associated with an approximately 8% increase in the risk of mortality by lung cancer [<xref ref-type="bibr" rid="bib253">253</xref>]. Tobacco smoke typically contains electrophilic or redox-active metals such as Cd (65 ng/cig.) and Pb (32 ng/cig.), or Cu (13 ng/cig.) and Fe (16.8 ng/cig.) [<xref ref-type="bibr" rid="bib254">254</xref>]. A case-series approach by Kresovich et al. and a cohort-study by White et al. reveal that the airborne concentrations of metals such as Cd and Co, or Hg, Cd, and Pb in residential areas are associated with developing estrogen receptor/progesterone receptor-negative breast cancer or a higher risk of postmenopausal breast cancer, respectively, suggesting that airborne metals affect the breast cancer risk [<xref ref-type="bibr" rid="bib255">255</xref>,<xref ref-type="bibr" rid="bib256">256</xref>]. An atmospheric sample collected at the University of Birmingham contains about 12 ng/m<sup>3</sup> and 3.9 ng/m<sup>3</sup> of redox-active quinones such as phenanthraquinone, naphthoquinones, and benzoquinones in the vapor and particle phase, respectively, and 17 ng/m<sup>3</sup> of phenanthrene in the vapor phase, which is a parent compound of 9,10- phenanthraquinone (9,10-PQ, <xref ref-type="fig" rid="fig2">Figs. 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>) [<xref ref-type="bibr" rid="bib257">257</xref>]. These air contaminants and the ROS derived from such components can injure lung tissue [<xref ref-type="bibr" rid="bib258">258</xref>]. Sagai et al. demonstrates that diesel exhaust particles (DEP) generate ROS such as superoxide (O<sub>2</sub><sup>•−</sup>) and hydroxyl radicals (<sup>•</sup>OH), and intratracheal administration of DEP to mice caused lung edema formation that is blocked by pretreatment with polyethylene glycerol-conjugated superoxide dismutase (PEG-SOD), suggesting that the pulmonary toxicity caused by DEP is attributable to large amounts of superoxide production. The production of excess ROS in DEP is caused by NADPH-cytochrome P450 reductase-mediated metabolic activation based on one-electron reduction of quinoid compounds in DEP [<xref ref-type="bibr" rid="bib259">259</xref>]. Notably, redox-active metals such as Fe and Cu in DEP and PM<sub>2.5</sub> are also associated with ROS generation, causing oxidative stress.<table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Examples of sources of air pollutants and their related diseases.</p></caption><alt-text id="alttext0040">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Exposure source</th><th>Disease</th><th>Refs</th></tr></thead><tbody><tr><td align="left">Ambient particulate matter</td><td align="left">Lower respiratory infections, cancers (trachea, bronchus, and lung), Ischaemic heart disease, cerebrovascular disease, COPD, coronary events</td><td align="left">[<xref ref-type="bibr" rid="bib239">[239]</xref>, <xref ref-type="bibr" rid="bib240">[240]</xref>, <xref ref-type="bibr" rid="bib241">[241]</xref>]</td></tr><tr><td align="left">Household air pollution from solid fuels</td><td align="left">Lower respiratory infections, cancers (trachea, bronchus, and lung), Ischaemic heart disease, cerebrovascular disease, COPD, cataract</td><td align="left">[<xref ref-type="bibr" rid="bib239">239</xref>]</td></tr><tr><td align="left">Second hand smoke</td><td align="left">Stroke, bronchitis, bronchiolitis, lower respiratory infections, asthma, lung cancer</td><td align="left">[<xref ref-type="bibr" rid="bib242">[242]</xref>, <xref ref-type="bibr" rid="bib243">[243]</xref>, <xref ref-type="bibr" rid="bib244">[244]</xref>, <xref ref-type="bibr" rid="bib245">[245]</xref>]</td></tr><tr><td align="left">Traffic-related air pollutant</td><td align="left">Cardiovascular mortality, deep vein thrombosis, coronary athteroclerosis, bronchitic symptom, asthma, stroke</td><td align="left">[<xref ref-type="bibr" rid="bib246">[246]</xref>, <xref ref-type="bibr" rid="bib247">[247]</xref>, <xref ref-type="bibr" rid="bib248">[248]</xref>, <xref ref-type="bibr" rid="bib249">[249]</xref>]</td></tr><tr><td align="left">Diesel engine exhaust (occupational exposure)</td><td align="left">Lung cancers</td><td align="left">[<xref ref-type="bibr" rid="bib250">250</xref>,<xref ref-type="bibr" rid="bib251">251</xref>]</td></tr></tbody></table></table-wrap><fig id="fig3"><label>Fig. 3</label><caption><p><bold>Average ambient concentrations of various toxicants in an atmospheric sample at the University of Birmingham.</bold> The data is derived from Delgado-Saborit JM et al. [<xref ref-type="bibr" rid="bib257">257</xref>]. An ambient air sample, taken for 5 days in Birmingham, is analyzed by GC-MS. The black and white bars indicate average ambient concentrations of aromatic hydrocarbons in the particle phase and vapor phase, respectively.</p></caption><alt-text id="alttext0025">Fig. 3</alt-text><graphic xlink:href="gr3"></graphic></fig></p>
<p id="p0330">Quinones can be generated by autoxidation of their parent aromatic hydrocarbons in the atmosphere (<xref ref-type="fig" rid="fig4">Fig. 4</xref>A) [<xref ref-type="bibr" rid="bib260">260</xref>,<xref ref-type="bibr" rid="bib261">261</xref>]. Kumagai et al. have established a GC-MS assay and quantitated four aromatic hydrocarbon quinones, including 9,10-PQ, in DEP and PM<sub>2.5</sub> and found that 9,10-PQ is abundant in these particles [<xref ref-type="bibr" rid="bib262">262</xref>]. Intratracheal administration of DEP or 9,10-PQ to ICR mice upregulates of IL-5 and other inflammatory response-related genes [<xref ref-type="bibr" rid="bib263">263</xref>,<xref ref-type="bibr" rid="bib264">264</xref>], and 9,10-PQ exposure recruits inflammatory cells to the murine airways [<xref ref-type="bibr" rid="bib265">265</xref>]. In A549 or MOLT-4 cells, 9,10-PQ exposure causes apoptotic cell death [<xref ref-type="bibr" rid="bib266">266</xref>,<xref ref-type="bibr" rid="bib267">267</xref>]. Quinone-mediated toxicity has been proposed to be caused by at least two mechanisms: (1) excess production of ROS through redox cycling as mentioned below, and (2) direct covalent modification to nucleophiles such as thiols by Michael addition chemistry. While 9,10-PQ has α,β-unsaturated carbonyl groups, this quinoid undergoes redox cycling, and does not serve as a Michael acceptor [<xref ref-type="bibr" rid="bib268">[268]</xref>, <xref ref-type="bibr" rid="bib269">[269]</xref>, <xref ref-type="bibr" rid="bib270">[270]</xref>]. This indicates that 9,10-PQ is a risk factor in the atmosphere specifically through excess ROS generation. Cd, which is detected in ambient air, enhances the pro-inflammatory responses induced by 9,10-PQ in airway epithelial cells, specifically the BEAS-2B cell line [<xref ref-type="bibr" rid="bib271">271</xref>].<fig id="fig4"><label>Fig. 4</label><caption><p><bold>The generation of quinones and the activation of redox signaling pathway.</bold> (A) Polyaromatic hydrocarbons, such as phenanthrene undergoes photo-oxidation in the environment or metabolic activation by enzymes, yielding its quinone. (B) 9,10-Phenanthraquinone (9,10-PQ) is reduced by enzymes such as NAD(P)H quinone dehydrogenase (NQO1) or aldo-keto reductase (AKR) to 9,10-dihydroxyphenanthrene (9,10-PQH<sub>2</sub>), which is conjugated with glucuronic acid by glucuronosyltransferases (UGT) and then excreted viamultidrug-associated proteins (MRP). 9,10-PQH<sub>2</sub> is also able to react with superoxide (O<sub>2</sub><sup>•–</sup>) to form its semiquinone radical (9,10-PQ<sup>•–</sup>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Alternatively, 9,10-PQ<sup>•–</sup> is generated by disproportionation reaction of 9,10-PQ with 9,10-PQH<sub>2</sub>. The 9,10-PQ<sup>•–</sup> produced interacts with molecular oxygen (O<sub>2</sub>) to form 9,10-PQ and O<sub>2</sub><sup>•–</sup>. Thus, H<sub>2</sub>O<sub>2</sub> during these redox cycle reactions of 9,10-PQ could activate redox signaling pathways mimicking endogenous H<sub>2</sub>O<sub>2</sub>.</p></caption><alt-text id="alttext0030">Fig. 4</alt-text><graphic xlink:href="gr4"></graphic></fig></p>
<p id="p0335">Nitric oxide synthase (NOS), which synthesizes NO from <sc>l</sc>-arginine, plays an important role in neurotransmission, vasorelaxation, and immune response [<xref ref-type="bibr" rid="bib272">272</xref>]. A C-terminal reductase domain in NOS is able to transfer electrons from NADPH to other acceptors [<xref ref-type="bibr" rid="bib273">273</xref>]. A variety of quinones inhibit neuronal NO synthase (nNOS) activity; in one study, among 21 quinones, 9,10-PQ (with a one-electron reduction potential of −124 mV) is the most potent inhibitor of nNOS. Using purified nNOS, Kumagai et al. have found that 9,10-PQ interacts with the NADPH-P450 reductase domain on nNOS and thus inhibits NO production (IC<sub>50</sub> = 10 μM) by shunting electrons away from the normal catalytic activity [<xref ref-type="bibr" rid="bib274">274</xref>]. 9,10-PQ is also a potent inhibitor of endothelial NOS activity (IC<sub>50</sub> = 0.6 μM), thereby suppressing acetylcholine-dependent vasorelaxation of the aortic rings of rats and increasing their blood pressure [<xref ref-type="bibr" rid="bib275">275</xref>]. 9,10-PQ also undergoes one-electron reduction by cytochrome P450 reductase in the presence of NADPH and by dithiols or persulfides such as dihydrolipoic acid, DTT, or Na<sub>2</sub>S<sub>2</sub> to yield the semiquinone radical of 9,10-PQ (9,10-PQ<sup>•−</sup>), which reacts with oxygen to form 9,10-PQ and superoxide (<xref ref-type="fig" rid="fig4">Fig. 4</xref>B) [<xref ref-type="bibr" rid="bib259">259</xref>,<xref ref-type="bibr" rid="bib268">268</xref>,<xref ref-type="bibr" rid="bib276">276</xref>,<xref ref-type="bibr" rid="bib277">277</xref>]. From these observations, O<sub>2</sub> is evidently a key factor to initiate 9,10-PQ-mediated toxicity through ROS generation. Consistent with this, the toxicity of this quinone to the marine bacterium <italic>Vibrio fischeri</italic> is found to be lower under anaerobic conditions [<xref ref-type="bibr" rid="bib278">278</xref>]. Furthermore, aldo-keto reductase (AKR) isozymes, NQO1, and <sc>l</sc>-xylulose reductase can catalyze two-electron reduction of 9,10-PQ to produce 9,10-dihydroxyphenanthrene (9,10-PQH<sub>2</sub>), which reacts with parent 9,10-PQ through a disproportionation reaction forming 9,10-PQ<sup>•−</sup> as well [<xref ref-type="bibr" rid="bib279">279</xref>]. However, the monoglucuronide of 9,10-PQH<sub>2</sub> (9,10-PQHG) produced by UDP-glucuronosyltransferase (UGT) isoforms is no longer redox-active and is excreted into extracellular space through multidrug-associated proteins (MRPs) (<xref ref-type="fig" rid="fig4">Fig. 4</xref>B) [<xref ref-type="bibr" rid="bib280">280</xref>]. Such a glucuronide of 9,10-PQ has been also detected in the urine of residents of suburban Kanazawa, Japan [<xref ref-type="bibr" rid="bib281">281</xref>]. The important thing is that the gene expressions of the AKRs, NQO1, UGTs, and MRPs involved in biotransformation of 9,10-PQ to 9,10-PQHG are cooperatively regulated by transcription factor NRF2 [<xref ref-type="bibr" rid="bib279">279</xref>,<xref ref-type="bibr" rid="bib280">280</xref>,<xref ref-type="bibr" rid="bib282">282</xref>,<xref ref-type="bibr" rid="bib283">283</xref>]. Therefore, NRF2 deletion is found to markedly enhance 9,10-PQ toxicity [<xref ref-type="bibr" rid="bib280">280</xref>]. Interestingly, ambient air samples collected in California activates NRF2 through oxidative and electrophilic stresses [<xref ref-type="bibr" rid="bib284">284</xref>,<xref ref-type="bibr" rid="bib285">285</xref>]. Suzuki et al. recently reports that H<sub>2</sub>O<sub>2</sub> oxidizes KEAP1 to form disulfide bonds between Cys226 and Cys613, Cys226 and Cys622/624, or Cys613 and Cys622/624 [<xref ref-type="bibr" rid="bib103">103</xref>], leading to NRF2 activation. Collectively, it appears that NRF2 activation mediated by exposure to air pollutants is, at least in part, caused by ROS generators such as 9,10-PQ through oxidation of KEAP1.</p>
</sec>
<sec id="sec8">
<label>8</label>
<title>Epigenetic regulations of NRF2 linked to cancer and other diseases by environmental chemicals</title>
<p id="p0340">Epigenetic regulations such as DNA methylation, histone modifications, microRNA (miRNA) and long noncoding RNA (lncRNA) degradation have been emergingly reported as NRF2 modulations.</p>
<sec id="sec8.1">
<label>8.1</label>
<title>DNA methylation</title>
<p id="p0345">DNA methylation is widely observed from prokaryotes to vertebrates. In mammalian cells, DNA methylation is established by three types of DNA methyltransferases (DNMTs), DNMT3a, DNMT3b and DNMT1. DNA methylation can be reversed by the ten eleven translocation (TET) enzymes [<xref ref-type="bibr" rid="bib286">286</xref>]. CpG islands are GC-rich DNA stretches mainly found in promoter regions of genes, and are predominantly nonmethylated [<xref ref-type="bibr" rid="bib287">287</xref>]. Methylation of the CpG islands is associated with alterations in chromatin structure, genomic imprinting, transposon and chromosome X inactivation, differentiation, and cancer [<xref ref-type="bibr" rid="bib288">288</xref>]. The effect of DNA methylation is achieved by proteins containing methyl-CpG binding domains (MBDs). Such MBD-containing proteins appear to act as structural proteins, which recruit a variety of histone deacetylase complexes and chromatin remodelling factors, leading to chromatin condensation and thus resulting in transcriptional repression [<xref ref-type="bibr" rid="bib289">289</xref>].</p>
<p id="p0350">DNA methylation on both KEAP1 and NRF2 can regulate the NRF2 signaling pathway. In solid tumors and cancers, the hypermethylation of KEAP1 promoter causes NRF2 nuclear accumulation in lung, breast, renal cell carcinoma, colorectal cancer, head and neck cancer tissues [<xref ref-type="bibr" rid="bib290">290</xref>]. On the other hand, the hypermethylation of KEAP1 promoter is mainly playing protective roles in oxidative stress related diseases, such as diabetes and aging [<xref ref-type="bibr" rid="bib291">[291]</xref>, <xref ref-type="bibr" rid="bib292">[292]</xref>, <xref ref-type="bibr" rid="bib293">[293]</xref>]. Epigenetic modifications on NRF2 are investigated to a lesser extent. Yu and colleagues have identified the CpG islands in the promoter region of NRF2; moreover, the repression of NRF2 in prostate tumors is due to the hypermethylation of those CpG islands. The addition of DNMT inhibitor restores NRF2 expression and dissociation of MBD2 and methylated histones [<xref ref-type="bibr" rid="bib294">294</xref>]. Suppression of NRF2 hypermethylation by γ-tocopherol–rich mixture of tocopherols (γ-TmT) in mice appears to be associated with higher NRF2 and NQO-1 protein levels, which is found to be involved in the action of many dietary chemo-preventive chemicals [<xref ref-type="bibr" rid="bib295">295</xref>]. Furthermore, 5-fluorouracil- (5-FU-) induced ROS activates DNA demethylases and produces a hypomethylated NRF2 promoter, which consequently activates the translocation of NRF2 and enhances the resistance to 5-FU in cancer cells [<xref ref-type="bibr" rid="bib296">296</xref>].</p>
</sec>
<sec id="sec8.2">
<label>8.2</label>
<title>Histone modifications</title>
<p id="p0355">Four core histone proteins wrap up eukaryotic DNA and fold into chromatin fibers. This highly organized protein-DNA complex consists of two configurations: condensed heterochromatin and easily transcribed euchromatin [<xref ref-type="bibr" rid="bib297">297</xref>,<xref ref-type="bibr" rid="bib298">298</xref>]. The post-translational modifications of histone residues modify chromatin structure and further regulate the transcriptional activity of various genes on the chromatin. Histone modifications consist of histone acetylation, methylation and modification on readers.</p>
<p id="p0360">Histone acetylation destabilizes the nucleosome structure and promotes the accessibility of transcriptional factors to a genetic locus, thereby activating gene transcription, supported by convincing evidence [<xref ref-type="bibr" rid="bib299">299</xref>]. Histone acetylation is achieved by histone acetyltransferases (HATs), while histone deacetylases (HDACs) remove the acetyl groups. The mammalian sirtuins (SIRT1-7) belong to NAD<sup>+</sup> dependent HDACs. As the most studied sirtuin, SIRT1 can deacetylate both histone and non-histone targets, thus is deeply involved in cellular processes, such as apoptosis, autophagy, aging and tumorigenesis [<xref ref-type="bibr" rid="bib300">300</xref>]. Amongst the various deacetylate targets of SIRT1, NRF2 deacetylation by SIRT1 enhances the activity of KEAP1/NRF2/ARE pathway in glomerular mesangial cells under oxidative stress [<xref ref-type="bibr" rid="bib301">301</xref>]. Huang et al. further noted that NRF2 positively regulates SIRT1 protein expression and deacetylase activity, forming a positive feedback loop to inhibit the development of diabetic nephropathy (DN) [<xref ref-type="bibr" rid="bib302">302</xref>]. This protective effect is further supported by a recent study adopting a potent SIRT1 activator, SRT2104 [<xref ref-type="bibr" rid="bib303">303</xref>]. Besides DN, SIRT1-induced NRF2 activation and related protective effects have been noted in acute lung injury [<xref ref-type="bibr" rid="bib304">304</xref>], optic neuritis [<xref ref-type="bibr" rid="bib305">305</xref>], oocytes aging [<xref ref-type="bibr" rid="bib306">306</xref>], and vascular calcification [<xref ref-type="bibr" rid="bib307">307</xref>], to name a few. The major roles of SIRT1 in response to environmental stress and DNA damage have been extensively reviewed elsewhere [<xref ref-type="bibr" rid="bib308">308</xref>]. Mn significantly suppresses the acetylation of histone H3 and H4 in PC12 and SHSY5Y cells by increasing HDAC3 and HDAC4 activities and inactivating HATs [<xref ref-type="bibr" rid="bib309">309</xref>]. Down-regulation of histone acetylation by HAT inhibitor anacardic acid causes inhibition of NRF2 nuclear translocation and suppresses Mn-activated NRF2/HO-1 pathway. This histone deacetylation also increases the ROS production and decreases GSH in neurons [<xref ref-type="bibr" rid="bib310">310</xref>]. Nevertheless, HDAC inhibition does not always lead to NRF2 activation, especially in airway epithelial cells or lung inflammation conditions [<xref ref-type="bibr" rid="bib311">311</xref>]. Furthermore, NRF2-mediated oxidative stress responses can have an epigenetic impact by modulations of HDAC activity conversely [<xref ref-type="bibr" rid="bib312">312</xref>,<xref ref-type="bibr" rid="bib313">313</xref>].</p>
<p id="p0365">EZH2, a methyltransferase involved in histone methylation, can trimethylate lysine 27 on histone H3 (H3K27Me3) in the NFR2 promoter region and leads to transcription repression [<xref ref-type="bibr" rid="bib289">289</xref>,<xref ref-type="bibr" rid="bib314">314</xref>]. In addition, histone-lysine N-methyltransferase (SetD7) monomethylates histone H3 lysine 4 (H3K4me1) and increases the binding of transcription factor [<xref ref-type="bibr" rid="bib315">315</xref>]. The findings suggest that histone methylation can lead to either gene activation or suppression depending on which residue is methylated and the degree of methylation.</p>
<p id="p0370">H<sub>2</sub>O<sub>2</sub> induced ROS production can be ameliorated by the inhibition of BET (bromodomain and extraterminal) proteins, which are known as acetyl-lysine readers and act as negative regulators of NRF2 signaling pathway [<xref ref-type="bibr" rid="bib316">316</xref>,<xref ref-type="bibr" rid="bib317">317</xref>]. However, in the toxicology field, not much study has been carried out yet.</p>
</sec>
<sec id="sec8.3">
<label>8.3</label>
<title>Noncoding RNAs</title>
<p id="p0375">miRNAs are single stranded non-coding RNA molecules of approximately 22 nucleotides. miRNAs are able to regulate gene expression by complementarily binding to the 3′-untranslated regions (3′-UTRs) of target mRNAs. The changes in miRNA levels can be induced by exposure to persistent chemicals, endocrine disrupting chemicals, heavy metals and pesticides. Next to redox stress, the toxicity of these environmental chemicals can also be mediated by the alteration of miRNAs, which participate in cellular processes by regulating target gene expressions. miRNAs are also able to “fine-tune” redox signaling by interacting with NRF2 [<xref ref-type="bibr" rid="bib318">318</xref>]. The first documented miRNA that negatively regulates NRF2 expression is miR-28, found in MCF-7 breast cancer cells [<xref ref-type="bibr" rid="bib319">319</xref>]. This modulation of NRF2 is then found in miR155 [<xref ref-type="bibr" rid="bib320">320</xref>], miR144 [<xref ref-type="bibr" rid="bib321">321</xref>], miR93 [<xref ref-type="bibr" rid="bib322">322</xref>], miR153, miR27a, miR-142-5p [<xref ref-type="bibr" rid="bib323">323</xref>], miR340 [<xref ref-type="bibr" rid="bib324">324</xref>], miR-507, miR-634, miR-450a and miR-129-5p [<xref ref-type="bibr" rid="bib325">325</xref>]. miR-140-5p attenuates oxidative stress in Cisplatin induced acute kidney injury by activating NRF2/ARE pathway through a KEAP1-independent mechanism. miR-140-5p directly targets the 3′-UTR of NRF2 mRNA and plays a positive role in the regulation of NRF2 expression [<xref ref-type="bibr" rid="bib326">326</xref>]. PQ and MPTP alter microRNA expression profiles and downregulate expression of miR‐17‐5p, which contributes to PQ‐ induced dopaminergic neurodegeneration [<xref ref-type="bibr" rid="bib327">327</xref>]. Moreover, Li et al. have found that miR-380-3p blocks the translation of Sp3 in the presence of PQ-induced neurotoxicity [<xref ref-type="bibr" rid="bib328">328</xref>].</p>
<p id="p0380">Not only the direct binding of miRNAs to NRF2 mRNA alters its activity, binding to KEAP1 mRNA also plays a role in NRF2 activity regulation. The first miRNA found to induce NRF2 nuclear translocation is miR-141 in ovarian carcinoma cell lines [<xref ref-type="bibr" rid="bib329">329</xref>].</p>
<p id="p0385">Other than miRNAs, lncRNAs larger than 200 nucleotides are also involved in regulating the KEAP1/NRF2 pathway. The smoke and cancer-associated lncRNA1 (SCAL1) is the first characterized lncRNA activated by NRF2, and it functions as a downstream mediator against oxidative stress [<xref ref-type="bibr" rid="bib330">330</xref>].</p>
</sec>
</sec>
<sec id="sec9">
<label>9</label>
<title>Summary and conclusions</title>
<p id="p0390">As shown in <xref ref-type="fig" rid="fig5">Fig. 5</xref>, KEAP1 binds to NRF2 under normal conditions, followed by NRF2 ubiquitination and degradation. When exposed to environmental chemicals such as atmospheric quinones, pesticides or heavy metals, oxidative stress is induced including ROS or electrophiles, causing disassociation of KEAP1 and NRF2. NRF2 then translocates from cytoplasm to nucleus and binds to ARE, following interaction with a partner protein small MAF (sMAF), activating the transcription of downstream detoxing enzymes and antioxidants such as HO-1 and NQO-1. Besides KEAP1/NRF2, redox cycling can activate other signaling pathways including PTP1B/EGFR, PTEN/Akt, HSP90/HSF1, etc. On the other hand, NRF2 signaling can be regulated by p21 and p62 induced KEAP1 inhibition or GSK-3 related NRF2 activation. Moreover, epigenetic modifications of NRF2 have drawn increasing attention, including DNA methylation, histone acetylation and noncoding RNAs-involved regulations.<fig id="fig5"><label>Fig. 5</label><caption><p><bold>NRF2 signaling pathway in the context of environmental pollutants induced redox toxicity and its regulation.</bold> Exposure of environmental toxicants such as atmospheric pollutants, pesticides and heavy metals could cause oxidative stress, including ROS and electrophiles. Besides the well-known PTP1B/EGFR, PTEN/AKT and HSP90/HSF1 pathways, NRF2 can be activated. This NRF2 activation can be induced by the negative regulation of KEAP1 through Cys residues or by the inhibition of KEAP1/NRF2 complex stability via p21, p62 and PKC. Upon the dissociation of KEAP1, NRF2 no longer proceeds to the ubiquitination and degradation, resulting in the translocation to the nucleus. The translocated NRF2 heterodimerizes with other nuclear factors such as sMAF and binds to AREs, driven the activation of detoxing enzymes and antioxidants. This process is also epigenetically regulated. For instance, the hypermethylation of KEAP1 promoter results in NRF2 nuclear translocation, while the hypermethylation of NRF2 promoter represses NRF2. Environmental pollutants could modulate histone acetylation through histone acetyltransferases (HATs) or histone deacetylases (HDACs). Finally, miRNAs and LncRNAs also involve in this regulation process.</p></caption><alt-text id="alttext0035">Fig. 5</alt-text><graphic xlink:href="gr5"></graphic></fig></p>
<p id="p0395">The regulation of NRF2 in response to various environmental toxicants is closely linked to human diseases. First of all, genes targeted by NRF2 protect cells from age-related pathologies by either neutralizing free radicals to prevent damages from occurring or fight against the damages. The lose of NRF2 results in neurodegenerative disorders such as PD, AD and age-related cancers [<xref ref-type="bibr" rid="bib331">331</xref>]. Morover, NRF2 activators have been proposed to be a therapeutic target in AD [<xref ref-type="bibr" rid="bib332">332</xref>]. In diabetic cardiomyopathy and hypertension, the protective role of NRF2 is also suggested [<xref ref-type="bibr" rid="bib333">333</xref>]. However, this activation of NRF2 has to be undertaken with cation. Some studies suggested that hyperactivation of NRF2 and its target gene HO-1 has a detrimental effect in atherosclerosis and vascular clacification owing to NRF2-mediated inflammation [<xref ref-type="bibr" rid="bib334">334</xref>,<xref ref-type="bibr" rid="bib335">335</xref>]. Moreover, constitutive NRF2 activation and its subsequent upregulation of iron storage protein can lead to enhanced proliferation of cancer and thus therapy resistance [<xref ref-type="bibr" rid="bib336">336</xref>]. Besides NRF2, other redox cycling activated pathways play a role in diseases. The activation PTP1B/EGFR pathway participates in endothelial dysfunction, resulting in cardiovascular disorders and diabetes [<xref ref-type="bibr" rid="bib337">337</xref>]. PTEN, the tumor suppressor which negatively regulates Akt, plays a key role in cell proliferation and migration, glucose uptake and ovarian dysfunction. Dysregulation of the signaling pathway may contribute to cancer, obesity, cardiovascular dysfunction and infertility [<xref ref-type="bibr" rid="bib338">338</xref>,<xref ref-type="bibr" rid="bib339">339</xref>]. HSP90 and HSF1 are also highly associated with neurodegenerative diseases and cancer owing to their role in protein misfolding [<xref ref-type="bibr" rid="bib340">340</xref>,<xref ref-type="bibr" rid="bib341">341</xref>]. In skin aging and skin carcinogenesis, however, a star transcription factor has to be pointed out, the aryl hydrocarbon receptor (AHR). AHR activated by environmental stressors such as organic compounds and UV radiation is of considerable importance in regulating keratinocyte proliferation, epidermal barrier function, immunity and melanogenesis. While long-term activation of AHR could result in premature aging [<xref ref-type="bibr" rid="bib342">342</xref>].</p>
<p id="p0400">Worth-pointing out, redox signaling impacts gut microbiome, metabolome and proteome. Thanks to the development of high-throughput techniques in defining and analyzing massive components, concepts such as microbiome, metabolome and proteome emerged. The gut microbiome is considered as an “organ” consisting of thousands of microoganisms and 150 times more genes than the human genome, The disturbance of microbiome by oxidative stress can affect health status by inducing pathophysiological responses in the host [<xref ref-type="bibr" rid="bib343">343</xref>]. The metabolic products from gut microbes can regulate host metabolism. The alterations in the metabolome can both be affected by and lead to redox toxicity, associating to various dietary disorders and diseases [<xref ref-type="bibr" rid="bib344">344</xref>,<xref ref-type="bibr" rid="bib345">345</xref>]. Similarly, proteome alterations and proteostasis disturbance are cellular responses to environmental exposure in a redox-dependent manner [<xref ref-type="bibr" rid="bib346">346</xref>].</p>
<p id="p0405">Although NRF2 has been discussed and studied extensively, as additional environmental issues emerge and (epi)genetic mechanisms are characterized, further studies will be required. For instance, the unresolved mechanisms involved in the activation of NRF2 pathway independent of oxidative stress nor KEAP1 need further investigations. Moreover, deeper understanding of pesticides or metals associated NRF2 regulations should be addressed on both upstream and downstream of NRF2-centered signaling pathways. Finally, given that several studies have shown correlative effects between toxicants and epigenetic regulation, more research is needed to draw a connective network of cellular responses to environmental chemicals.</p>
<p id="p0410">In conclusion, our review summarizes the activation mechanisms of NRF2 and related pathways upon exposure to environmental toxicants, including metals, pesticides and atmospheric pollutants. This regulation of NRF2 can be achieved both genetically and epigenetically. The adverse redox signaling by environmental chemicals impacts multiple clinical disorders, such as cancer, cardiovascular and neurodegenerative diseases. Nonetheless, addtional research on the topic is needed to better characterize up- and down-stream regulators of the pathway.</p>
</sec>
<sec id="sec10">
<title>Funding</title>
<p id="p0415">This work is supported by the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source> [grant numbers R01ES07331, R01ES10563], the <funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source> [grant number 81573195, 81903352, 81973083], the Joint Funds for the <funding-source id="gs4">Innovation of Science and Technology, Fujian province</funding-source> [grant number 2017Y9105] and grant-in-aids for scientific research from the <funding-source id="gs5"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001700</institution-id><institution>Ministry of Education, Culture, Sports, Science, and Technology of Japan</institution></institution-wrap></funding-source> [grant number 18H05293, 17K15489].</p>
</sec>
<sec sec-type="COI-statement">
<title>Declaration of competing interest</title>
<p id="p0420">We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled “<bold>Redox Toxicology of Environmental Chemicals Causing Oxidative Stress</bold>”.</p>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<label>1</label>
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>A.O.W.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>M.H.</given-names>
</name>
</person-group>
<article-title>The association of environmental toxicants and autism spectrum disorders in children</article-title>
<source/>Environ. Pollut.
          <volume>227</volume>
<year>2017</year>
<fpage>234</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="pmid">28475976</pub-id>
</element-citation>
</ref>
<ref id="bib2">
<label>2</label>
<element-citation id="sref2" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahn</surname>
<given-names>L.G.</given-names>
</name>
<name>
<surname>Trasande</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Environmental toxicant exposure and hypertensive disorders of pregnancy: recent findings</article-title>
<source/>Curr. Hypertens. Rep.
          <volume>20</volume>
<issue>10</issue>
<year>2018</year>
<fpage>87</fpage>
<pub-id pub-id-type="pmid">30090982</pub-id>
</element-citation>
</ref>
<ref id="bib3">
<label>3</label>
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riancho</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The increasing importance of environmental conditions in amyotrophic lateral sclerosis</article-title>
<source/>Int. J. Biometeorol.
          <volume>62</volume>
<issue>8</issue>
<year>2018</year>
<fpage>1361</fpage>
<lpage>1374</lpage>
<pub-id pub-id-type="pmid">29713861</pub-id>
</element-citation>
</ref>
<ref id="bib4">
<label>4</label>
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drechsel</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease</article-title>
<source/>Free Radic. Biol. Med.
          <volume>44</volume>
<issue>11</issue>
<year>2008</year>
<fpage>1873</fpage>
<lpage>1886</lpage>
<pub-id pub-id-type="pmid">18342017</pub-id>
</element-citation>
</ref>
<ref id="bib5">
<label>5</label>
<element-citation id="sref5" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cosselman</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Navas-Acien</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Environmental factors in cardiovascular disease</article-title>
<source/>Nat. Rev. Cardiol.
          <volume>12</volume>
<issue>11</issue>
<year>2015</year>
<fpage>627</fpage>
<pub-id pub-id-type="pmid">26461967</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<label>6</label>
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navas-Acien</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Lead exposure and cardiovascular disease—a systematic review</article-title>
<source/>Environ. Health Perspect.
          <volume>115</volume>
<issue>3</issue>
<year>2007</year>
<fpage>472</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="pmid">17431501</pub-id>
</element-citation>
</ref>
<ref id="bib7">
<label>7</label>
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tellez-Plaza</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Cadmium exposure and clinical cardiovascular disease: a systematic review</article-title>
<source/>Curr. Atherosclerosis Rep.
          <volume>15</volume>
<issue>10</issue>
<year>2013</year>
<fpage>356</fpage>
</element-citation>
</ref>
<ref id="bib8">
<label>8</label>
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ke</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Post-translational modifications in MeHg-induced neurotoxicity</article-title>
<source/>Biochim. Biophys. Acta (BBA) - Mol. Basis Dis.
          <volume>1865</volume>
<issue>8</issue>
<year>2019</year>
<fpage>2068</fpage>
<lpage>2081</lpage>
</element-citation>
</ref>
<ref id="bib9">
<label>9</label>
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Elucidating conserved transcriptional networks underlying pesticide exposure and Parkinson's disease: a focus on chemicals of epidemiological relevance</article-title>
<source/>Front. Genet.
          <volume>9</volume>
<year>2019</year>
<fpage>701</fpage>
<pub-id pub-id-type="pmid">30740124</pub-id>
</element-citation>
</ref>
<ref id="bib10">
<label>10</label>
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lind</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Lind</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Endocrine-disrupting chemicals and risk of diabetes: an evidence-based review</article-title>
<source/>Diabetologia
          <volume>61</volume>
<issue>7</issue>
<year>2018</year>
<fpage>1495</fpage>
<lpage>1502</lpage>
<pub-id pub-id-type="pmid">29744538</pub-id>
</element-citation>
</ref>
<ref id="bib11">
<label>11</label>
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humblet</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Dioxins and cardiovascular disease mortality</article-title>
<source/>Environ. Health Perspect.
          <volume>116</volume>
<issue>11</issue>
<year>2008</year>
<fpage>1443</fpage>
<lpage>1448</lpage>
<pub-id pub-id-type="pmid">19057694</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<label>12</label>
<element-citation id="sref12" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourdrel</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Cardiovascular effects of air pollution</article-title>
<source/>Arch. Cardiovasc. Dis.
          <volume>110</volume>
<issue>11</issue>
<year>2017</year>
<fpage>634</fpage>
<lpage>642</lpage>
<pub-id pub-id-type="pmid">28735838</pub-id>
</element-citation>
</ref>
<ref id="bib13">
<label>13</label>
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antunes Dos Santos</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in methylmercury-induced cell toxicity</article-title>
<source/>Toxics
          <volume>6</volume>
<issue>3</issue>
<year>2018</year>
</element-citation>
</ref>
<ref id="bib14">
<label>14</label>
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Cadmium exposure in living organisms: a short review</article-title>
<source/>Sci. Total Environ.
          <volume>678</volume>
<year>2019</year>
<fpage>761</fpage>
<lpage>767</lpage>
<pub-id pub-id-type="pmid">31085492</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<label>15</label>
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammadi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Pyrethroid exposure and neurotoxicity: a mechanistic approach</article-title>
<source/>Arh. Hig. Rada. Toksikol.
          <volume>70</volume>
<issue>2</issue>
<year>2019</year>
<fpage>74</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="pmid">31246571</pub-id>
</element-citation>
</ref>
<ref id="bib16">
<label>16</label>
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lushchak</surname>
<given-names>V.I.</given-names>
</name>
</person-group>
<article-title>Pesticide toxicity: a mechanistic approach</article-title>
<source/>EXCLI J
          <volume>17</volume>
<year>2018</year>
<fpage>1101</fpage>
<lpage>1136</lpage>
<pub-id pub-id-type="pmid">30564086</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<label>17</label>
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Thurston</surname>
<given-names>G.D.</given-names>
</name>
</person-group>
<article-title>Air pollution, oxidative stress, and diabetes: a life course epidemiologic perspective</article-title>
<source/>Curr. Diabetes Rep.
          <volume>19</volume>
<issue>8</issue>
<year>2019</year>
<fpage>58</fpage>
</element-citation>
</ref>
<ref id="bib18">
<label>18</label>
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo Conte</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>K.S.</given-names>
</name>
</person-group>
<article-title>The redox biochemistry of protein sulfenylation and sulfinylation</article-title>
<source/>J. Biol. Chem.
          <volume>288</volume>
<issue>37</issue>
<year>2013</year>
<fpage>26480</fpage>
<lpage>26488</lpage>
<pub-id pub-id-type="pmid">23861405</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<label>19</label>
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finkel</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Signal transduction by reactive oxygen species</article-title>
<source/>J. Cell Biol.
          <volume>194</volume>
<issue>1</issue>
<year>2011</year>
<fpage>7</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">21746850</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<label>20</label>
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Transcriptional responses to oxidative stress: pathological and toxicological implications</article-title>
<source/>Pharmacol. Ther.
          <volume>125</volume>
<issue>3</issue>
<year>2010</year>
<fpage>376</fpage>
<lpage>393</lpage>
<pub-id pub-id-type="pmid">19945483</pub-id>
</element-citation>
</ref>
<ref id="bib21">
<label>21</label>
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Role of nrf2 in oxidative stress and toxicity</article-title>
<source/>Annu. Rev. Pharmacol. Toxicol.
          <volume>53</volume>
<year>2013</year>
<fpage>401</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="pmid">23294312</pub-id>
</element-citation>
</ref>
<ref id="bib22">
<label>22</label>
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Influence of mental stress and environmental toxins on circadian clocks - implications for redox regulation of the heart and cardioprotection</article-title>
<source/>Br. J. Pharmacol.
          <year>2019</year>
</element-citation>
</ref>
<ref id="bib23">
<label>23</label>
<element-citation id="sref23" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haberzettl</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Circadian toxicity of environmental pollution. Inhalation of polluted air to give a precedent</article-title>
<source/>Curr. Opin. Physiol.
          <volume>5</volume>
<year>2018</year>
<fpage>16</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">30931418</pub-id>
</element-citation>
</ref>
<ref id="bib24">
<label>24</label>
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parmalee</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Aschner</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Metals and circadian rhythms</article-title>
<source/>Adv. Neurotoxicol.
          <volume>1</volume>
<year>2017</year>
<fpage>119</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="pmid">30729219</pub-id>
</element-citation>
</ref>
<ref id="bib25">
<label>25</label>
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>F.L.</given-names>
</name>
</person-group>
<article-title>Emerging evidence for the interrelationship of xenobiotic exposure and circadian rhythms: a review</article-title>
<source/>Xenobiotica
          <volume>36</volume>
<issue>10–11</issue>
<year>2006</year>
<fpage>1140</fpage>
<lpage>1151</lpage>
<pub-id pub-id-type="pmid">17118921</pub-id>
</element-citation>
</ref>
<ref id="bib26">
<label>26</label>
<element-citation id="sref26" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Wild</surname>
<given-names>C.P.</given-names>
</name>
</person-group>
<chapter-title>Complementing the Genome with an “Exposome”: the Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology</chapter-title>
<year>2005</year>
<publisher-name>AACR</publisher-name>
</element-citation>
</ref>
<ref id="bib27">
<label>27</label>
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rappaport</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Implications of the exposome for exposure science</article-title>
<source/>J. Expo. Sci. Environ. Epidemiol.
          <volume>21</volume>
<issue>1</issue>
<year>2011</year>
<fpage>5</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">21081972</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<label>28</label>
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vrijheid</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The exposome: a new paradigm to study the impact of environment on health</article-title>
<source/>Thorax
          <volume>69</volume>
<issue>9</issue>
<year>2014</year>
<fpage>876</fpage>
<lpage>878</lpage>
<pub-id pub-id-type="pmid">24906490</pub-id>
</element-citation>
</ref>
<ref id="bib29">
<label>29</label>
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vineis</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The exposome in practice: design of the EXPOsOMICS project</article-title>
<source/>Int. J. Hyg Environ. Health
          <volume>220</volume>
<issue>2</issue>
<year>2017</year>
<fpage>142</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="pmid">27576363</pub-id>
</element-citation>
</ref>
<ref id="bib30">
<label>30</label>
<element-citation id="sref30" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva-Islas</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Maldonado</surname>
<given-names>P.D.</given-names>
</name>
</person-group>
<article-title>Canonical and non-canonical mechanisms of Nrf2 activation</article-title>
<source/>Pharmacol. Res.
          <year>2018</year>
</element-citation>
</ref>
<ref id="bib31">
<label>31</label>
<element-citation id="sref31" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winterbourn</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Hampton</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>Thiol chemistry and specificity in redox signaling</article-title>
<source/>Free Radic. Biol. Med.
          <volume>45</volume>
<issue>5</issue>
<year>2008</year>
<fpage>549</fpage>
<lpage>561</lpage>
<pub-id pub-id-type="pmid">18544350</pub-id>
</element-citation>
</ref>
<ref id="bib32">
<label>32</label>
<element-citation id="sref32" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumagai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Abiko</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Environmental electrophiles: protein adducts, modulation of redox signaling, and interaction with persulfides/polysulfides</article-title>
<source/>Chem. Res. Toxicol.
          <volume>30</volume>
<issue>1</issue>
<year>2017</year>
<fpage>203</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="pmid">27981839</pub-id>
</element-citation>
</ref>
<ref id="bib33">
<label>33</label>
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>Radical-free biology of oxidative stress</article-title>
<source/>Am. J. Physiol. Cell Physiol.
          <volume>295</volume>
<issue>4</issue>
<year>2008</year>
<fpage>C849</fpage>
<lpage>C868</lpage>
<pub-id pub-id-type="pmid">18684987</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<label>34</label>
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudolph</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Transduction of redox signaling by electrophile-protein reactions</article-title>
<source/>Sci. Signal.
          <volume>2</volume>
<issue>90</issue>
<year>2009</year>
<fpage>re7</fpage>
<pub-id pub-id-type="pmid">19797270</pub-id>
</element-citation>
</ref>
<ref id="bib35">
<label>35</label>
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.Y.</given-names>
</name>
</person-group>
<article-title>Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis</article-title>
<source/>Crit. Rev. Biochem. Mol. Biol.
          <volume>33</volume>
<issue>1</issue>
<year>1998</year>
<fpage>1</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="pmid">9543627</pub-id>
</element-citation>
</ref>
<ref id="bib36">
<label>36</label>
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bae</surname>
<given-names>Y.S.</given-names>
</name>
</person-group>
<article-title>Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation</article-title>
<source/>J. Biol. Chem.
          <volume>272</volume>
<issue>1</issue>
<year>1997</year>
<fpage>217</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">8995250</pub-id>
</element-citation>
</ref>
<ref id="bib37">
<label>37</label>
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor</article-title>
<source/>J. Biol. Chem.
          <volume>273</volume>
<issue>25</issue>
<year>1998</year>
<fpage>15366</fpage>
<lpage>15372</lpage>
<pub-id pub-id-type="pmid">9624118</pub-id>
</element-citation>
</ref>
<ref id="bib38">
<label>38</label>
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiganis</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Protein tyrosine phosphatases: dephosphorylating the epidermal growth factor receptor</article-title>
<source/>IUBMB Life
          <volume>53</volume>
<issue>1</issue>
<year>2002</year>
<fpage>3</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">12018405</pub-id>
</element-citation>
</ref>
<ref id="bib39">
<label>39</label>
<element-citation id="sref39" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumagai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>The chemical biology of naphthoquinones and its environmental implications</article-title>
<source/>Annu. Rev. Pharmacol. Toxicol.
          <volume>52</volume>
<year>2012</year>
<fpage>221</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">21942631</pub-id>
</element-citation>
</ref>
<ref id="bib40">
<label>40</label>
<element-citation id="sref40" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwamoto</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Chemical knockdown of protein-tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor</article-title>
<source/>J. Biol. Chem.
          <volume>282</volume>
<issue>46</issue>
<year>2007</year>
<fpage>33396</fpage>
<lpage>33404</lpage>
<pub-id pub-id-type="pmid">17878162</pub-id>
</element-citation>
</ref>
<ref id="bib41">
<label>41</label>
<element-citation id="sref41" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname>
<given-names>J.N.</given-names>
</name>
</person-group>
<article-title>Structural and evolutionary relationships among protein tyrosine phosphatase domains</article-title>
<source/>Mol. Cell Biol.
          <volume>21</volume>
<issue>21</issue>
<year>2001</year>
<fpage>7117</fpage>
<lpage>7136</lpage>
<pub-id pub-id-type="pmid">11585896</pub-id>
</element-citation>
</ref>
<ref id="bib42">
<label>42</label>
<element-citation id="sref42" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine residue</article-title>
<source/>Biochemistry
          <volume>44</volume>
<issue>21</issue>
<year>2005</year>
<fpage>7704</fpage>
<lpage>7712</lpage>
<pub-id pub-id-type="pmid">15909985</pub-id>
</element-citation>
</ref>
<ref id="bib43">
<label>43</label>
<element-citation id="sref43" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Methylmercury promotes prostacyclin release from cultured human brain microvascular endothelial cells via induction of cyclooxygenase-2 through activation of the EGFR-p38 MAPK pathway by inhibiting protein tyrosine phosphatase 1B activity</article-title>
<source/>Toxicology
          <volume>392</volume>
<year>2017</year>
<fpage>40</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">28958600</pub-id>
</element-citation>
</ref>
<ref id="bib44">
<label>44</label>
<element-citation id="sref44" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simpson</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>Association constants of methylmercury with sulfhydryl and other bases</article-title>
<source/>J. Am. Chem. Soc.
          <volume>83</volume>
<issue>23</issue>
<year>1961</year>
<fpage>4711</fpage>
<lpage>&amp;</lpage>
</element-citation>
</ref>
<ref id="bib45">
<label>45</label>
<element-citation id="sref45" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yehia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>65 years OF the double helix: one gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine</article-title>
<source/>Endocr. Relat. Canc.
          <volume>25</volume>
<issue>8</issue>
<year>2018</year>
<fpage>T121</fpage>
<lpage>T140</lpage>
</element-citation>
</ref>
<ref id="bib46">
<label>46</label>
<element-citation id="sref46" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maehama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate</article-title>
<source/>J. Biol. Chem.
          <volume>273</volume>
<issue>22</issue>
<year>1998</year>
<fpage>13375</fpage>
<lpage>13378</lpage>
<pub-id pub-id-type="pmid">9593664</pub-id>
</element-citation>
</ref>
<ref id="bib47">
<label>47</label>
<element-citation id="sref47" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marte</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Downward</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond</article-title>
<source/>Trends Biochem. Sci.
          <volume>22</volume>
<issue>9</issue>
<year>1997</year>
<fpage>355</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="pmid">9301337</pub-id>
</element-citation>
</ref>
<ref id="bib48">
<label>48</label>
<element-citation id="sref48" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebner</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>PI(3,4,5)P3 engagement restricts Akt activity to cellular membranes</article-title>
<source/>Mol. Cell.
          <volume>65</volume>
<issue>3</issue>
<year>2017</year>
<fpage>416</fpage>
<lpage>431 e6</lpage>
<pub-id pub-id-type="pmid">28157504</pub-id>
</element-citation>
</ref>
<ref id="bib49">
<label>49</label>
<element-citation id="sref49" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarbassov</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex</article-title>
<source/>Science
          <volume>307</volume>
<issue>5712</issue>
<year>2005</year>
<fpage>1098</fpage>
<lpage>1101</lpage>
<pub-id pub-id-type="pmid">15718470</pub-id>
</element-citation>
</ref>
<ref id="bib50">
<label>50</label>
<element-citation id="sref50" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alessi</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha</article-title>
<source/>Curr. Biol.
          <volume>7</volume>
<issue>4</issue>
<year>1997</year>
<fpage>261</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">9094314</pub-id>
</element-citation>
</ref>
<ref id="bib51">
<label>51</label>
<element-citation id="sref51" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stambolic</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN</article-title>
<source/>Cell
          <volume>95</volume>
<issue>1</issue>
<year>1998</year>
<fpage>29</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">9778245</pub-id>
</element-citation>
</ref>
<ref id="bib52">
<label>52</label>
<element-citation id="sref52" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.O.</given-names>
</name>
</person-group>
<article-title>Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association</article-title>
<source/>Cell
          <volume>99</volume>
<issue>3</issue>
<year>1999</year>
<fpage>323</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="pmid">10555148</pub-id>
</element-citation>
</ref>
<ref id="bib53">
<label>53</label>
<element-citation id="sref53" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Reversible inactivation of the tumor suppressor PTEN by H2O2</article-title>
<source/>J. Biol. Chem.
          <volume>277</volume>
<issue>23</issue>
<year>2002</year>
<fpage>20336</fpage>
<lpage>20342</lpage>
<pub-id pub-id-type="pmid">11916965</pub-id>
</element-citation>
</ref>
<ref id="bib54">
<label>54</label>
<element-citation id="sref54" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numajiri</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN)</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>108</volume>
<issue>25</issue>
<year>2011</year>
<fpage>10349</fpage>
<lpage>10354</lpage>
<pub-id pub-id-type="pmid">21646525</pub-id>
</element-citation>
</ref>
<ref id="bib55">
<label>55</label>
<element-citation id="sref55" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shearn</surname>
<given-names>C.T.</given-names>
</name>
</person-group>
<article-title>Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis</article-title>
<source/>Free Radic. Biol. Med.
          <volume>65</volume>
<year>2013</year>
<fpage>680</fpage>
<lpage>692</lpage>
<pub-id pub-id-type="pmid">23872024</pub-id>
</element-citation>
</ref>
<ref id="bib56">
<label>56</label>
<element-citation id="sref56" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abiko</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Polysulfide Na2S4 regulates the activation of PTEN/Akt/CREB signaling and cytotoxicity mediated by 1,4-naphthoquinone through formation of sulfur adducts</article-title>
<source/>Sci. Rep.
          <volume>7</volume>
<issue>1</issue>
<year>2017</year>
<fpage>4814</fpage>
<pub-id pub-id-type="pmid">28684787</pub-id>
</element-citation>
</ref>
<ref id="bib57">
<label>57</label>
<element-citation id="sref57" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miura</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Initial response and cellular protection through the Keap1/Nrf2 system during the exposure of primary mouse hepatocytes to 1,2-naphthoquinone</article-title>
<source/>Chem. Res. Toxicol.
          <volume>24</volume>
<issue>4</issue>
<year>2011</year>
<fpage>559</fpage>
<lpage>567</lpage>
<pub-id pub-id-type="pmid">21384861</pub-id>
</element-citation>
</ref>
<ref id="bib58">
<label>58</label>
<element-citation id="sref58" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds</article-title>
<source/>Mol. Cell Biol.
          <volume>29</volume>
<issue>2</issue>
<year>2009</year>
<fpage>493</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="pmid">19001094</pub-id>
</element-citation>
</ref>
<ref id="bib59">
<label>59</label>
<element-citation id="sref59" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unoki</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Methylmercury, an environmental electrophile capable of activation and disruption of the Akt/CREB/Bcl-2 signal transduction pathway in SH-SY5Y cells</article-title>
<source/>Sci. Rep.
          <volume>6</volume>
<year>2016</year>
<fpage>28944</fpage>
<pub-id pub-id-type="pmid">27357941</pub-id>
</element-citation>
</ref>
<ref id="bib60">
<label>60</label>
<element-citation id="sref60" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindquist</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>E.A.</given-names>
</name>
</person-group>
<article-title>The heat-shock proteins</article-title>
<source/>Annu. Rev. Genet.
          <volume>22</volume>
<year>1988</year>
<fpage>631</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="pmid">2853609</pub-id>
</element-citation>
</ref>
<ref id="bib61">
<label>61</label>
<element-citation id="sref61" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjork</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Sistonen</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Regulation of the members of the mammalian heat shock factor family</article-title>
<source/>FEBS J.
          <volume>277</volume>
<issue>20</issue>
<year>2010</year>
<fpage>4126</fpage>
<lpage>4139</lpage>
<pub-id pub-id-type="pmid">20945529</pub-id>
</element-citation>
</ref>
<ref id="bib62">
<label>62</label>
<element-citation id="sref62" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carbone</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease</article-title>
<source/>J. Pharmacol. Exp. Therapeut.
          <volume>315</volume>
<issue>1</issue>
<year>2005</year>
<fpage>8</fpage>
<lpage>15</lpage>
</element-citation>
</ref>
<ref id="bib63">
<label>63</label>
<element-citation id="sref63" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carbone</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal</article-title>
<source/>Chem. Res. Toxicol.
          <volume>17</volume>
<issue>11</issue>
<year>2004</year>
<fpage>1459</fpage>
<lpage>1467</lpage>
<pub-id pub-id-type="pmid">15540944</pub-id>
</element-citation>
</ref>
<ref id="bib64">
<label>64</label>
<element-citation id="sref64" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hickey</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Sequence and regulation of a gene encoding a human 89-kilodalton heat shock protein</article-title>
<source/>Mol. Cell Biol.
          <volume>9</volume>
<issue>6</issue>
<year>1989</year>
<fpage>2615</fpage>
<lpage>2626</lpage>
<pub-id pub-id-type="pmid">2527334</pub-id>
</element-citation>
</ref>
<ref id="bib65">
<label>65</label>
<element-citation id="sref65" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinkai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Cadmium-mediated activation of the HSP90/HSF1 pathway regulated by reactive persulfides/polysulfides</article-title>
<source/>Toxicol. Sci.
          <volume>156</volume>
<issue>2</issue>
<year>2017</year>
<fpage>412</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="pmid">28115653</pub-id>
</element-citation>
</ref>
<ref id="bib66">
<label>66</label>
<element-citation id="sref66" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The HSP90 family of genes in the human genome: insights into their divergence and evolution</article-title>
<source/>Genomics
          <volume>86</volume>
<issue>6</issue>
<year>2005</year>
<fpage>627</fpage>
<lpage>637</lpage>
<pub-id pub-id-type="pmid">16269234</pub-id>
</element-citation>
</ref>
<ref id="bib67">
<label>67</label>
<element-citation id="sref67" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation</article-title>
<source/>Br. J. Canc.
          <volume>110</volume>
<issue>1</issue>
<year>2014</year>
<fpage>71</fpage>
<lpage>82</lpage>
</element-citation>
</ref>
<ref id="bib68">
<label>68</label>
<element-citation id="sref68" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibata</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Transthiocarbamoylation of proteins by thiolated isothiocyanates</article-title>
<source/>J. Biol. Chem.
          <volume>286</volume>
<issue>49</issue>
<year>2011</year>
<fpage>42150</fpage>
<lpage>42161</lpage>
<pub-id pub-id-type="pmid">21998322</pub-id>
</element-citation>
</ref>
<ref id="bib69">
<label>69</label>
<element-citation id="sref69" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuse</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Conservation of the keap1-nrf2 system: an evolutionary journey through stressful space and time</article-title>
<source/>Molecules
          <volume>22</volume>
<issue>3</issue>
<year>2017</year>
</element-citation>
</ref>
<ref id="bib70">
<label>70</label>
<element-citation id="sref70" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>91</volume>
<issue>21</issue>
<year>1994</year>
<fpage>9926</fpage>
<lpage>9930</lpage>
<pub-id pub-id-type="pmid">7937919</pub-id>
</element-citation>
</ref>
<ref id="bib71">
<label>71</label>
<element-citation id="sref71" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itoh</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins</article-title>
<source/>Mol. Cell Biol.
          <volume>15</volume>
<issue>8</issue>
<year>1995</year>
<fpage>4184</fpage>
<lpage>4193</lpage>
<pub-id pub-id-type="pmid">7623813</pub-id>
</element-citation>
</ref>
<ref id="bib72">
<label>72</label>
<element-citation id="sref72" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>93</volume>
<issue>24</issue>
<year>1996</year>
<fpage>13943</fpage>
<lpage>13948</lpage>
<pub-id pub-id-type="pmid">8943040</pub-id>
</element-citation>
</ref>
<ref id="bib73">
<label>73</label>
<element-citation id="sref73" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroha</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Ablation of Nrf2 function does not increase the erythroid or megakaryocytic cell lineage dysfunction caused by p45 NF-E2 gene disruption</article-title>
<source/>J. Biochem.
          <volume>123</volume>
<issue>3</issue>
<year>1998</year>
<fpage>376</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="pmid">9538217</pub-id>
</element-citation>
</ref>
<ref id="bib74">
<label>74</label>
<element-citation id="sref74" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itoh</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <volume>236</volume>
<issue>2</issue>
<year>1997</year>
<fpage>313</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="pmid">9240432</pub-id>
</element-citation>
</ref>
<ref id="bib75">
<label>75</label>
<element-citation id="sref75" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alam</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene</article-title>
<source/>J. Biol. Chem.
          <volume>274</volume>
<issue>37</issue>
<year>1999</year>
<fpage>26071</fpage>
<lpage>26078</lpage>
<pub-id pub-id-type="pmid">10473555</pub-id>
</element-citation>
</ref>
<ref id="bib76">
<label>76</label>
<element-citation id="sref76" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wild</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Moinova</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Mulcahy</surname>
<given-names>R.T.</given-names>
</name>
</person-group>
<article-title>Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2</article-title>
<source/>J. Biol. Chem.
          <volume>274</volume>
<issue>47</issue>
<year>1999</year>
<fpage>33627</fpage>
<lpage>33636</lpage>
<pub-id pub-id-type="pmid">10559251</pub-id>
</element-citation>
</ref>
<ref id="bib77">
<label>77</label>
<element-citation id="sref77" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanigawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>D.X.</given-names>
</name>
</person-group>
<article-title>Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin</article-title>
<source/>Free Radic. Biol. Med.
          <volume>42</volume>
<issue>11</issue>
<year>2007</year>
<fpage>1690</fpage>
<lpage>1703</lpage>
<pub-id pub-id-type="pmid">17462537</pub-id>
</element-citation>
</ref>
<ref id="bib78">
<label>78</label>
<element-citation id="sref78" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarantini</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Nrf2 deficiency exacerbates obesity-induced oxidative stress, neurovascular dysfunction, blood-brain barrier disruption, neuroinflammation, amyloidogenic gene expression, and cognitive decline in mice, mimicking the aging phenotype</article-title>
<source/>J. Gerontol. A Biol. Sci. Med. Sci.
          <volume>73</volume>
<issue>7</issue>
<year>2018</year>
<fpage>853</fpage>
<lpage>863</lpage>
<pub-id pub-id-type="pmid">29905772</pub-id>
</element-citation>
</ref>
<ref id="bib79">
<label>79</label>
<element-citation id="sref79" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toyama</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Cytoprotective role of Nrf2/Keap1 system in methylmercury toxicity</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <volume>363</volume>
<issue>3</issue>
<year>2007</year>
<fpage>645</fpage>
<lpage>650</lpage>
<pub-id pub-id-type="pmid">17904103</pub-id>
</element-citation>
</ref>
<ref id="bib80">
<label>80</label>
<element-citation id="sref80" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Ambient PM2.5 caused depressive-like responses through Nrf2/NLRP3 signaling pathway modulating inflammation</article-title>
<source/>J. Hazard Mater.
          <volume>369</volume>
<year>2019</year>
<fpage>180</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="pmid">30776601</pub-id>
</element-citation>
</ref>
<ref id="bib81">
<label>81</label>
<element-citation id="sref81" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouvier</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression</article-title>
<source/>Mol. Psychiatr.
          <volume>22</volume>
<issue>12</issue>
<year>2017</year>
<fpage>1701</fpage>
<lpage>1713</lpage>
</element-citation>
</ref>
<ref id="bib82">
<label>82</label>
<element-citation id="sref82" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zolnourian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Galea</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bulters</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Neuroprotective role of the Nrf2 pathway in subarachnoid haemorrhage and its therapeutic potential</article-title>
<source/>Oxid. Med. Cell. Longev.
          <volume>2019</volume>
<year>2019</year>
<fpage>6218239</fpage>
<pub-id pub-id-type="pmid">31191800</pub-id>
</element-citation>
</ref>
<ref id="bib83">
<label>83</label>
<element-citation id="sref83" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The roles of Nrf2 and autophagy in modulating inflammation mediated by TLR4 - NFkappaB in A549cell exposed to layer house particulate matter 2.5 (PM2.5)</article-title>
<source/>Chemosphere
          <volume>235</volume>
<year>2019</year>
<fpage>1134</fpage>
<lpage>1145</lpage>
<pub-id pub-id-type="pmid">31561304</pub-id>
</element-citation>
</ref>
<ref id="bib84">
<label>84</label>
<element-citation id="sref84" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toyama</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Isothiocyanates reduce mercury accumulation via an Nrf2-dependent mechanism during exposure of mice to methylmercury</article-title>
<source/>Environ. Health Perspect.
          <volume>119</volume>
<issue>8</issue>
<year>2011</year>
<fpage>1117</fpage>
<lpage>1122</lpage>
<pub-id pub-id-type="pmid">21382770</pub-id>
</element-citation>
</ref>
<ref id="bib85">
<label>85</label>
<element-citation id="sref85" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury</article-title>
<source/>Behav. Brain Res.
          <volume>336</volume>
<year>2018</year>
<fpage>32</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">28851669</pub-id>
</element-citation>
</ref>
<ref id="bib86">
<label>86</label>
<element-citation id="sref86" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>p62 links autophagy and Nrf2 signaling</article-title>
<source/>Free Radic. Biol. Med.
          <volume>88</volume>
<issue>Pt B</issue>
<year>2015</year>
<fpage>199</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="pmid">26117325</pub-id>
</element-citation>
</ref>
<ref id="bib87">
<label>87</label>
<element-citation id="sref87" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahroba</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The Role of Nrf2 signaling in cancer stem cells: from stemness and self-renewal to tumorigenesis and chemoresistance</article-title>
<source/>Life Sci.
          <year>2019</year>
<fpage>116986</fpage>
<pub-id pub-id-type="pmid">31678283</pub-id>
</element-citation>
</ref>
<ref id="bib88">
<label>88</label>
<element-citation id="sref88" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rojo de la Vega</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>NRF2 and the hallmarks of cancer</article-title>
<source/>Canc. Cell
          <volume>34</volume>
<issue>1</issue>
<year>2018</year>
<fpage>21</fpage>
<lpage>43</lpage>
</element-citation>
</ref>
<ref id="bib89">
<label>89</label>
<element-citation id="sref89" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos-Gomez</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>98</volume>
<issue>6</issue>
<year>2001</year>
<fpage>3410</fpage>
<lpage>3415</lpage>
<pub-id pub-id-type="pmid">11248092</pub-id>
</element-citation>
</ref>
<ref id="bib90">
<label>90</label>
<element-citation id="sref90" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knatko</surname>
<given-names>E.V.</given-names>
</name>
</person-group>
<article-title>Nrf2 activation protects against solar-simulated ultraviolet radiation in mice and humans</article-title>
<source/>Canc. Prev. Res.
          <volume>8</volume>
<issue>6</issue>
<year>2015</year>
<fpage>475</fpage>
<lpage>486</lpage>
</element-citation>
</ref>
<ref id="bib91">
<label>91</label>
<element-citation id="sref91" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekhar</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Nrf2 promotes survival following exposure to ionizing radiation</article-title>
<source/>Free Radic. Biol. Med.
          <volume>88</volume>
<issue>Pt B</issue>
<year>2015</year>
<fpage>268</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="pmid">25975985</pub-id>
</element-citation>
</ref>
<ref id="bib92">
<label>92</label>
<element-citation id="sref92" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Homma</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer</article-title>
<source/>Clin. Canc. Res.
          <volume>15</volume>
<issue>10</issue>
<year>2009</year>
<fpage>3423</fpage>
<lpage>3432</lpage>
</element-citation>
</ref>
<ref id="bib93">
<label>93</label>
<element-citation id="sref93" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menegon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Columbano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Giordano</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The dual roles of NRF2 in cancer</article-title>
<source/>Trends Mol. Med.
          <volume>22</volume>
<issue>7</issue>
<year>2016</year>
<fpage>578</fpage>
<lpage>593</lpage>
<pub-id pub-id-type="pmid">27263465</pub-id>
</element-citation>
</ref>
<ref id="bib94">
<label>94</label>
<element-citation id="sref94" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinkova-Kostova</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Kostov</surname>
<given-names>R.V.</given-names>
</name>
<name>
<surname>Canning</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants</article-title>
<source/>Arch. Biochem. Biophys.
          <volume>617</volume>
<year>2017</year>
<fpage>84</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">27497696</pub-id>
</element-citation>
</ref>
<ref id="bib95">
<label>95</label>
<element-citation id="sref95" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canning</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases</article-title>
<source/>J. Biol. Chem.
          <volume>288</volume>
<issue>11</issue>
<year>2013</year>
<fpage>7803</fpage>
<lpage>7814</lpage>
<pub-id pub-id-type="pmid">23349464</pub-id>
</element-citation>
</ref>
<ref id="bib96">
<label>96</label>
<element-citation id="sref96" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>K.I.</given-names>
</name>
</person-group>
<article-title>Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model</article-title>
<source/>Mol. Cell Biol.
          <volume>26</volume>
<issue>8</issue>
<year>2006</year>
<fpage>2887</fpage>
<lpage>2900</lpage>
<pub-id pub-id-type="pmid">16581765</pub-id>
</element-citation>
</ref>
<ref id="bib97">
<label>97</label>
<element-citation id="sref97" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canning</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sorrell</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Bullock</surname>
<given-names>A.N.</given-names>
</name>
</person-group>
<article-title>Structural basis of Keap1 interactions with Nrf2</article-title>
<source/>Free Radic. Biol. Med.
          <volume>88</volume>
<issue>Pt B</issue>
<year>2015</year>
<fpage>101</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="pmid">26057936</pub-id>
</element-citation>
</ref>
<ref id="bib98">
<label>98</label>
<element-citation id="sref98" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Regulation of Nrf2 transactivation domain activity by p160 RAC3/SRC3 and other nuclear co-regulators</article-title>
<source/>J. Biochem. Mol. Biol.
          <volume>39</volume>
<issue>3</issue>
<year>2006</year>
<fpage>304</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="pmid">16756760</pub-id>
</element-citation>
</ref>
<ref id="bib99">
<label>99</label>
<element-citation id="sref99" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryan</surname>
<given-names>H.K.</given-names>
</name>
</person-group>
<article-title>The Nrf2 cell defence pathway: keap1-dependent and -independent mechanisms of regulation</article-title>
<source/>Biochem. Pharmacol.
          <volume>85</volume>
<issue>6</issue>
<year>2013</year>
<fpage>705</fpage>
<lpage>717</lpage>
<pub-id pub-id-type="pmid">23219527</pub-id>
</element-citation>
</ref>
<ref id="bib100">
<label>100</label>
<element-citation id="sref100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krajka-Kuzniak</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Paluszczak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baer-Dubowska</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>The Nrf2-ARE signaling pathway: an update on its regulation and possible role in cancer prevention and treatment</article-title>
<source/>Pharmacol. Rep.
          <volume>69</volume>
<issue>3</issue>
<year>2017</year>
<fpage>393</fpage>
<lpage>402</lpage>
</element-citation>
</ref>
<ref id="bib101">
<label>101</label>
<element-citation id="sref101" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Motohashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution</article-title>
<source/>Gene Cell.
          <volume>16</volume>
<issue>2</issue>
<year>2011</year>
<fpage>123</fpage>
<lpage>140</lpage>
</element-citation>
</ref>
<ref id="bib102">
<label>102</label>
<element-citation id="sref102" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress</article-title>
<source/>J. Biol. Chem.
          <volume>292</volume>
<issue>41</issue>
<year>2017</year>
<fpage>16817</fpage>
<lpage>16824</lpage>
<pub-id pub-id-type="pmid">28842501</pub-id>
</element-citation>
</ref>
<ref id="bib103">
<label>103</label>
<element-citation id="sref103" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Molecular mechanism of cellular oxidative stress sensing by Keap1</article-title>
<source/>Cell Rep.
          <volume>28</volume>
<issue>3</issue>
<year>2019</year>
<fpage>746</fpage>
<lpage>758 e4</lpage>
<pub-id pub-id-type="pmid">31315052</pub-id>
</element-citation>
</ref>
<ref id="bib104">
<label>104</label>
<element-citation id="sref104" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Bitar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gali-Muhtasib</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The role of the cyclin dependent kinase inhibitor p21(cip1/waf1) in targeting cancer: molecular mechanisms and novel therapeutics</article-title>
<source/>Cancers
          <volume>11</volume>
<issue>10</issue>
<year>2019</year>
</element-citation>
</ref>
<ref id="bib105">
<label>105</label>
<element-citation id="sref105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response</article-title>
<source/>Mol. Cell.
          <volume>34</volume>
<issue>6</issue>
<year>2009</year>
<fpage>663</fpage>
<lpage>673</lpage>
<pub-id pub-id-type="pmid">19560419</pub-id>
</element-citation>
</ref>
<ref id="bib106">
<label>106</label>
<element-citation id="sref106" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villeneuve</surname>
<given-names>N.F.</given-names>
</name>
</person-group>
<article-title>Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels</article-title>
<source/>Cell Cycle
          <volume>8</volume>
<issue>20</issue>
<year>2009</year>
<fpage>3255</fpage>
<lpage>3256</lpage>
<pub-id pub-id-type="pmid">19806015</pub-id>
</element-citation>
</ref>
<ref id="bib107">
<label>107</label>
<element-citation id="sref107" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shan</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Prophylaxis of diallyl disulfide on skin carcinogenic model via p21-dependent Nrf2 stabilization</article-title>
<source/>Sci. Rep.
          <volume>6</volume>
<year>2016</year>
<fpage>35676</fpage>
<pub-id pub-id-type="pmid">27759091</pub-id>
</element-citation>
</ref>
<ref id="bib108">
<label>108</label>
<element-citation id="sref108" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez-Martin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Komatsu</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>p62/SQSTM1 - steering the cell through health and disease</article-title>
<source/>J. Cell Sci.
          <volume>131</volume>
<issue>21</issue>
<year>2018</year>
</element-citation>
</ref>
<ref id="bib109">
<label>109</label>
<element-citation id="sref109" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kageyama</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Negative regulation of the keap1-nrf2 pathway by a p62/sqstm1 splicing variant</article-title>
<source/>Mol. Cell Biol.
          <volume>38</volume>
<issue>7</issue>
<year>2018</year>
</element-citation>
</ref>
<ref id="bib110">
<label>110</label>
<element-citation id="sref110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numazawa</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress</article-title>
<source/>Am. J. Physiol. Cell Physiol.
          <volume>285</volume>
<issue>2</issue>
<year>2003</year>
<fpage>C334</fpage>
<lpage>C342</lpage>
<pub-id pub-id-type="pmid">12700136</pub-id>
</element-citation>
</ref>
<ref id="bib111">
<label>111</label>
<element-citation id="sref111" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pickett</surname>
<given-names>C.B.</given-names>
</name>
</person-group>
<article-title>Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription</article-title>
<source/>J. Biol. Chem.
          <volume>277</volume>
<issue>45</issue>
<year>2002</year>
<fpage>42769</fpage>
<lpage>42774</lpage>
<pub-id pub-id-type="pmid">12198130</pub-id>
</element-citation>
</ref>
<ref id="bib112">
<label>112</label>
<element-citation id="sref112" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>The complexity of the Nrf2 pathway: beyond the antioxidant response</article-title>
<source/>J. Nutr. Biochem.
          <volume>26</volume>
<issue>12</issue>
<year>2015</year>
<fpage>1401</fpage>
<lpage>1413</lpage>
<pub-id pub-id-type="pmid">26419687</pub-id>
</element-citation>
</ref>
<ref id="bib113">
<label>113</label>
<element-citation id="sref113" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response</article-title>
<source/>PloS One
          <volume>4</volume>
<issue>8</issue>
<year>2009</year>
<fpage>e6588</fpage>
<pub-id pub-id-type="pmid">19668370</pub-id>
</element-citation>
</ref>
<ref id="bib114">
<label>114</label>
<element-citation id="sref114" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>H.K.</given-names>
</name>
</person-group>
<article-title>Nrf2 activation involves an oxidative-stress independent pathway in tetrafluoroethylcysteine-induced cytotoxicity</article-title>
<source/>Toxicol. Sci.
          <volume>86</volume>
<issue>2</issue>
<year>2005</year>
<fpage>354</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="pmid">15901913</pub-id>
</element-citation>
</ref>
<ref id="bib115">
<label>115</label>
<element-citation id="sref115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cullinan</surname>
<given-names>S.B.</given-names>
</name>
</person-group>
<article-title>Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival</article-title>
<source/>Mol. Cell Biol.
          <volume>23</volume>
<issue>20</issue>
<year>2003</year>
<fpage>7198</fpage>
<lpage>7209</lpage>
<pub-id pub-id-type="pmid">14517290</pub-id>
</element-citation>
</ref>
<ref id="bib116">
<label>116</label>
<element-citation id="sref116" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duda</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging</article-title>
<source/>Expert Opin. Ther. Targets
          <volume>22</volume>
<issue>10</issue>
<year>2018</year>
<fpage>833</fpage>
<lpage>848</lpage>
<pub-id pub-id-type="pmid">30244615</pub-id>
</element-citation>
</ref>
<ref id="bib117">
<label>117</label>
<element-citation id="sref117" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayes</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of beta-TrCP and GSK-3</article-title>
<source/>Biochem. Soc. Trans.
          <volume>43</volume>
<issue>4</issue>
<year>2015</year>
<fpage>611</fpage>
<lpage>620</lpage>
<pub-id pub-id-type="pmid">26551701</pub-id>
</element-citation>
</ref>
<ref id="bib118">
<label>118</label>
<element-citation id="sref118" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Culbreth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Aschner</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Methylmercury augments Nrf2 activity by downregulation of the Src family kinase Fyn</article-title>
<source/>Neurotoxicology
          <volume>62</volume>
<year>2017</year>
<fpage>200</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="pmid">28736149</pub-id>
</element-citation>
</ref>
<ref id="bib119">
<label>119</label>
<element-citation id="sref119" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Nrf2-mediated liver protection by esculentoside A against acetaminophen toxicity through the AMPK/Akt/GSK3beta pathway</article-title>
<source/>Free Radic. Biol. Med.
          <volume>101</volume>
<year>2016</year>
<fpage>401</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="pmid">27836781</pub-id>
</element-citation>
</ref>
<ref id="bib120">
<label>120</label>
<element-citation id="sref120" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calkins</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease</article-title>
<source/>Antioxidants Redox Signal.
          <volume>11</volume>
<issue>3</issue>
<year>2009</year>
<fpage>497</fpage>
<lpage>508</lpage>
</element-citation>
</ref>
<ref id="bib121">
<label>121</label>
<element-citation id="sref121" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMahon</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron</article-title>
<source/>J. Biol. Chem.
          <volume>279</volume>
<issue>30</issue>
<year>2004</year>
<fpage>31556</fpage>
<lpage>31567</lpage>
<pub-id pub-id-type="pmid">15143058</pub-id>
</element-citation>
</ref>
<ref id="bib122">
<label>122</label>
<element-citation id="sref122" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuadrado</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/beta-TrCP</article-title>
<source/>Free Radic. Biol. Med.
          <volume>88</volume>
<issue>Pt B</issue>
<year>2015</year>
<fpage>147</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">25937177</pub-id>
</element-citation>
</ref>
<ref id="bib123">
<label>123</label>
<element-citation id="sref123" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jain</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Jaiswal</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2</article-title>
<source/>J. Biol. Chem.
          <volume>282</volume>
<issue>22</issue>
<year>2007</year>
<fpage>16502</fpage>
<lpage>16510</lpage>
<pub-id pub-id-type="pmid">17403689</pub-id>
</element-citation>
</ref>
<ref id="bib124">
<label>124</label>
<element-citation id="sref124" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Compeau</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Bartha</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Sulfate-reducing bacteria: principal methylators of mercury in anoxic estuarine sediment</article-title>
<source/>Appl. Environ. Microbiol.
          <volume>50</volume>
<issue>2</issue>
<year>1985</year>
<fpage>498</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="pmid">16346866</pub-id>
</element-citation>
</ref>
<ref id="bib125">
<label>125</label>
<element-citation id="sref125" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hintelmann</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Organomercurials. Their formation and pathways in the environment</article-title>
<source/>Met. Ions Life Sci.
          <volume>7</volume>
<year>2010</year>
<fpage>365</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="pmid">20877813</pub-id>
</element-citation>
</ref>
<ref id="bib126">
<label>126</label>
<element-citation id="sref126" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bisen-Hersh</surname>
<given-names>E.B.</given-names>
</name>
</person-group>
<article-title>Behavioral effects of developmental methylmercury drinking water exposure in rodents</article-title>
<source/>J. Trace Elem. Med. Biol.
          <volume>28</volume>
<issue>2</issue>
<year>2014</year>
<fpage>117</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="pmid">24210169</pub-id>
</element-citation>
</ref>
<ref id="bib127">
<label>127</label>
<element-citation id="sref127" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albores-Garcia</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Early developmental low-dose methylmercury exposure alters learning and memory in periadolescent but not young adult rats</article-title>
<source/>BioMed Res. Int.
          <volume>2016</volume>
<year>2016</year>
<fpage>6532108</fpage>
<pub-id pub-id-type="pmid">26885512</pub-id>
</element-citation>
</ref>
<ref id="bib128">
<label>128</label>
<element-citation id="sref128" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farina</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aschner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>J.B.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in MeHg-induced neurotoxicity</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <volume>256</volume>
<issue>3</issue>
<year>2011</year>
<fpage>405</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="pmid">21601588</pub-id>
</element-citation>
</ref>
<ref id="bib129">
<label>129</label>
<element-citation id="sref129" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karpova</surname>
<given-names>N.N.</given-names>
</name>
</person-group>
<article-title>TrkB overexpression in mice buffers against memory deficits and depression-like behavior but not all anxiety- and stress-related symptoms induced by developmental exposure to methylmercury</article-title>
<source/>Front. Behav. Neurosci.
          <volume>8</volume>
<year>2014</year>
<fpage>315</fpage>
<pub-id pub-id-type="pmid">25309367</pub-id>
</element-citation>
</ref>
<ref id="bib130">
<label>130</label>
<element-citation id="sref130" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Sulforaphane prevents methylmercury-induced oxidative damage and excitotoxicity through activation of the nrf2-ARE pathway</article-title>
<source/>Mol. Neurobiol.
          <volume>54</volume>
<issue>1</issue>
<year>2017</year>
<fpage>375</fpage>
<lpage>391</lpage>
<pub-id pub-id-type="pmid">26742517</pub-id>
</element-citation>
</ref>
<ref id="bib131">
<label>131</label>
<element-citation id="sref131" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity</article-title>
<source/>Glia
          <volume>59</volume>
<issue>5</issue>
<year>2011</year>
<fpage>810</fpage>
<lpage>820</lpage>
<pub-id pub-id-type="pmid">21351162</pub-id>
</element-citation>
</ref>
<ref id="bib132">
<label>132</label>
<element-citation id="sref132" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Methylmercury toxicity and Nrf2-dependent detoxification in astrocytes</article-title>
<source/>Toxicol. Sci.
          <volume>107</volume>
<issue>1</issue>
<year>2009</year>
<fpage>135</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="pmid">18815141</pub-id>
</element-citation>
</ref>
<ref id="bib133">
<label>133</label>
<element-citation id="sref133" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumagai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>The role of the Keap1/Nrf2 pathway in the cellular response to methylmercury</article-title>
<source/>Oxid. Med. Cell. Longev.
          <volume>2013</volume>
<year>2013</year>
<fpage>848279</fpage>
<pub-id pub-id-type="pmid">23878621</pub-id>
</element-citation>
</ref>
<ref id="bib134">
<label>134</label>
<element-citation id="sref134" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toyama</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Convenient method to assess chemical modification of protein thiols by electrophilic metals</article-title>
<source/>J. Toxicol. Sci.
          <volume>38</volume>
<issue>3</issue>
<year>2013</year>
<fpage>477</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="pmid">23719925</pub-id>
</element-citation>
</ref>
<ref id="bib135">
<label>135</label>
<element-citation id="sref135" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Abiko</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kumagai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Glutathione adduct of methylmercury activates the Keap1-Nrf2 pathway in SH-SY5Y cells</article-title>
<source/>Chem. Res. Toxicol.
          <volume>27</volume>
<issue>10</issue>
<year>2014</year>
<fpage>1780</fpage>
<lpage>1786</lpage>
<pub-id pub-id-type="pmid">25271560</pub-id>
</element-citation>
</ref>
<ref id="bib136">
<label>136</label>
<element-citation id="sref136" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levonen</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products</article-title>
<source/>Biochem. J.
          <volume>378</volume>
<issue>Pt 2</issue>
<year>2004</year>
<fpage>373</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="pmid">14616092</pub-id>
</element-citation>
</ref>
<ref id="bib137">
<label>137</label>
<element-citation id="sref137" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unoki</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Molecular pathways associated with methylmercury-induced Nrf2 modulation</article-title>
<source/>Front. Genet.
          <volume>9</volume>
<year>2018</year>
<fpage>373</fpage>
<pub-id pub-id-type="pmid">30271424</pub-id>
</element-citation>
</ref>
<ref id="bib138">
<label>138</label>
<element-citation id="sref138" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Underwood</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Trace metals in human and animal health</article-title>
<source/>J. Human Nutr.
          <year>1981</year>
</element-citation>
</ref>
<ref id="bib139">
<label>139</label>
<element-citation id="sref139" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephenson</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and N-acetylcysteine</article-title>
<source/>Toxicol. Lett.
          <volume>218</volume>
<issue>3</issue>
<year>2013</year>
<fpage>299</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="pmid">23296100</pub-id>
</element-citation>
</ref>
<ref id="bib140">
<label>140</label>
<element-citation id="sref140" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guilarte</surname>
<given-names>T.R.</given-names>
</name>
</person-group>
<article-title>Manganese and Parkinson's disease: a critical review and new findings</article-title>
<source/>Environ. Health Perspect.
          <volume>118</volume>
<issue>8</issue>
<year>2010</year>
<fpage>1071</fpage>
<lpage>1080</lpage>
<pub-id pub-id-type="pmid">20403794</pub-id>
</element-citation>
</ref>
<ref id="bib141">
<label>141</label>
<element-citation id="sref141" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guilarte</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>K.K.</given-names>
</name>
</person-group>
<article-title>Manganese-induced parkinsonism is not idiopathic Parkinson's disease: environmental and genetic evidence</article-title>
<source/>Toxicol. Sci.
          <volume>146</volume>
<issue>2</issue>
<year>2015</year>
<fpage>204</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="pmid">26220508</pub-id>
</element-citation>
</ref>
<ref id="bib142">
<label>142</label>
<element-citation id="sref142" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Nrf2/HO‐1 pathway activation by manganese is associated with reactive oxygen species and ubiquitin–proteasome pathway, not MAPKs signaling</article-title>
<source/>J. Appl. Toxicol.
          <volume>31</volume>
<issue>7</issue>
<year>2011</year>
<fpage>690</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="pmid">21384399</pub-id>
</element-citation>
</ref>
<ref id="bib143">
<label>143</label>
<element-citation id="sref143" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>W.-D.</given-names>
</name>
</person-group>
<article-title>Impairment of gill structural integrity by manganese deficiency or excess related to induction of oxidative damage, apoptosis and dysfunction of the physical barrier as regulated by NF-κB, caspase and Nrf2 signaling in fish</article-title>
<source/>Fish Shellfish Immunol.
          <volume>70</volume>
<year>2017</year>
<fpage>280</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="pmid">28887111</pub-id>
</element-citation>
</ref>
<ref id="bib144">
<label>144</label>
<element-citation id="sref144" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>W.-D.</given-names>
</name>
</person-group>
<article-title>Manganese deficiency or excess caused the depression of intestinal immunity, induction of inflammation and dysfunction of the intestinal physical barrier, as regulated by NF-κB, TOR and Nrf2 signalling, in grass carp (Ctenopharyngodon idella)</article-title>
<source/>Fish Shellfish Immunol.
          <volume>46</volume>
<issue>2</issue>
<year>2015</year>
<fpage>406</fpage>
<lpage>416</lpage>
<pub-id pub-id-type="pmid">26072140</pub-id>
</element-citation>
</ref>
<ref id="bib145">
<label>145</label>
<element-citation id="sref145" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>The effect of manganese exposure on GnRH secretion via Nrf2/mGluR5/COX-2/PGE2/signaling pathway</article-title>
<source/>Toxicol. Ind. Health
          <volume>35</volume>
<issue>3</issue>
<year>2019</year>
<fpage>211</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">30862296</pub-id>
</element-citation>
</ref>
<ref id="bib146">
<label>146</label>
<element-citation id="sref146" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Melatonin antagonizes Mn-induced oxidative injury through the activation of keap1–Nrf2–ARE signaling pathway in the striatum of mice</article-title>
<source/>Neurotox. Res.
          <volume>27</volume>
<issue>2</issue>
<year>2015</year>
<fpage>156</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="pmid">25288107</pub-id>
</element-citation>
</ref>
<ref id="bib147">
<label>147</label>
<element-citation id="sref147" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>NF-E2-related factor 2 activation in PC12 cells: its protective role in manganese-induced damage</article-title>
<source/>Arch. Toxicol.
          <volume>85</volume>
<issue>8</issue>
<year>2011</year>
<fpage>901</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="pmid">21107535</pub-id>
</element-citation>
</ref>
<ref id="bib148">
<label>148</label>
<element-citation id="sref148" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>15-Deoxy-Δ12, 14-prostaglandin J2 modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes</article-title>
<source/>Free Radic. Biol. Med.
          <volume>52</volume>
<issue>6</issue>
<year>2012</year>
<fpage>1067</fpage>
<lpage>1074</lpage>
<pub-id pub-id-type="pmid">22245093</pub-id>
</element-citation>
</ref>
<ref id="bib149">
<label>149</label>
<element-citation id="sref149" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahar</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS/NF-κB and HO-1/Nrf2 pathways</article-title>
<source/>Int. J. Mol. Sci.
          <volume>18</volume>
<issue>9</issue>
<year>2017</year>
<fpage>1989</fpage>
</element-citation>
</ref>
<ref id="bib150">
<label>150</label>
<element-citation id="sref150" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anetor</surname>
<given-names>J.I.</given-names>
</name>
</person-group>
<article-title>Rising environmental cadmium levels in developing countries: threat to genome stability and health</article-title>
<source/>Niger. J. Physiol. Sci.
          <volume>27</volume>
<issue>2</issue>
<year>2012</year>
<fpage>103</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="pmid">23652223</pub-id>
</element-citation>
</ref>
<ref id="bib151">
<label>151</label>
<element-citation id="sref151" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimada</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Strain difference of cadmium accumulation by liver slices of inbred Wistar-Imamichi and Fischer 344 rats</article-title>
<source/>Toxicol. Vitro
          <volume>22</volume>
<issue>2</issue>
<year>2008</year>
<fpage>338</fpage>
<lpage>343</lpage>
</element-citation>
</ref>
<ref id="bib152">
<label>152</label>
<element-citation id="sref152" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erbanova</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Export of arsenic from forested catchments under easing atmospheric pollution</article-title>
<source/>Environ. Sci. Technol.
          <volume>42</volume>
<issue>19</issue>
<year>2008</year>
<fpage>7187</fpage>
<lpage>7192</lpage>
<pub-id pub-id-type="pmid">18939545</pub-id>
</element-citation>
</ref>
<ref id="bib153">
<label>153</label>
<element-citation id="sref153" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patra</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rautray</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Swarup</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in lead and cadmium toxicity and its amelioration</article-title>
<source/>Vet. Med. Int.
          <volume>2011</volume>
<year>2011</year>
</element-citation>
</ref>
<ref id="bib154">
<label>154</label>
<element-citation id="sref154" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kadiiska</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>Role of oxidative stress in cadmium toxicity and carcinogenesis</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <volume>238</volume>
<issue>3</issue>
<year>2009</year>
<fpage>209</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">19236887</pub-id>
</element-citation>
</ref>
<ref id="bib155">
<label>155</label>
<element-citation id="sref155" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thevenod</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>W.K.</given-names>
</name>
</person-group>
<article-title>Cadmium and cellular signaling cascades: interactions between cell death and survival pathways</article-title>
<source/>Arch. Toxicol.
          <volume>87</volume>
<issue>10</issue>
<year>2013</year>
<fpage>1743</fpage>
<lpage>1786</lpage>
<pub-id pub-id-type="pmid">23982889</pub-id>
</element-citation>
</ref>
<ref id="bib156">
<label>156</label>
<element-citation id="sref156" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernhoft</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Cadmium toxicity and treatment</article-title>
<source/>Sci. World J.
          <volume>2013</volume>
<year>2013</year>
</element-citation>
</ref>
<ref id="bib157">
<label>157</label>
<element-citation id="sref157" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Cancer</surname>
<given-names>I.A.f.R.o.</given-names>
</name>
</person-group>
<chapter-title>IARC monographs on the evaluation of carcinogenic risks to humans</chapter-title>
<source/>Dry cleaning, some chlorinated solvents and other industrial chemicals
          <volume>63</volume>
<year>1995</year>
<fpage>443</fpage>
<lpage>465</lpage>
</element-citation>
</ref>
<ref id="bib158">
<label>158</label>
<element-citation id="sref158" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hettick</surname>
<given-names>B.E.</given-names>
</name>
</person-group>
<article-title>Arsenic: a review of the element's toxicity, plant interactions, and potential methods of remediation</article-title>
<source/>J. Agric. Food Chem.
          <volume>63</volume>
<issue>32</issue>
<year>2015</year>
<fpage>7097</fpage>
<lpage>7107</lpage>
<pub-id pub-id-type="pmid">26241522</pub-id>
</element-citation>
</ref>
<ref id="bib159">
<label>159</label>
<element-citation id="sref159" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jomova</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Arsenic: toxicity, oxidative stress and human disease</article-title>
<source/>J. Appl. Toxicol.
          <volume>31</volume>
<issue>2</issue>
<year>2011</year>
<fpage>95</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="pmid">21321970</pub-id>
</element-citation>
</ref>
<ref id="bib160">
<label>160</label>
<element-citation id="sref160" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Activation of Nrf2 in defense against cadmium-induced oxidative stress</article-title>
<source/>Chem. Res. Toxicol.
          <volume>21</volume>
<issue>7</issue>
<year>2008</year>
<fpage>1375</fpage>
<lpage>1383</lpage>
<pub-id pub-id-type="pmid">18512965</pub-id>
</element-citation>
</ref>
<ref id="bib161">
<label>161</label>
<element-citation id="sref161" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>Z.A.</given-names>
</name>
</person-group>
<article-title>Activation of Nrf2 by cadmium and its role in protection against cadmium-induced apoptosis in rat kidney cells</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <volume>241</volume>
<issue>1</issue>
<year>2009</year>
<fpage>81</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="pmid">19682480</pub-id>
</element-citation>
</ref>
<ref id="bib162">
<label>162</label>
<element-citation id="sref162" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: involvement of cellular adaptive response to oxidative stress</article-title>
<source/>Environ. Health Perspect.
          <volume>118</volume>
<issue>6</issue>
<year>2010</year>
<fpage>864</fpage>
<lpage>870</lpage>
<pub-id pub-id-type="pmid">20100676</pub-id>
</element-citation>
</ref>
<ref id="bib163">
<label>163</label>
<element-citation id="sref163" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinkai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Partial contribution of the Keap1-Nrf2 system to cadmium-mediated metallothionein expression in vascular endothelial cells</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <volume>295</volume>
<year>2016</year>
<fpage>37</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">26827822</pub-id>
</element-citation>
</ref>
<ref id="bib164">
<label>164</label>
<element-citation id="sref164" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuder</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Petrache</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Pathogenesis of chronic obstructive pulmonary disease</article-title>
<source/>J. Clin. Invest.
          <volume>122</volume>
<issue>8</issue>
<year>2012</year>
<fpage>2749</fpage>
<lpage>2755</lpage>
<pub-id pub-id-type="pmid">22850885</pub-id>
</element-citation>
</ref>
<ref id="bib165">
<label>165</label>
<element-citation id="sref165" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinkai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes</article-title>
<source/>FEBS Lett.
          <volume>580</volume>
<issue>7</issue>
<year>2006</year>
<fpage>1771</fpage>
<lpage>1774</lpage>
<pub-id pub-id-type="pmid">16516206</pub-id>
</element-citation>
</ref>
<ref id="bib166">
<label>166</label>
<element-citation id="sref166" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>NRF2 is a potential modulator of hyperresistance to arsenic toxicity in stem-like keratinocytes</article-title>
<source/>Oxid. Med. Cell. Longev.
          <volume>2017</volume>
<year>2017</year>
</element-citation>
</ref>
<ref id="bib167">
<label>167</label>
<element-citation id="sref167" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohajeri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rezaee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sahebkar</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Cadmium‐induced toxicity is rescued by curcumin: a review</article-title>
<source/>Biofactors
          <volume>43</volume>
<issue>5</issue>
<year>2017</year>
<fpage>645</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="pmid">28719149</pub-id>
</element-citation>
</ref>
<ref id="bib168">
<label>168</label>
<element-citation id="sref168" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Klaassen</surname>
<given-names>C.D.</given-names>
</name>
</person-group>
<article-title>Nrf2 activation prevents cadmium-induced acute liver injury</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <volume>263</volume>
<issue>1</issue>
<year>2012</year>
<fpage>14</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">22677785</pub-id>
</element-citation>
</ref>
<ref id="bib169">
<label>169</label>
<element-citation id="sref169" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>A review for the pharmacological effect of lycopene in central nervous system disorders</article-title>
<source/>Biomed. Pharmacother.
          <volume>111</volume>
<year>2019</year>
<fpage>791</fpage>
<lpage>801</lpage>
<pub-id pub-id-type="pmid">30616078</pub-id>
</element-citation>
</ref>
<ref id="bib170">
<label>170</label>
<element-citation id="sref170" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vineetha</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<article-title>L-ascorbic acid and α-tocopherol attenuate arsenic trioxide-induced toxicity in H9c2 cardiomyocytes by the activation of Nrf2 and Bcl2 transcription factors</article-title>
<source/>Toxicol. Mech. Methods
          <volume>28</volume>
<issue>5</issue>
<year>2018</year>
<fpage>353</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="pmid">29297235</pub-id>
</element-citation>
</ref>
<ref id="bib171">
<label>171</label>
<element-citation id="sref171" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Lutein alleviates arsenic-induced reproductive toxicity in male mice via Nrf2 signaling</article-title>
<source/>Hum. Exp. Toxicol.
          <volume>35</volume>
<issue>5</issue>
<year>2016</year>
<fpage>491</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="pmid">26187899</pub-id>
</element-citation>
</ref>
<ref id="bib172">
<label>172</label>
<element-citation id="sref172" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Brain structure and function in patients after metal-on-metal hip resurfacing</article-title>
<source/>Am. J. Neuroradiol.
          <volume>35</volume>
<issue>9</issue>
<year>2014</year>
<fpage>1753</fpage>
<lpage>1758</lpage>
<pub-id pub-id-type="pmid">24722312</pub-id>
</element-citation>
</ref>
<ref id="bib173">
<label>173</label>
<element-citation id="sref173" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelclova</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Severe cobalt intoxication following hip replacement revision: clinical features and outcome</article-title>
<source/>Clin. Toxicol.
          <volume>50</volume>
<issue>4</issue>
<year>2012</year>
<fpage>262</fpage>
<lpage>265</lpage>
</element-citation>
</ref>
<ref id="bib174">
<label>174</label>
<element-citation id="sref174" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheung</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Systemic cobalt toxicity from total hip arthroplasties: review of a rare condition Part 1-history, mechanism, measurements, and pathophysiology</article-title>
<source/>Bone Joint J.
          <volume>98</volume>
<issue>1</issue>
<year>2016</year>
<fpage>6</fpage>
<lpage>13</lpage>
</element-citation>
</ref>
<ref id="bib175">
<label>175</label>
<element-citation id="sref175" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zywiel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Systemic cobalt toxicity from total hip arthroplasties: review of a rare condition Part 2. measurement, risk factors, and step-wise approach to treatment</article-title>
<source/>Bone Joint J.
          <volume>98</volume>
<issue>1</issue>
<year>2016</year>
<fpage>14</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="bib176">
<label>176</label>
<element-citation id="sref176" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leyssens</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Cobalt toxicity in humans—a review of the potential sources and systemic health effects</article-title>
<source/>Toxicology
          <volume>387</volume>
<year>2017</year>
<fpage>43</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">28572025</pub-id>
</element-citation>
</ref>
<ref id="bib177">
<label>177</label>
<element-citation id="sref177" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Comparison of the neurotoxicity associated with cobalt nanoparticles and cobalt chloride in Wistar rats</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <volume>369</volume>
<year>2019</year>
<fpage>90</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">30849457</pub-id>
</element-citation>
</ref>
<ref id="bib178">
<label>178</label>
<element-citation id="sref178" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akhtar</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Nanotoxicity of cobalt induced by oxidant generation and glutathione depletion in MCF-7 cells</article-title>
<source/>Toxicol. Vitro
          <volume>40</volume>
<year>2017</year>
<fpage>94</fpage>
<lpage>101</lpage>
</element-citation>
</ref>
<ref id="bib179">
<label>179</label>
<element-citation id="sref179" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.D.</given-names>
</name>
</person-group>
<article-title>Tungsten carbide-cobalt particles activate Nrf2 and its downstream target genes in JB6 cells possibly by ROS generation</article-title>
<source/>J. Environ. Pathol. Toxicol. Oncol.
          <volume>29</volume>
<issue>1</issue>
<year>2010</year>
<fpage>31</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">20528745</pub-id>
</element-citation>
</ref>
<ref id="bib180">
<label>180</label>
<element-citation id="sref180" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cappellini</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Mechanistic insight into reactivity and (geno) toxicity of well-characterized nanoparticles of cobalt metal and oxides</article-title>
<source/>Nanotoxicology
          <volume>12</volume>
<issue>6</issue>
<year>2018</year>
<fpage>602</fpage>
<lpage>620</lpage>
<pub-id pub-id-type="pmid">29790399</pub-id>
</element-citation>
</ref>
<ref id="bib181">
<label>181</label>
<element-citation id="sref181" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group>
<chapter-title>Evaluation of Nrf2 with exposure to nanoparticles</chapter-title>
<source/>Nanotoxicity
          <year>2019</year>
<publisher-name>Springer</publisher-name>
<fpage>229</fpage>
<lpage>246</lpage>
</element-citation>
</ref>
<ref id="bib182">
<label>182</label>
<element-citation id="sref182" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Permenter</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Exposure to cobalt causes transcriptomic and proteomic changes in two rat liver derived cell lines</article-title>
<source/>PloS One
          <volume>8</volume>
<issue>12</issue>
<year>2013</year>
<object-id pub-id-type="publisher-id">e83751</object-id>
</element-citation>
</ref>
<ref id="bib183">
<label>183</label>
<element-citation id="sref183" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Protective roles of NRF2 signaling pathway in cobalt chloride-induced hypoxic cytotoxicity in human HaCaT keratinocytes</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <volume>355</volume>
<year>2018</year>
<fpage>189</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="pmid">29966676</pub-id>
</element-citation>
</ref>
<ref id="bib184">
<label>184</label>
<element-citation id="sref184" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>NRF2 overexpression in mesenchymal stem cells induces stem-cell marker expression and enhances osteoblastic differentiation</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <volume>491</volume>
<issue>1</issue>
<year>2017</year>
<fpage>228</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="pmid">28720497</pub-id>
</element-citation>
</ref>
<ref id="bib185">
<label>185</label>
<element-citation id="sref185" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Thymoquinone protects against cobalt chloride-induced neurotoxicity via Nrf2/GCL-regulated glutathione homeostasis</article-title>
<source/>J. Biol. Regul. Homeost. Agents
          <volume>31</volume>
<issue>4</issue>
<year>2017</year>
<fpage>843</fpage>
<lpage>853</lpage>
<pub-id pub-id-type="pmid">29254287</pub-id>
</element-citation>
</ref>
<ref id="bib186">
<label>186</label>
<element-citation id="sref186" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>mfat‐1 transgene protects cultured adult neural stem cells against cobalt chloride‐mediated hypoxic injury by activating Nrf2/ARE pathways</article-title>
<source/>J. Neurosci. Res.
          <volume>96</volume>
<issue>1</issue>
<year>2018</year>
<fpage>87</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="pmid">28639376</pub-id>
</element-citation>
</ref>
<ref id="bib187">
<label>187</label>
<element-citation id="sref187" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Andrographolide inhibits hypoxia‐induced HIF‐1α‐driven endothelin 1 secretion by activating Nrf2/HO‐1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells</article-title>
<source/>Environ. Toxicol.
          <volume>32</volume>
<issue>3</issue>
<year>2017</year>
<fpage>918</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="pmid">27297870</pub-id>
</element-citation>
</ref>
<ref id="bib188">
<label>188</label>
<element-citation id="sref188" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casida</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Mechanisms of selective action of pyrethroid insecticides</article-title>
<source/>Annu. Rev. Pharmacol. Toxicol.
          <volume>23</volume>
<issue>1</issue>
<year>1983</year>
<fpage>413</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="pmid">6347050</pub-id>
</element-citation>
</ref>
<ref id="bib189">
<label>189</label>
<element-citation id="sref189" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soderlund</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment</article-title>
<source/>Toxicology
          <volume>171</volume>
<issue>1</issue>
<year>2002</year>
<fpage>3</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="pmid">11812616</pub-id>
</element-citation>
</ref>
<ref id="bib190">
<label>190</label>
<element-citation id="sref190" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirby</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Castagnoli</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bloomquist</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>In vivo effects of deltamethrin on dopamine neurochemistry and the role of augmented neurotransmitter release</article-title>
<source/>Pestic. Biochem. Physiol.
          <volume>65</volume>
<issue>3</issue>
<year>1999</year>
<fpage>160</fpage>
<lpage>168</lpage>
</element-citation>
</ref>
<ref id="bib191">
<label>191</label>
<element-citation id="sref191" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Deltamethrin induces delayed apoptosis and altered expression of p53 and bax in rat brain</article-title>
<source/>Environ. Toxicol. Pharmacol.
          <volume>8</volume>
<issue>3</issue>
<year>2000</year>
<fpage>183</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="pmid">10925071</pub-id>
</element-citation>
</ref>
<ref id="bib192">
<label>192</label>
<element-citation id="sref192" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Apoptotic cell death in rat brain following deltamethrin treatment</article-title>
<source/>Neurosci. Lett.
          <volume>279</volume>
<issue>2</issue>
<year>2000</year>
<fpage>85</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmid">10674627</pub-id>
</element-citation>
</ref>
<ref id="bib193">
<label>193</label>
<element-citation id="sref193" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Deltamethrin induces altered expression of P53, Bax and Bcl-2 in rat brain</article-title>
<source/>Neurosci. Lett.
          <volume>284</volume>
<issue>1–2</issue>
<year>2000</year>
<fpage>29</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">10771154</pub-id>
</element-citation>
</ref>
<ref id="bib194">
<label>194</label>
<element-citation id="sref194" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>G.-p.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Tyrosine hydroxylase as a target for deltamethrin in the nigrostriatal dopaminergic pathway</article-title>
<source/>Biomed. Environ. Sci.
          <volume>19</volume>
<issue>1</issue>
<year>2006</year>
<fpage>27</fpage>
<pub-id pub-id-type="pmid">16673815</pub-id>
</element-citation>
</ref>
<ref id="bib195">
<label>195</label>
<element-citation id="sref195" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>G.-P.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>The inhibitory effects of deltamethrin on dopamine biosynthesis in rat PC12 cells</article-title>
<source/>Toxicol. Lett.
          <volume>161</volume>
<issue>3</issue>
<year>2006</year>
<fpage>195</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="pmid">16229977</pub-id>
</element-citation>
</ref>
<ref id="bib196">
<label>196</label>
<element-citation id="sref196" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S.-Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Transcription factor Nrf2 activation by deltamethrin in PC12 cells: involvement of ROS</article-title>
<source/>Toxicol. Lett.
          <volume>171</volume>
<issue>1–2</issue>
<year>2007</year>
<fpage>87</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">17540521</pub-id>
</element-citation>
</ref>
<ref id="bib197">
<label>197</label>
<element-citation id="sref197" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The pesticide deltamethrin increases free radical production and promotes nuclear translocation of the stress response transcription factor Nrf2 in rat brain</article-title>
<source/>Toxicol. Ind. Health
          <volume>27</volume>
<issue>7</issue>
<year>2011</year>
<fpage>579</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="pmid">21398409</pub-id>
</element-citation>
</ref>
<ref id="bib198">
<label>198</label>
<element-citation id="sref198" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Neuroprotective effects of tert-butylhydroquinone on paraquat-induced dopaminergic cell degeneration in C57BL/6 mice and in PC12 cells</article-title>
<source/>Arch. Toxicol.
          <volume>86</volume>
<issue>11</issue>
<year>2012</year>
<fpage>1729</fpage>
<lpage>1740</lpage>
<pub-id pub-id-type="pmid">22983789</pub-id>
</element-citation>
</ref>
<ref id="bib199">
<label>199</label>
<element-citation id="sref199" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>NF-E2 related factor 2 activation and heme oxygenase-1 induction by tert-butylhydroquinone protect against deltamethrin-mediated oxidative stress in PC12 cells</article-title>
<source/>Chem. Res. Toxicol.
          <volume>20</volume>
<issue>9</issue>
<year>2007</year>
<fpage>1242</fpage>
<lpage>1251</lpage>
<pub-id pub-id-type="pmid">17676812</pub-id>
</element-citation>
</ref>
<ref id="bib200">
<label>200</label>
<element-citation id="sref200" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saoudi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Deltamethrin induced oxidative stress in kidney and brain of rats: protective effect of Artemisia campestris essential oil</article-title>
<source/>Biomed. Pharmacother.
          <volume>94</volume>
<year>2017</year>
<fpage>955</fpage>
<lpage>963</lpage>
<pub-id pub-id-type="pmid">28810533</pub-id>
</element-citation>
</ref>
<ref id="bib201">
<label>201</label>
<element-citation id="sref201" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Curcumin synergistically potentiates the protective effect of sitagliptin against chronic deltamethrin nephrotoxicity in rats: impact on pro‐inflammatory cytokines and Nrf2/Ho‐1 pathway</article-title>
<source/>J. Biochem. Mol. Toxicol.
          <volume>33</volume>
<issue>10</issue>
<year>2019</year>
<object-id pub-id-type="publisher-id">e22386</object-id>
</element-citation>
</ref>
<ref id="bib202">
<label>202</label>
<element-citation id="sref202" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lungu-Mitea</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Oskarsson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lundqvist</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Development of an oxidative stress in vitro assay in zebrafish (Danio rerio) cell lines</article-title>
<source/>Sci. Rep.
          <volume>8</volume>
<issue>1</issue>
<year>2018</year>
<fpage>12380</fpage>
<pub-id pub-id-type="pmid">30120374</pub-id>
</element-citation>
</ref>
<ref id="bib203">
<label>203</label>
<element-citation id="sref203" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Exploring the correlation between deltamethrin stress and keap1-nrf2-are pathway from drosophila melanogaster RNASeq Data</article-title>
<source/>Genomics
          <year>2019</year>
</element-citation>
</ref>
<ref id="bib204">
<label>204</label>
<element-citation id="sref204" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice</article-title>
<source/>Toxicol. Lett.
          <volume>188</volume>
<issue>2</issue>
<year>2009</year>
<fpage>148</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="pmid">19446248</pub-id>
</element-citation>
</ref>
<ref id="bib205">
<label>205</label>
<element-citation id="sref205" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease</article-title>
<source/>J. Occup. Environ. Med.
          <volume>47</volume>
<issue>10</issue>
<year>2005</year>
<fpage>1059</fpage>
<lpage>1087</lpage>
<pub-id pub-id-type="pmid">16217247</pub-id>
</element-citation>
</ref>
<ref id="bib206">
<label>206</label>
<element-citation id="sref206" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betarbet</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Chronic systemic pesticide exposure reproduces features of Parkinson's disease</article-title>
<source/>Nat. Neurosci.
          <volume>3</volume>
<issue>12</issue>
<year>2000</year>
<fpage>1301</fpage>
<pub-id pub-id-type="pmid">11100151</pub-id>
</element-citation>
</ref>
<ref id="bib207">
<label>207</label>
<element-citation id="sref207" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liou</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Environmental risk factors and Parkinson's disease: a case‐control study in Taiwan</article-title>
<source/>Neurology
          <volume>48</volume>
<issue>6</issue>
<year>1997</year>
<fpage>1583</fpage>
<lpage>1588</lpage>
<pub-id pub-id-type="pmid">9191770</pub-id>
</element-citation>
</ref>
<ref id="bib208">
<label>208</label>
<element-citation id="sref208" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCormack</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat</article-title>
<source/>Neurobiol. Dis.
          <volume>10</volume>
<issue>2</issue>
<year>2002</year>
<fpage>119</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="pmid">12127150</pub-id>
</element-citation>
</ref>
<ref id="bib209">
<label>209</label>
<element-citation id="sref209" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway</article-title>
<source/>J. Biol. Chem.
          <volume>279</volume>
<issue>31</issue>
<year>2004</year>
<fpage>32626</fpage>
<lpage>32632</lpage>
<pub-id pub-id-type="pmid">15155744</pub-id>
</element-citation>
</ref>
<ref id="bib210">
<label>210</label>
<element-citation id="sref210" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manning-Bog</surname>
<given-names>A.B.</given-names>
</name>
</person-group>
<article-title>The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice paraquat and α-synuclein</article-title>
<source/>J. Biol. Chem.
          <volume>277</volume>
<issue>3</issue>
<year>2002</year>
<fpage>1641</fpage>
<lpage>1644</lpage>
<pub-id pub-id-type="pmid">11707429</pub-id>
</element-citation>
</ref>
<ref id="bib211">
<label>211</label>
<element-citation id="sref211" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Protective effect of tert-butylhydroquinone on cerebral inflammatory response following traumatic brain injury in mice</article-title>
<source/>Injury
          <volume>42</volume>
<issue>7</issue>
<year>2011</year>
<fpage>714</fpage>
<lpage>718</lpage>
<pub-id pub-id-type="pmid">21466884</pub-id>
</element-citation>
</ref>
<ref id="bib212">
<label>212</label>
<element-citation id="sref212" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nouhi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Dietary supplementation with tBHQ, an Nrf2 stabilizer molecule, confers neuroprotection against apoptosis in amyloid β-injected rat</article-title>
<source/>Neurochem. Res.
          <volume>36</volume>
<issue>5</issue>
<year>2011</year>
<fpage>870</fpage>
<lpage>878</lpage>
<pub-id pub-id-type="pmid">21293924</pub-id>
</element-citation>
</ref>
<ref id="bib213">
<label>213</label>
<element-citation id="sref213" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toulouse</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Progress in Parkinson's disease—where do we stand?</article-title>
<source/>Prog. Neurobiol.
          <volume>85</volume>
<issue>4</issue>
<year>2008</year>
<fpage>376</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="pmid">18582530</pub-id>
</element-citation>
</ref>
<ref id="bib214">
<label>214</label>
<element-citation id="sref214" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dauer</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Przedborski</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Parkinson's disease: mechanisms and models</article-title>
<source/>Neuron
          <volume>39</volume>
<issue>6</issue>
<year>2003</year>
<fpage>889</fpage>
<lpage>909</lpage>
<pub-id pub-id-type="pmid">12971891</pub-id>
</element-citation>
</ref>
<ref id="bib215">
<label>215</label>
<element-citation id="sref215" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Paraquat induces cyclooxygenase-2 (COX-2) implicated toxicity in human neuroblastoma SH-SY5Y cells</article-title>
<source/>Toxicol. Lett.
          <volume>199</volume>
<issue>3</issue>
<year>2010</year>
<fpage>239</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="pmid">20851755</pub-id>
</element-citation>
</ref>
<ref id="bib216">
<label>216</label>
<element-citation id="sref216" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishii</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages</article-title>
<source/>J. Biol. Chem.
          <volume>275</volume>
<issue>21</issue>
<year>2000</year>
<fpage>16023</fpage>
<lpage>16029</lpage>
<pub-id pub-id-type="pmid">10821856</pub-id>
</element-citation>
</ref>
<ref id="bib217">
<label>217</label>
<element-citation id="sref217" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izumi</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Compensatory role of the Nrf2–ARE pathway against paraquat toxicity: relevance of 26S proteasome activity</article-title>
<source/>J. Pharmacol. Sci.
          <volume>129</volume>
<issue>3</issue>
<year>2015</year>
<fpage>150</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="pmid">26598004</pub-id>
</element-citation>
</ref>
<ref id="bib218">
<label>218</label>
<element-citation id="sref218" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanco-Ayala</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Andérica-Romero</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pedraza-Chaverri</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>New insights into antioxidant strategies against paraquat toxicity</article-title>
<source/>Free Radic. Res.
          <volume>48</volume>
<issue>6</issue>
<year>2014</year>
<fpage>623</fpage>
<lpage>640</lpage>
<pub-id pub-id-type="pmid">24593876</pub-id>
</element-citation>
</ref>
<ref id="bib219">
<label>219</label>
<element-citation id="sref219" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>JWA antagonizes paraquat-induced neurotoxicity via activation of Nrf2</article-title>
<source/>Toxicol. Lett.
          <volume>277</volume>
<year>2017</year>
<fpage>32</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">28428137</pub-id>
</element-citation>
</ref>
<ref id="bib220">
<label>220</label>
<element-citation id="sref220" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betarbet</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Chronic systemic pesticide exposure reproduces features of Parkinson's disease</article-title>
<source/>Nat. Neurosci.
          <volume>3</volume>
<issue>12</issue>
<year>2000</year>
<fpage>1301</fpage>
<lpage>1306</lpage>
<pub-id pub-id-type="pmid">11100151</pub-id>
</element-citation>
</ref>
<ref id="bib221">
<label>221</label>
<element-citation id="sref221" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Bobrovskaya</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions</article-title>
<source/>Neurotoxicology
          <volume>46</volume>
<year>2015</year>
<fpage>101</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="pmid">25514659</pub-id>
</element-citation>
</ref>
<ref id="bib222">
<label>222</label>
<element-citation id="sref222" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talpade</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone</article-title>
<source/>J. Neurochem.
          <volume>75</volume>
<issue>6</issue>
<year>2000</year>
<fpage>2611</fpage>
<lpage>2621</lpage>
<pub-id pub-id-type="pmid">11080215</pub-id>
</element-citation>
</ref>
<ref id="bib223">
<label>223</label>
<element-citation id="sref223" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Nisticò</surname>
<given-names>R.</given-names>
</name>
</person-group>
<chapter-title>Paraquat-and Rotenone-Induced Models of Parkinson's Disease</chapter-title>
<year>2011</year>
<publisher-name>SAGE Publications Sage UK</publisher-name>
<publisher-loc>London, England</publisher-loc>
</element-citation>
</ref>
<ref id="bib224">
<label>224</label>
<element-citation id="sref224" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Circu</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Aw</surname>
<given-names>T.Y.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species, cellular redox systems, and apoptosis</article-title>
<source/>Free Radic. Biol. Med.
          <volume>48</volume>
<issue>6</issue>
<year>2010</year>
<fpage>749</fpage>
<lpage>762</lpage>
<pub-id pub-id-type="pmid">20045723</pub-id>
</element-citation>
</ref>
<ref id="bib225">
<label>225</label>
<element-citation id="sref225" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zagoura</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells</article-title>
<source/>Neurochem. Int.
          <volume>106</volume>
<year>2017</year>
<fpage>62</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">27615060</pub-id>
</element-citation>
</ref>
<ref id="bib226">
<label>226</label>
<element-citation id="sref226" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>p38MAPK/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease</article-title>
<source/>Neurochem. Int.
          <volume>63</volume>
<issue>3</issue>
<year>2013</year>
<fpage>133</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="pmid">23714208</pub-id>
</element-citation>
</ref>
<ref id="bib227">
<label>227</label>
<element-citation id="sref227" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>W.-S.</given-names>
</name>
</person-group>
<article-title>JNK3 mediates paraquat-and rotenone-induced dopaminergic neuron death</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <volume>69</volume>
<issue>5</issue>
<year>2010</year>
<fpage>511</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="pmid">20418776</pub-id>
</element-citation>
</ref>
<ref id="bib228">
<label>228</label>
<element-citation id="sref228" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vezina</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kudelski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sehgal</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Rapamycin (AY-22, 989), a new antifungal antibiotic</article-title>
<source/>J. Antibiot.
          <volume>28</volume>
<issue>10</issue>
<year>1975</year>
<fpage>721</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="pmid">1102508</pub-id>
</element-citation>
</ref>
<ref id="bib229">
<label>229</label>
<element-citation id="sref229" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoo</surname>
<given-names>Y.J.</given-names>
</name>
</person-group>
<article-title>An overview of rapamycin: from discovery to future perspectives</article-title>
<source/>J. Ind. Microbiol. Biotechnol.
          <volume>44</volume>
<issue>4–5</issue>
<year>2017</year>
<fpage>537</fpage>
<lpage>553</lpage>
<pub-id pub-id-type="pmid">27613310</pub-id>
</element-citation>
</ref>
<ref id="bib230">
<label>230</label>
<element-citation id="sref230" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Blenis</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Rapamycin: one drug, many effects</article-title>
<source/>Cell Metabol.
          <volume>19</volume>
<issue>3</issue>
<year>2014</year>
<fpage>373</fpage>
<lpage>379</lpage>
</element-citation>
</ref>
<ref id="bib231">
<label>231</label>
<element-citation id="sref231" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laplante</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>mTOR signaling in growth control and disease</article-title>
<source/>Cell
          <volume>149</volume>
<issue>2</issue>
<year>2012</year>
<fpage>274</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="pmid">22500797</pub-id>
</element-citation>
</ref>
<ref id="bib232">
<label>232</label>
<element-citation id="sref232" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loewith</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>M.N.</given-names>
</name>
</person-group>
<article-title>Target of rapamycin (TOR) in nutrient signaling and growth control</article-title>
<source/>Genetics
          <volume>189</volume>
<issue>4</issue>
<year>2011</year>
<fpage>1177</fpage>
<lpage>1201</lpage>
<pub-id pub-id-type="pmid">22174183</pub-id>
</element-citation>
</ref>
<ref id="bib233">
<label>233</label>
<element-citation id="sref233" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Targeted inhibition of rictor/mTORC2 in cancer treatment: a new era after rapamycin</article-title>
<source/>Curr. Cancer Drug Targets
          <volume>16</volume>
<issue>4</issue>
<year>2016</year>
<fpage>288</fpage>
<lpage>304</lpage>
<pub-id pub-id-type="pmid">26563881</pub-id>
</element-citation>
</ref>
<ref id="bib234">
<label>234</label>
<element-citation id="sref234" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saraiva</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Exposure of Drosophila melanogaster to mancozeb induces oxidative Damage and modulates Nrf2 and HSP70/83</article-title>
<source/>Oxid. Med. Cell. Longev.
          <volume>2018</volume>
<year>2018</year>
</element-citation>
</ref>
<ref id="bib235">
<label>235</label>
<element-citation id="sref235" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundqvist</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hellman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Oskarsson</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Fungicide prochloraz induces oxidative stress and DNA damage in vitro</article-title>
<source/>Food Chem. Toxicol.
          <volume>91</volume>
<year>2016</year>
<fpage>36</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">26945613</pub-id>
</element-citation>
</ref>
<ref id="bib236">
<label>236</label>
<element-citation id="sref236" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez-Cortes</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Epigenetic modulation of Nrf2 and Ogg1 gene expression in testicular germ cells by methyl parathion exposure</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <volume>346</volume>
<year>2018</year>
<fpage>19</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">29540303</pub-id>
</element-citation>
</ref>
<ref id="bib237">
<label>237</label>
<element-citation id="sref237" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebov</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Pesticide use and risk of end-stage renal disease among licensed pesticide applicators in the Agricultural Health Study</article-title>
<source/>Occup. Environ. Med.
          <volume>73</volume>
<issue>1</issue>
<year>2016</year>
<fpage>3</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">26177651</pub-id>
</element-citation>
</ref>
<ref id="bib238">
<label>238</label>
<element-citation id="sref238" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Lycopene triggers nrf2–AMPK cross talk to alleviate atrazine-induced nephrotoxicity in mice</article-title>
<source/>J. Agric. Food Chem.
          <volume>66</volume>
<issue>46</issue>
<year>2018</year>
<fpage>12385</fpage>
<lpage>12394</lpage>
<pub-id pub-id-type="pmid">30360616</pub-id>
</element-citation>
</ref>
<ref id="bib239">
<label>239</label>
<element-citation id="sref239" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>S.S.</given-names>
</name>
</person-group>
<article-title>A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010</article-title>
<source/>Lancet
          <volume>380</volume>
<issue>9859</issue>
<year>2012</year>
<fpage>2224</fpage>
<lpage>2260</lpage>
<pub-id pub-id-type="pmid">23245609</pub-id>
</element-citation>
</ref>
<ref id="bib240">
<label>240</label>
<element-citation id="sref240" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cesaroni</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Long term exposure to ambient air pollution and incidence of acute coronary events: prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE Project</article-title>
<source/>BMJ
          <volume>348</volume>
<year>2014</year>
<fpage>f7412</fpage>
<pub-id pub-id-type="pmid">24452269</pub-id>
</element-citation>
</ref>
<ref id="bib241">
<label>241</label>
<element-citation id="sref241" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>K.A.</given-names>
</name>
</person-group>
<article-title>Long-term exposure to air pollution and incidence of cardiovascular events in women</article-title>
<source/>N. Engl. J. Med.
          <volume>356</volume>
<issue>5</issue>
<year>2007</year>
<fpage>447</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="pmid">17267905</pub-id>
</element-citation>
</ref>
<ref id="bib242">
<label>242</label>
<element-citation id="sref242" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oono</surname>
<given-names>I.P.</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Pell</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Meta-analysis of the association between secondhand smoke exposure and stroke</article-title>
<source/>J. Public Health
          <volume>33</volume>
<issue>4</issue>
<year>2011</year>
<fpage>496</fpage>
<lpage>502</lpage>
</element-citation>
</ref>
<ref id="bib243">
<label>243</label>
<element-citation id="sref243" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>L.L.</given-names>
</name>
</person-group>
<article-title>Parental smoking and the risk of middle ear disease in children: a systematic review and meta-analysis</article-title>
<source/>Arch. Pediatr. Adolesc. Med.
          <volume>166</volume>
<issue>1</issue>
<year>2012</year>
<fpage>18</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">21893640</pub-id>
</element-citation>
</ref>
<ref id="bib244">
<label>244</label>
<element-citation id="sref244" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tinuoye</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Pell</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>Meta-analysis of the association between secondhand smoke exposure and physician-diagnosed childhood asthma</article-title>
<source/>Nicotine Tob. Res.
          <volume>15</volume>
<issue>9</issue>
<year>2013</year>
<fpage>1475</fpage>
<lpage>1483</lpage>
<pub-id pub-id-type="pmid">23539174</pub-id>
</element-citation>
</ref>
<ref id="bib245">
<label>245</label>
<element-citation id="sref245" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hori</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies</article-title>
<source/>Jpn. J. Clin. Oncol.
          <volume>46</volume>
<issue>10</issue>
<year>2016</year>
<fpage>942</fpage>
<lpage>951</lpage>
<pub-id pub-id-type="pmid">27511987</pub-id>
</element-citation>
</ref>
<ref id="bib246">
<label>246</label>
<element-citation id="sref246" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Long-term exposure to traffic-related air pollution and cardiovascular mortality</article-title>
<source/>Epidemiology
          <volume>24</volume>
<issue>1</issue>
<year>2013</year>
<fpage>35</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="pmid">23222554</pub-id>
</element-citation>
</ref>
<ref id="bib247">
<label>247</label>
<element-citation id="sref247" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baccarelli</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Living near major traffic roads and risk of deep vein thrombosis</article-title>
<source/>Circulation
          <volume>119</volume>
<issue>24</issue>
<year>2009</year>
<fpage>3118</fpage>
<lpage>3124</lpage>
<pub-id pub-id-type="pmid">19506111</pub-id>
</element-citation>
</ref>
<ref id="bib248">
<label>248</label>
<element-citation id="sref248" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Residential exposure to traffic is associated with coronary atherosclerosis</article-title>
<source/>Circulation
          <volume>116</volume>
<issue>5</issue>
<year>2007</year>
<fpage>489</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="pmid">17638927</pub-id>
</element-citation>
</ref>
<ref id="bib249">
<label>249</label>
<element-citation id="sref249" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korek</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Traffic-related air pollution exposure and incidence of stroke in four cohorts from Stockholm</article-title>
<source/>J. Expo. Sci. Environ. Epidemiol.
          <volume>25</volume>
<issue>5</issue>
<year>2015</year>
<fpage>517</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="pmid">25827311</pub-id>
</element-citation>
</ref>
<ref id="bib250">
<label>250</label>
<element-citation id="sref250" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipsett</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Campleman</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Occupational exposure to diesel exhaust and lung cancer: a meta-analysis</article-title>
<source/>Am. J. Publ. Health
          <volume>89</volume>
<issue>7</issue>
<year>1999</year>
<fpage>1009</fpage>
<lpage>1017</lpage>
</element-citation>
</ref>
<ref id="bib251">
<label>251</label>
<element-citation id="sref251" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname>
<given-names>D.T.</given-names>
</name>
</person-group>
<article-title>The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust</article-title>
<source/>J. Natl. Cancer Inst.
          <volume>104</volume>
<issue>11</issue>
<year>2012</year>
<fpage>855</fpage>
<lpage>868</lpage>
<pub-id pub-id-type="pmid">22393209</pub-id>
</element-citation>
</ref>
<ref id="bib252">
<label>252</label>
<element-citation id="sref252" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farmer</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Ambient and household air pollution: complex triggers of disease</article-title>
<source/>Am. J. Physiol. Heart Circ. Physiol.
          <volume>307</volume>
<issue>4</issue>
<year>2014</year>
<fpage>H467</fpage>
<lpage>H476</lpage>
<pub-id pub-id-type="pmid">24929855</pub-id>
</element-citation>
</ref>
<ref id="bib253">
<label>253</label>
<element-citation id="sref253" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pope</surname>
<given-names>C.A.</given-names>
<suffix>3rd</suffix>
</name>
</person-group>
<article-title>Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution</article-title>
<source/>J. Am. Med. Assoc.
          <volume>287</volume>
<issue>9</issue>
<year>2002</year>
<fpage>1132</fpage>
<lpage>1141</lpage>
</element-citation>
</ref>
<ref id="bib254">
<label>254</label>
<element-citation id="sref254" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Krivna</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Multi-element analysis of tobacco and smoke condensate by instrumental neutron activation analysis and atomic absorption spectrometry</article-title>
<source/>Int. J. Environ. Anal. Chem.
          <volume>53</volume>
<issue>2</issue>
<year>1993</year>
<fpage>87</fpage>
<lpage>100</lpage>
</element-citation>
</ref>
<ref id="bib255">
<label>255</label>
<element-citation id="sref255" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kresovich</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Metallic air pollutants and breast cancer heterogeneity</article-title>
<source/>Environ. Res.
          <volume>177</volume>
<year>2019</year>
<fpage>108639</fpage>
<pub-id pub-id-type="pmid">31419716</pub-id>
</element-citation>
</ref>
<ref id="bib256">
<label>256</label>
<element-citation id="sref256" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Metallic air pollutants and breast cancer risk in a nationwide cohort study</article-title>
<source/>Epidemiology
          <volume>30</volume>
<issue>1</issue>
<year>2019</year>
<fpage>20</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="pmid">30198937</pub-id>
</element-citation>
</ref>
<ref id="bib257">
<label>257</label>
<element-citation id="sref257" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delgado-Saborit</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Analysis of atmospheric concentrations of quinones and polycyclic aromatic hydrocarbons in vapour and particulate phases</article-title>
<source/>Atmos. Environ.
          <volume>77</volume>
<year>2013</year>
<fpage>974</fpage>
<lpage>982</lpage>
</element-citation>
</ref>
<ref id="bib258">
<label>258</label>
<element-citation id="sref258" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doelman</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Bast</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Oxygen radicals in lung pathology</article-title>
<source/>Free Radic. Biol. Med.
          <volume>9</volume>
<issue>5</issue>
<year>1990</year>
<fpage>381</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="pmid">1705530</pub-id>
</element-citation>
</ref>
<ref id="bib259">
<label>259</label>
<element-citation id="sref259" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumagai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Generation of reactive oxygen species during interaction of diesel exhaust particle components with NADPH-cytochrome P450 reductase and involvement of the bioactivation in the DNA damage</article-title>
<source/>Free Radic. Biol. Med.
          <volume>22</volume>
<issue>3</issue>
<year>1997</year>
<fpage>479</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="pmid">8981040</pub-id>
</element-citation>
</ref>
<ref id="bib260">
<label>260</label>
<element-citation id="sref260" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kautzman</surname>
<given-names>K.E.</given-names>
</name>
</person-group>
<article-title>Chemical composition of gas- and aerosol-phase products from the photooxidation of naphthalene</article-title>
<source/>J. Phys. Chem.
          <volume>114</volume>
<issue>2</issue>
<year>2010</year>
<fpage>913</fpage>
<lpage>934</lpage>
</element-citation>
</ref>
<ref id="bib261">
<label>261</label>
<element-citation id="sref261" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>S.N.</given-names>
</name>
</person-group>
<article-title>Ozone oxidation of surface-adsorbed polycyclic aromatic hydrocarbons: role of PAH-surface interaction</article-title>
<source/>J. Am. Chem. Soc.
          <volume>132</volume>
<issue>45</issue>
<year>2010</year>
<fpage>15968</fpage>
<lpage>15975</lpage>
<pub-id pub-id-type="pmid">20973527</pub-id>
</element-citation>
</ref>
<ref id="bib262">
<label>262</label>
<element-citation id="sref262" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Determination of four quinones in diesel exhaust particles, SRM 1649a, an atmospheric PM2.5</article-title>
<source/>Aerosol. Sci. Technol.
          <volume>38</volume>
<year>2004</year>
<fpage>68</fpage>
<lpage>81</lpage>
</element-citation>
</ref>
<ref id="bib263">
<label>263</label>
<element-citation id="sref263" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takano</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice</article-title>
<source/>Am. J. Respir. Crit. Care Med.
          <volume>156</volume>
<issue>1</issue>
<year>1997</year>
<fpage>36</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">9230723</pub-id>
</element-citation>
</ref>
<ref id="bib264">
<label>264</label>
<element-citation id="sref264" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiyoshi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Effects of phenanthraquinone on allergic airway inflammation in mice</article-title>
<source/>Clin. Exp. Allergy
          <volume>35</volume>
<issue>9</issue>
<year>2005</year>
<fpage>1243</fpage>
<lpage>1248</lpage>
<pub-id pub-id-type="pmid">16164454</pub-id>
</element-citation>
</ref>
<ref id="bib265">
<label>265</label>
<element-citation id="sref265" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiyoshi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Effects of a single intratracheal administration of phenanthraquinone on murine lung</article-title>
<source/>J. Appl. Toxicol.
          <volume>25</volume>
<issue>1</issue>
<year>2005</year>
<fpage>47</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="pmid">15669044</pub-id>
</element-citation>
</ref>
<ref id="bib266">
<label>266</label>
<element-citation id="sref266" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugimoto</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>9,10-Phenanthraquinone in diesel exhaust particles downregulates Cu,Zn-SOD and HO-1 in human pulmonary epithelial cells: intracellular iron scavenger 1,10-phenanthroline affords protection against apoptosis</article-title>
<source/>Free Radic. Biol. Med.
          <volume>38</volume>
<issue>3</issue>
<year>2005</year>
<fpage>388</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="pmid">15629867</pub-id>
</element-citation>
</ref>
<ref id="bib267">
<label>267</label>
<element-citation id="sref267" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsunaga</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells</article-title>
<source/>Free Radic. Biol. Med.
          <volume>44</volume>
<issue>6</issue>
<year>2008</year>
<fpage>1191</fpage>
<lpage>1202</lpage>
<pub-id pub-id-type="pmid">18206670</pub-id>
</element-citation>
</ref>
<ref id="bib268">
<label>268</label>
<element-citation id="sref268" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumagai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Oxidation of proximal protein sulfhydryls by phenanthraquinone, a component of diesel exhaust particles</article-title>
<source/>Chem. Res. Toxicol.
          <volume>15</volume>
<issue>4</issue>
<year>2002</year>
<fpage>483</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="pmid">11952333</pub-id>
</element-citation>
</ref>
<ref id="bib269">
<label>269</label>
<element-citation id="sref269" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>C.E.</given-names>
</name>
</person-group>
<article-title>An examination of quinone toxicity using the yeast Saccharomyces cerevisiae model system</article-title>
<source/>Toxicology
          <volume>201</volume>
<issue>1–3</issue>
<year>2004</year>
<fpage>185</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="pmid">15297032</pub-id>
</element-citation>
</ref>
<ref id="bib270">
<label>270</label>
<element-citation id="sref270" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>C.E.</given-names>
</name>
</person-group>
<article-title>The interactions of 9,10-phenanthrenequinone with glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a potential site for toxic actions</article-title>
<source/>Chem. Biol. Interact.
          <volume>155</volume>
<issue>1–2</issue>
<year>2005</year>
<fpage>97</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="pmid">15950210</pub-id>
</element-citation>
</ref>
<ref id="bib271">
<label>271</label>
<element-citation id="sref271" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honda</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Synergic effects of 9,10-phenanthrenequinone and cadmium on pro-inflammatory responses in airway epithelial cells</article-title>
<source/>Environ. Toxicol. Pharmacol.
          <volume>52</volume>
<year>2017</year>
<fpage>276</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="pmid">28477472</pub-id>
</element-citation>
</ref>
<ref id="bib272">
<label>272</label>
<element-citation id="sref272" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moncada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Higgs</surname>
<given-names>E.A.</given-names>
</name>
</person-group>
<article-title>Nitric oxide: physiology, pathophysiology, and pharmacology</article-title>
<source/>Pharmacol. Rev.
          <volume>43</volume>
<issue>2</issue>
<year>1991</year>
<fpage>109</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="pmid">1852778</pub-id>
</element-citation>
</ref>
<ref id="bib273">
<label>273</label>
<element-citation id="sref273" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stuehr</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Structure-function aspects in the nitric oxide synthases</article-title>
<source/>Annu. Rev. Pharmacol. Toxicol.
          <volume>37</volume>
<year>1997</year>
<fpage>339</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="pmid">9131257</pub-id>
</element-citation>
</ref>
<ref id="bib274">
<label>274</label>
<element-citation id="sref274" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumagai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Inhibition of nitric oxide formation by neuronal nitric oxide synthase by quinones: nitric oxide synthase as a quinone reductase</article-title>
<source/>Chem. Res. Toxicol.
          <volume>11</volume>
<issue>6</issue>
<year>1998</year>
<fpage>608</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="pmid">9625728</pub-id>
</element-citation>
</ref>
<ref id="bib275">
<label>275</label>
<element-citation id="sref275" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumagai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Phenanthraquinone inhibits eNOS activity and suppresses vasorelaxation</article-title>
<source/>Am. J. Physiol. Regul. Integr. Comp. Physiol.
          <volume>281</volume>
<issue>1</issue>
<year>2001</year>
<fpage>R25</fpage>
<lpage>R30</lpage>
<pub-id pub-id-type="pmid">11404275</pub-id>
</element-citation>
</ref>
<ref id="bib276">
<label>276</label>
<element-citation id="sref276" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koizumi</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Interaction of 9,10-phenanthraquinone with dithiol causes oxidative modification of Cu,Zn-superoxide dismutase (SOD) through redox cycling</article-title>
<source/>J. Toxicol. Sci.
          <volume>38</volume>
<issue>3</issue>
<year>2013</year>
<fpage>317</fpage>
<lpage>324</lpage>
<pub-id pub-id-type="pmid">23665930</pub-id>
</element-citation>
</ref>
<ref id="bib277">
<label>277</label>
<element-citation id="sref277" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abiko</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Interaction of quinone-related electron acceptors with hydropersulfide Na2S2: evidence for one-electron reduction reaction</article-title>
<source/>Chem. Res. Toxicol.
          <volume>32</volume>
<issue>4</issue>
<year>2019</year>
<fpage>551</fpage>
<lpage>556</lpage>
<pub-id pub-id-type="pmid">30719914</pub-id>
</element-citation>
</ref>
<ref id="bib278">
<label>278</label>
<element-citation id="sref278" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.X.</given-names>
</name>
</person-group>
<article-title>Examination of the mechanism of phenanthrenequinone toxicity to Vibrio fischeri: evidence for a reactive oxygen species-mediated toxicity mechanism</article-title>
<source/>Environ. Toxicol. Chem.
          <volume>28</volume>
<issue>8</issue>
<year>2009</year>
<fpage>1655</fpage>
<lpage>1662</lpage>
<pub-id pub-id-type="pmid">19265456</pub-id>
</element-citation>
</ref>
<ref id="bib279">
<label>279</label>
<element-citation id="sref279" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taguchi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>An approach to evaluate two-electron reduction of 9,10-phenanthraquinone and redox activity of the hydroquinone associated with oxidative stress</article-title>
<source/>Free Radic. Biol. Med.
          <volume>43</volume>
<issue>5</issue>
<year>2007</year>
<fpage>789</fpage>
<lpage>799</lpage>
<pub-id pub-id-type="pmid">17664142</pub-id>
</element-citation>
</ref>
<ref id="bib280">
<label>280</label>
<element-citation id="sref280" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taguchi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Redox cycling of 9,10-phenanthraquinone to cause oxidative stress is terminated through its monoglucuronide conjugation in human pulmonary epithelial A549 cells</article-title>
<source/>Free Radic. Biol. Med.
          <volume>44</volume>
<issue>8</issue>
<year>2008</year>
<fpage>1645</fpage>
<lpage>1655</lpage>
<pub-id pub-id-type="pmid">18294972</pub-id>
</element-citation>
</ref>
<ref id="bib281">
<label>281</label>
<element-citation id="sref281" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asahi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Identification and quantification of in vivo metabolites of 9,10-phenanthrenequinone in human urine associated with producing reactive oxygen species</article-title>
<source/>Chem. Res. Toxicol.
          <volume>27</volume>
<issue>1</issue>
<year>2014</year>
<fpage>76</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">24443938</pub-id>
</element-citation>
</ref>
<ref id="bib282">
<label>282</label>
<element-citation id="sref282" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Role of NRF2 in protection against hyperoxic lung injury in mice</article-title>
<source/>Am. J. Respir. Cell Mol. Biol.
          <volume>26</volume>
<issue>2</issue>
<year>2002</year>
<fpage>175</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="pmid">11804867</pub-id>
</element-citation>
</ref>
<ref id="bib283">
<label>283</label>
<element-citation id="sref283" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maher</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway</article-title>
<source/>Hepatology
          <volume>46</volume>
<issue>5</issue>
<year>2007</year>
<fpage>1597</fpage>
<lpage>1610</lpage>
<pub-id pub-id-type="pmid">17668877</pub-id>
</element-citation>
</ref>
<ref id="bib284">
<label>284</label>
<element-citation id="sref284" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwamoto</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Biochemical and cellular effects of electrophiles present in ambient air samples</article-title>
<source/>Atmos. Environ.
          <volume>44</volume>
<issue>12</issue>
<year>2010</year>
<fpage>1483</fpage>
<lpage>1489</lpage>
</element-citation>
</ref>
<ref id="bib285">
<label>285</label>
<element-citation id="sref285" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinkai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Ambient vapor samples activate the nrf2-ARE pathway in human bronchial epithelial BEAS-2B cells</article-title>
<source/>Environ. Toxicol.
          <volume>29</volume>
<issue>11</issue>
<year>2014</year>
<fpage>1292</fpage>
<lpage>1300</lpage>
<pub-id pub-id-type="pmid">23649983</pub-id>
</element-citation>
</ref>
<ref id="bib286">
<label>286</label>
<element-citation id="sref286" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schübeler</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Function and information content of DNA methylation</article-title>
<source/>Nature
          <volume>517</volume>
<issue>7534</issue>
<year>2015</year>
<fpage>321</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="pmid">25592537</pub-id>
</element-citation>
</ref>
<ref id="bib287">
<label>287</label>
<element-citation id="sref287" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edwards</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>The origins of genomic imprinting in mammals</article-title>
<source/>Reprod. Fertil. Dev.
          <year>2019</year>
</element-citation>
</ref>
<ref id="bib288">
<label>288</label>
<element-citation id="sref288" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Takai</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The role of DNA methylation in mammalian epigenetics</article-title>
<source/>Science
          <volume>293</volume>
<issue>5532</issue>
<year>2001</year>
<fpage>1068</fpage>
<lpage>1070</lpage>
<pub-id pub-id-type="pmid">11498573</pub-id>
</element-citation>
</ref>
<ref id="bib289">
<label>289</label>
<element-citation id="sref289" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2</article-title>
<source/>FEBS Lett.
          <volume>588</volume>
<issue>17</issue>
<year>2014</year>
<fpage>3000</fpage>
<lpage>3007</lpage>
<pub-id pub-id-type="pmid">24928441</pub-id>
</element-citation>
</ref>
<ref id="bib290">
<label>290</label>
<element-citation id="sref290" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fabrizio</surname>
<given-names>F.P.</given-names>
</name>
</person-group>
<article-title>Epigenetic versus genetic deregulation of the KEAP1/NRF2 Axis in solid tumors: focus on methylation and noncoding RNAs</article-title>
<source/>Oxid. Med. Cell. Longev.
          <volume>2018</volume>
<year>2018</year>
<fpage>2492063</fpage>
<pub-id pub-id-type="pmid">29643973</pub-id>
</element-citation>
</ref>
<ref id="bib291">
<label>291</label>
<element-citation id="sref291" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elanchezhian</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Age-related cataracts: homocysteine coupled endoplasmic reticulum stress and suppression of Nrf2-dependent antioxidant protection</article-title>
<source/>Chem. Biol. Interact.
          <volume>200</volume>
<issue>1</issue>
<year>2012</year>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">22964297</pub-id>
</element-citation>
</ref>
<ref id="bib292">
<label>292</label>
<element-citation id="sref292" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palsamy</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Promoter demethylation of Keap1 gene in human diabetic cataractous lenses</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <volume>423</volume>
<issue>3</issue>
<year>2012</year>
<fpage>542</fpage>
<lpage>548</lpage>
<pub-id pub-id-type="pmid">22683333</pub-id>
</element-citation>
</ref>
<ref id="bib293">
<label>293</label>
<element-citation id="sref293" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Human age-related cataracts: epigenetic suppression of the nuclear factor erythroid 2-related factor 2-mediated antioxidant system</article-title>
<source/>Mol. Med. Rep.
          <volume>11</volume>
<issue>2</issue>
<year>2015</year>
<fpage>1442</fpage>
<lpage>1447</lpage>
<pub-id pub-id-type="pmid">25370996</pub-id>
</element-citation>
</ref>
<ref id="bib294">
<label>294</label>
<element-citation id="sref294" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice</article-title>
<source/>PloS One
          <volume>5</volume>
<issue>1</issue>
<year>2010</year>
<fpage>e8579</fpage>
<pub-id pub-id-type="pmid">20062804</pub-id>
</element-citation>
</ref>
<ref id="bib295">
<label>295</label>
<element-citation id="sref295" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>A γ-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation</article-title>
<source/>J. Nutr.
          <volume>142</volume>
<issue>5</issue>
<year>2012</year>
<fpage>818</fpage>
<lpage>823</lpage>
<pub-id pub-id-type="pmid">22457388</pub-id>
</element-citation>
</ref>
<ref id="bib296">
<label>296</label>
<element-citation id="sref296" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation</article-title>
<source/>Cell Death Dis.
          <volume>5</volume>
<issue>4</issue>
<year>2014</year>
<fpage>e1183</fpage>
<pub-id pub-id-type="pmid">24743738</pub-id>
</element-citation>
</ref>
<ref id="bib297">
<label>297</label>
<element-citation id="sref297" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kornberg</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Lorch</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome</article-title>
<source/>Cell
          <volume>98</volume>
<issue>3</issue>
<year>1999</year>
<fpage>285</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="pmid">10458604</pub-id>
</element-citation>
</ref>
<ref id="bib298">
<label>298</label>
<element-citation id="sref298" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huisinga</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Brower-Toland</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Elgin</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>The contradictory definitions of heterochromatin: transcription and silencing</article-title>
<source/>Chromosoma
          <volume>115</volume>
<issue>2</issue>
<year>2006</year>
<fpage>110</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">16506022</pub-id>
</element-citation>
</ref>
<ref id="bib299">
<label>299</label>
<element-citation id="sref299" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ura</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Histone acetylation: influence on transcription, nucleosome mobility and positioning, and linker histone‐dependent transcriptional repression</article-title>
<source/>EMBO J.
          <volume>16</volume>
<issue>8</issue>
<year>1997</year>
<fpage>2096</fpage>
<lpage>2107</lpage>
<pub-id pub-id-type="pmid">9155035</pub-id>
</element-citation>
</ref>
<ref id="bib300">
<label>300</label>
<element-citation id="sref300" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves-Fernandes</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Jasiulionis</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>The role of SIRT1 on DNA damage response and epigenetic alterations in cancer</article-title>
<source/>Int. J. Mol. Sci.
          <volume>20</volume>
<issue>13</issue>
<year>2019</year>
</element-citation>
</ref>
<ref id="bib301">
<label>301</label>
<element-citation id="sref301" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells</article-title>
<source/>Free Radic. Biol. Med.
          <volume>65</volume>
<year>2013</year>
<fpage>528</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="pmid">23891678</pub-id>
</element-citation>
</ref>
<ref id="bib302">
<label>302</label>
<element-citation id="sref302" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>The crosstalk between Sirt1 and Keap1/Nrf2/ARE anti-oxidative pathway forms a positive feedback loop to inhibit FN and TGF-beta1 expressions in rat glomerular mesangial cells</article-title>
<source/>Exp. Cell Res.
          <volume>361</volume>
<issue>1</issue>
<year>2017</year>
<fpage>63</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">28986066</pub-id>
</element-citation>
</ref>
<ref id="bib303">
<label>303</label>
<element-citation id="sref303" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy</article-title>
<source/>Biochim. Biophys. Acta Mol. Cell Res.
          <volume>1866</volume>
<issue>8</issue>
<year>2019</year>
<fpage>1272</fpage>
<lpage>1281</lpage>
<pub-id pub-id-type="pmid">30959066</pub-id>
</element-citation>
</ref>
<ref id="bib304">
<label>304</label>
<element-citation id="sref304" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chai</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Nrf2 activation induced by Sirt1 ameliorates acute lung injury after intestinal ischemia/reperfusion through NOX4-mediated gene regulation</article-title>
<source/>Cell. Physiol. Biochem.
          <volume>46</volume>
<issue>2</issue>
<year>2018</year>
<fpage>781</fpage>
<lpage>792</lpage>
<pub-id pub-id-type="pmid">29621765</pub-id>
</element-citation>
</ref>
<ref id="bib305">
<label>305</label>
<element-citation id="sref305" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDougald</surname>
<given-names>D.S.</given-names>
</name>
</person-group>
<article-title>SIRT1 and NRF2 gene transfer mediate distinct neuroprotective effects upon retinal ganglion cell survival and function in experimental optic neuritis</article-title>
<source/>Invest. Ophthalmol. Vis. Sci.
          <volume>59</volume>
<issue>3</issue>
<year>2018</year>
<fpage>1212</fpage>
<lpage>1220</lpage>
<pub-id pub-id-type="pmid">29494741</pub-id>
</element-citation>
</ref>
<ref id="bib306">
<label>306</label>
<element-citation id="sref306" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Sirt1/Nrf2 pathway is involved in oocyte aging by regulating Cyclin B1</article-title>
<source/>Aging
          <volume>10</volume>
<issue>10</issue>
<year>2018</year>
<fpage>2991</fpage>
<lpage>3004</lpage>
<pub-id pub-id-type="pmid">30368232</pub-id>
</element-citation>
</ref>
<ref id="bib307">
<label>307</label>
<element-citation id="sref307" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Resveratrol ameliorated vascular calcification by regulating sirt-1 and Nrf2</article-title>
<source/>Transplant. Proc.
          <volume>48</volume>
<issue>10</issue>
<year>2016</year>
<fpage>3378</fpage>
<lpage>3386</lpage>
<pub-id pub-id-type="pmid">27931585</pub-id>
</element-citation>
</ref>
<ref id="bib308">
<label>308</label>
<element-citation id="sref308" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ong</surname>
<given-names>A.L.C.</given-names>
</name>
<name>
<surname>Ramasamy</surname>
<given-names>T.S.</given-names>
</name>
</person-group>
<article-title>Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming</article-title>
<source/>Ageing Res. Rev.
          <volume>43</volume>
<year>2018</year>
<fpage>64</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">29476819</pub-id>
</element-citation>
</ref>
<ref id="bib309">
<label>309</label>
<element-citation id="sref309" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Manganese chloride induces histone acetylation changes in neuronal cells: its role in manganese-induced damage</article-title>
<source/>Neurotoxicology
          <volume>65</volume>
<year>2018</year>
<fpage>255</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="pmid">29155171</pub-id>
</element-citation>
</ref>
<ref id="bib310">
<label>310</label>
<element-citation id="sref310" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Role of histone acetylation in activation of nuclear factor erythroid 2-related factor 2/heme oxygenase 1 pathway by manganese chloride</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <volume>336</volume>
<year>2017</year>
<fpage>94</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="pmid">29054681</pub-id>
</element-citation>
</ref>
<ref id="bib311">
<label>311</label>
<element-citation id="sref311" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercado</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <volume>406</volume>
<issue>2</issue>
<year>2011</year>
<fpage>292</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="pmid">21320471</pub-id>
</element-citation>
</ref>
<ref id="bib312">
<label>312</label>
<element-citation id="sref312" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adenuga</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <volume>403</volume>
<issue>3–4</issue>
<year>2010</year>
<fpage>452</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="pmid">21094147</pub-id>
</element-citation>
</ref>
<ref id="bib313">
<label>313</label>
<element-citation id="sref313" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Histone deacetylase 6–mediated selective autophagy regulates COPD-associated cilia dysfunction</article-title>
<source/>J. Clin. Invest.
          <volume>123</volume>
<issue>12</issue>
<year>2013</year>
<fpage>5212</fpage>
<lpage>5230</lpage>
<pub-id pub-id-type="pmid">24200693</pub-id>
</element-citation>
</ref>
<ref id="bib314">
<label>314</label>
<element-citation id="sref314" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chase</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Aberrations of EZH2 in cancer</article-title>
<source/>Clin. Canc. Res.
          <volume>17</volume>
<issue>9</issue>
<year>2011</year>
<fpage>2613</fpage>
<lpage>2618</lpage>
</element-citation>
</ref>
<ref id="bib315">
<label>315</label>
<element-citation id="sref315" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruthenburg</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Allis</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Wysocka</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark</article-title>
<source/>Mol. Cell
          <volume>25</volume>
<issue>1</issue>
<year>2007</year>
<fpage>15</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">17218268</pub-id>
</element-citation>
</ref>
<ref id="bib316">
<label>316</label>
<element-citation id="sref316" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M.-M.</given-names>
</name>
</person-group>
<article-title>The role of human bromodomains in chromatin biology and gene transcription</article-title>
<source/>Curr. Opin. Drug Discov. Dev
          <volume>12</volume>
<issue>5</issue>
<year>2009</year>
<fpage>659</fpage>
</element-citation>
</ref>
<ref id="bib317">
<label>317</label>
<element-citation id="sref317" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michaeloudes</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Bromodomain and extraterminal proteins suppress NF-E2–Related factor 2–mediated antioxidant gene expression</article-title>
<source/>J. Immunol.
          <volume>192</volume>
<issue>10</issue>
<year>2014</year>
<fpage>4913</fpage>
<lpage>4920</lpage>
<pub-id pub-id-type="pmid">24733848</pub-id>
</element-citation>
</ref>
<ref id="bib318">
<label>318</label>
<element-citation id="sref318" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miguel</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>The role of MicroRNAs in environmental risk factors, noise-induced hearing loss, and mental stress</article-title>
<source/>Antioxidants Redox Signal.
          <volume>28</volume>
<issue>9</issue>
<year>2018</year>
<fpage>773</fpage>
<lpage>796</lpage>
</element-citation>
</ref>
<ref id="bib319">
<label>319</label>
<element-citation id="sref319" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism</article-title>
<source/>Breast Canc. Res. Treat.
          <volume>129</volume>
<issue>3</issue>
<year>2011</year>
<fpage>983</fpage>
<lpage>991</lpage>
</element-citation>
</ref>
<ref id="bib320">
<label>320</label>
<element-citation id="sref320" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>MicroRNA-155 regulates arsenite-induced malignant transformation by targeting Nrf2-mediated oxidative damage in human bronchial epithelial cells</article-title>
<source/>Toxicol. Lett.
          <volume>278</volume>
<year>2017</year>
<fpage>38</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="pmid">28688901</pub-id>
</element-citation>
</ref>
<ref id="bib321">
<label>321</label>
<element-citation id="sref321" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>MicroRNA-144 modulates oxidative stress tolerance in SH-SY5Y cells by regulating nuclear factor erythroid 2-related factor 2-glutathione axis</article-title>
<source/>Neurosci. Lett.
          <volume>655</volume>
<year>2017</year>
<fpage>21</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">28663050</pub-id>
</element-citation>
</ref>
<ref id="bib322">
<label>322</label>
<element-citation id="sref322" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis</article-title>
<source/>Carcinogenesis
          <volume>34</volume>
<issue>5</issue>
<year>2013</year>
<fpage>1165</fpage>
<lpage>1172</lpage>
<pub-id pub-id-type="pmid">23492819</pub-id>
</element-citation>
</ref>
<ref id="bib323">
<label>323</label>
<element-citation id="sref323" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narasimhan</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells</article-title>
<source/>PloS One
          <volume>7</volume>
<issue>12</issue>
<year>2012</year>
<fpage>e51111</fpage>
<pub-id pub-id-type="pmid">23236440</pub-id>
</element-citation>
</ref>
<ref id="bib324">
<label>324</label>
<element-citation id="sref324" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>miR-340 reverses cisplatin resistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway</article-title>
<source/>Asian Pac. J. Cancer Prev. APJCP
          <volume>15</volume>
<issue>23</issue>
<year>2015</year>
<fpage>10439</fpage>
<lpage>10444</lpage>
</element-citation>
</ref>
<ref id="bib325">
<label>325</label>
<element-citation id="sref325" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qaisiya</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway</article-title>
<source/>Cell. Signal.
          <volume>26</volume>
<issue>3</issue>
<year>2014</year>
<fpage>512</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="pmid">24308969</pub-id>
</element-citation>
</ref>
<ref id="bib326">
<label>326</label>
<element-citation id="sref326" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism</article-title>
<source/>Exp. Cell Res.
          <volume>360</volume>
<issue>2</issue>
<year>2017</year>
<fpage>292</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="pmid">28928081</pub-id>
</element-citation>
</ref>
<ref id="bib327">
<label>327</label>
<element-citation id="sref327" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Paraquat and MPTP alter microRNA expression profiles, and downregulated expression of miR‐17‐5p contributes to PQ‐induced dopaminergic neurodegeneration</article-title>
<source/>J. Appl. Toxicol.
          <volume>38</volume>
<issue>5</issue>
<year>2018</year>
<fpage>665</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="pmid">29250806</pub-id>
</element-citation>
</ref>
<ref id="bib328">
<label>328</label>
<element-citation id="sref328" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Nrf2-regulated miR-380-3p blocks the translation of Sp3 protein and its mediation of paraquat-induced toxicity in mouse neuroblastoma N2a cells</article-title>
<source/>Toxicol. Sci.
          <volume>171</volume>
<issue>2</issue>
<year>2019</year>
<fpage>515</fpage>
<lpage>529</lpage>
</element-citation>
</ref>
<ref id="bib329">
<label>329</label>
<element-citation id="sref329" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Jaarsveld</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells</article-title>
<source/>Oncogene
          <volume>32</volume>
<issue>36</issue>
<year>2013</year>
<fpage>4284</fpage>
<pub-id pub-id-type="pmid">23045278</pub-id>
</element-citation>
</ref>
<ref id="bib330">
<label>330</label>
<element-citation id="sref330" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>N.M.</given-names>
</name>
</person-group>
<article-title>Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer</article-title>
<source/>Genome Biol.
          <volume>15</volume>
<issue>8</issue>
<year>2014</year>
<fpage>429</fpage>
<pub-id pub-id-type="pmid">25116943</pub-id>
</element-citation>
</ref>
<ref id="bib331">
<label>331</label>
<element-citation id="sref331" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidlin</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Redox regulation by NRF2 in aging and disease</article-title>
<source/>Free Radic. Biol. Med.
          <volume>134</volume>
<year>2019</year>
<fpage>702</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="pmid">30654017</pub-id>
</element-citation>
</ref>
<ref id="bib332">
<label>332</label>
<element-citation id="sref332" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahn</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jo</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Therapeutic approaches to alzheimer's disease through modulation of NRF2</article-title>
<source/>NeuroMolecular Med.
          <volume>21</volume>
<issue>1</issue>
<year>2019</year>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">30617737</pub-id>
</element-citation>
</ref>
<ref id="bib333">
<label>333</label>
<element-citation id="sref333" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satta</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The role of Nrf2 in cardiovascular function and disease</article-title>
<source/>Oxid. Med. Cell. Longev.
          <volume>2017</volume>
<year>2017</year>
<fpage>9237263</fpage>
<pub-id pub-id-type="pmid">29104732</pub-id>
</element-citation>
</ref>
<ref id="bib334">
<label>334</label>
<element-citation id="sref334" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sim</surname>
<given-names>H.-J.</given-names>
</name>
</person-group>
<article-title>Glucose oxidase facilitates osteogenic differentiation and mineralization of embryonic stem cells through the activation of Nrf2 and ERK signal transduction pathways</article-title>
<source/>Mol. Cell. Biochem.
          <volume>419</volume>
<issue>1–2</issue>
<year>2016</year>
<fpage>157</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="pmid">27431005</pub-id>
</element-citation>
</ref>
<ref id="bib335">
<label>335</label>
<element-citation id="sref335" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freigang</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis</article-title>
<source/>Eur. J. Immunol.
          <volume>41</volume>
<issue>7</issue>
<year>2011</year>
<fpage>2040</fpage>
<lpage>2051</lpage>
<pub-id pub-id-type="pmid">21484785</pub-id>
</element-citation>
</ref>
<ref id="bib336">
<label>336</label>
<element-citation id="sref336" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerins</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Ooi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The roles of NRF2 in modulating cellular iron homeostasis</article-title>
<source/>Antioxidants Redox Signal.
          <volume>29</volume>
<issue>17</issue>
<year>2018</year>
<fpage>1756</fpage>
<lpage>1773</lpage>
</element-citation>
</ref>
<ref id="bib337">
<label>337</label>
<element-citation id="sref337" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdelsalam</surname>
<given-names>S.S.</given-names>
</name>
</person-group>
<article-title>The role of protein tyrosine phosphatase (PTP)-1B in cardiovascular disease and its interplay with insulin resistance</article-title>
<source/>Biomolecules
          <volume>9</volume>
<issue>7</issue>
<year>2019</year>
</element-citation>
</ref>
<ref id="bib338">
<label>338</label>
<element-citation id="sref338" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>PTEN, insulin resistance and cancer</article-title>
<source/>Curr. Pharmaceut. Des.
          <volume>23</volume>
<issue>25</issue>
<year>2017</year>
<fpage>3667</fpage>
<lpage>3676</lpage>
</element-citation>
</ref>
<ref id="bib339">
<label>339</label>
<element-citation id="sref339" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Goel</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Mahdi</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update</article-title>
<source/>J. Mol. Endocrinol.
          <volume>53</volume>
<issue>3</issue>
<year>2014</year>
<fpage>R103</fpage>
<lpage>R118</lpage>
<pub-id pub-id-type="pmid">25312969</pub-id>
</element-citation>
</ref>
<ref id="bib340">
<label>340</label>
<element-citation id="sref340" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>El-Sabban</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Naim</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>The HSP90 family: structure, regulation, function, and implications in health and disease</article-title>
<source/>Int. J. Mol. Sci.
          <volume>19</volume>
<issue>9</issue>
<year>2018</year>
</element-citation>
</ref>
<ref id="bib341">
<label>341</label>
<element-citation id="sref341" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomez-Pastor</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Burchfiel</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Thiele</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Regulation of heat shock transcription factors and their roles in physiology and disease</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <volume>19</volume>
<issue>1</issue>
<year>2018</year>
<fpage>4</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="pmid">28852220</pub-id>
</element-citation>
</ref>
<ref id="bib342">
<label>342</label>
<element-citation id="sref342" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogeley</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Role of the aryl hydrocarbon receptor in environmentally induced skin aging and skin carcinogenesis</article-title>
<source/>Int. J. Mol. Sci.
          <volume>20</volume>
<issue>23</issue>
<year>2019</year>
</element-citation>
</ref>
<ref id="bib343">
<label>343</label>
<element-citation id="sref343" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Gut dysbiosis in animals due to environmental chemical exposures</article-title>
<source/>Front. Cell. Infect. Microbiol.
          <volume>7</volume>
<year>2017</year>
<fpage>396</fpage>
<pub-id pub-id-type="pmid">28936425</pub-id>
</element-citation>
</ref>
<ref id="bib344">
<label>344</label>
<element-citation id="sref344" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Metabolomics and microbiomes as potential tools to evaluate the effects of the mediterranean diet</article-title>
<source/>Nutrients
          <volume>11</volume>
<issue>1</issue>
<year>2019</year>
</element-citation>
</ref>
<ref id="bib345">
<label>345</label>
<element-citation id="sref345" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirata</surname>
<given-names>S.I.</given-names>
</name>
<name>
<surname>Kunisawa</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Gut microbiome, metabolome, and allergic diseases</article-title>
<source/>Allergol. Int.
          <volume>66</volume>
<issue>4</issue>
<year>2017</year>
<fpage>523</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="pmid">28693971</pub-id>
</element-citation>
</ref>
<ref id="bib346">
<label>346</label>
<element-citation id="sref346" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Mass spectrometry-based proteomics for system-level characterization of biological responses to engineered nanomaterials</article-title>
<source/>Anal. Bioanal. Chem.
          <volume>410</volume>
<issue>24</issue>
<year>2018</year>
<fpage>6067</fpage>
<lpage>6077</lpage>
<pub-id pub-id-type="pmid">29947897</pub-id>
</element-citation>
</ref>
</ref-list>
<ack id="ack0010">
<title>Acknowledgments</title>
<p>We thank Leo Holroyd, PhD, from Edanz Group (<ext-link ext-link-type="uri" id="intref0010" xlink:href="http://www.edanzediting.com/ac">www.edanzediting.com/ac</ext-link>) for editing a part of this manuscript.</p>
</ack>
</back>
</article>
</pmc-articleset>